<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="2.0" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">

<channel>
<title cf:type="text">American Conference Institute</title>
<link>http://www.americanconference.com/</link>
<description cf:type="text">Business Information In A Global Context</description>
<copyright>C5 Group Inc.</copyright>
<category>Education/Conferences</category>
<image>
<url>http://www.americanconference.com/images/rss/aci.png</url>
<title>American Conference Institute</title>
<link>http://www.americanconference.com/</link>
</image>


<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Life Sciences Collaborative Agreements &amp; Acquisitions</title>
<link>http://www.americanconference.com/2012/875/life-sciences-collaborative-agreements--acquisitions/</link>
<pubDate>Mon 27 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | With future success dependent on building successful partnerships, attend &lt;b&gt;ACI's 16th Advanced Forum on Structuring, Negotiating and Managing Life Sciences Collaborative Agreements and Acquisitions&lt;/b&gt; to learn how to be able to secure the best terms available for meeting your company's critical needs. A front line faculty of leading deal-makers will help you to develop a dynamic alliance strategy and negotiate successful and lucrative deals.&lt;br&gt;&lt;br&gt;You will learn best practices that will enable your company to advance its key business development strategies, including putting more products in the pipeline and providing for jumpstarts in revenues. Specific guidance will be provided on how to structure transactions to allow for &lt;b&gt;entry into important emerging markets&lt;/b&gt;, and on building flexible provisions for &lt;b&gt;potential future M&amp;amp;A&lt;/b&gt; into your agreements. You will learn how to structure options and payments in alternative ways to meet specific financial needs, and to provide for the sharing of costs and risks relating to clinical trial results and securing regulatory approvals. In addition, special insights will be provided for overcoming the unique challenges raised by negotiating with different types of &lt;b&gt;research institutions.&lt;/b&gt;&lt;br&gt;&lt;br&gt;While collaborations can be used to replenish pipelines and open up emerging areas, potential partners are increasingly seeking to retain valuable product rights, and power dynamics make it difficult to secure licenses or market access without granting potentially lucrative co-development options. In addition, international competition is increasing, markets are changing, and M&amp;amp;A activity is heating up again and must be factored into any negotiation going forward. &lt;br&gt;&lt;br&gt;Add significant value to your experience by attending our Post-Conference &lt;b&gt;Master Class&lt;/b&gt;: &lt;i&gt;&lt;b&gt;Life Sciences M&amp;amp;A/Strategic Alliances Due Diligence Boot Camp&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;br&gt;This in-depth session will help ensure that you make informed decisions regarding how the IP at issue will increase the company's overall value, either by expanding product lines or entering new markets. Special attention will also be paid to antitrust and other legal risks that may occur when the diligence process fails to sufficiently identify areas of current government concern and inquiries. &lt;br&gt;&lt;br&gt;Register now for this timely event by calling &lt;b&gt;888.224.2480&lt;/b&gt;; by faxing your registration form to &lt;b&gt;877.927.1563&lt;/b&gt;; or registering online at &lt;b&gt;www.americanconference.com/collab2012&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/875/life-sciences-collaborative-agreements--acquisitions/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">ITC Litigation &amp; Enforcement</title>
<link>http://www.americanconference.com/2012/850/itc-litigation--enforcement/</link>
<pubDate>Mon 27 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;br&gt;&lt;div style=&quot;text-align: center;&quot;&gt;&lt;img src=&quot;http://www.americanconference.com/images/speakers/JudgeLuckern.jpg&quot;&gt;&lt;br&gt;&lt;br&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:1;
	mso-tstyle-colband-size:1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;}
&lt;/style&gt;
&lt;![endif]--&gt;

&lt;p&gt;The American Conference Institute
dedicates this conference to the memory of the Honorable Paul J. Luckern. &lt;br&gt;&lt;br&gt;

We offer our deepest condolences
to Judge Luckern's family and friends.&lt;/p&gt;
&lt;hr&gt;
&lt;/div&gt;
&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Section 337 litigation is set to surpass yet another record this year. &lt;/b&gt;&lt;br&gt;&lt;b&gt;How will your company or client benefit from the speedy results offered by Section 337?&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;As the ITC braces for what is expected to be another year of record filings, one fact is clear ? the ITC has quickly become the new &quot;rocket docket.&quot; Despite talk of the continued strain on resources at the ITC, companies across industries continue to view the International Trade Commission as the most valuable forum for quickly resolving high-stakes IP infringement disputes. Offering great benefits for patent holders while creating tremendous challenges for those who sit on the opposing side, one must come to the ITC &lt;u&gt;well-equipped to litigate under the highest pressure in order to achieve success.&lt;/u&gt;&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Be a part of the one annual event that shapes ITC practice.&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;The &lt;i&gt;4th annual&lt;/i&gt; installment of &lt;b&gt;American Conference Institute's&lt;/b&gt; &lt;i&gt;Expert Forum&lt;/i&gt; on ITC Litigation &amp;amp; Enforcement will provide attendees with a combination of insider insights and in-depth practical guidance from an industry-leading faculty of judges, senior ITC officials and expert litigators in the field.&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Network and benchmark with your peers while getting updated on key legal issues impacting Section 337 investigation&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;b&gt;New for this year:&lt;/b&gt;&lt;br&gt;&lt;br&gt;? A special &lt;i&gt;two-session&lt;/i&gt;&lt;b&gt;&lt;i&gt; Focus on Customs Enforcement&lt;/i&gt;&lt;/b&gt; that will address &lt;b&gt;Proposed Initiatives Relevant to the Enforcement of ITC Exclusion Orders&lt;/b&gt; as well as insights into &lt;b&gt;How to Successfully Seek Enforcement of ITC Exclusion Orders and Address Re-Designs and Work Arounds&lt;/b&gt;&lt;br&gt;&lt;br&gt;The one and only forum for practitioners in the industry to get updated on current issues impacting practice before the ITC, learn how to master the unique procedures and nuances of ITC practice while getting updated on the evolution of key legal issues impacting Section 337 investigations. &lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>International Trade</category>
<category>Litigation</category>
<category>Intellectual Property</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/850/itc-litigation--enforcement/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Contracting in Iraq &amp; Afghanistan</title>
<link>http://www.americanconference.com/2012/853/contracting-in-iraq--afghanistan/</link>
<pubDate>Mon 27 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Benchmark with Experts from the U.S., Iraq and Afghanistan on Minimizing Emerging Legal,  Compliance and Security Risks in Rapid-Response Environments&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;As the United States draws down its forces in Iraq and continues its military and stabilization operations in Afghanistan, contractors face the daunting task of complying with U.S. and local laws and customs to compete effectively during this time of development in the region. There is heavy reliance on contractors to help stabilize the area and establish reconstruction efforts from building roads and hospitals, to setting up satellite communications and providing security to ensure contract performance.&lt;/p&gt;
&lt;p&gt;At &lt;strong&gt;American Conference Institute's 2nd National Summit on Contingency Contracting in Iraq &amp;amp; Afghanistan&lt;/strong&gt;, you will have the rare opportunity to hear from &lt;strong&gt;Iraqi and US Government officials&lt;/strong&gt;, a local&lt;strong&gt; Afghan &lt;/strong&gt;tax expert, the former General Counsel from the Commission on Wartime Contracting in Iraq and Afghanistan, along with senior level executives from a broad range of companies doing business in these countries and other contingency environments. Building off the success of last year's program, you will have the unique opportunity to benchmark your practices with other companies that have been doing business in these countries for over a decade. The networking and business development opportunities that you will gain at this conference are invaluable as reconstruction efforts continue in the region.&lt;/p&gt;
&lt;p&gt;Critical topics will include:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; How	the	Commission on Wartime Contracting Final Report to Congress will impact contractor's daily work flow on existing and future contracts&lt;/li&gt;
  &lt;li&gt; The	future	&quot;non-use&quot; of private security contractors by local governments&lt;/li&gt;
  &lt;li&gt; Addressing	unsettled	claims,	audits,	and	disputes	amid	the	drawdown	of troops in Iraq, and the transition to the Department of State&lt;/li&gt;
  &lt;li&gt; Update	on	major	defenses	to	&quot;contractors	on	the	battlefield&quot;	cases	and	the DBA, the political question doctrine, and the combatant activities exception&lt;/li&gt;
  &lt;li&gt;Maintaining	adequate record-keeping and documentation  in contingency environments&lt;/li&gt;
  &lt;li&gt; Managing	conflicts	between	FCPA requirements and local laws, customs and regulations&lt;/li&gt;
  &lt;li&gt; Preventing contract performance delays in a rapid response environment&lt;/li&gt;
  &lt;li&gt; A	roundtable	discussion	on	meeting	emerging,	complex procurement and compliance challenges in the Middle East and Africa&lt;/li&gt;
  &lt;li&gt; What	recent	DCAA audits tell us about compliance expectations  for battlespace contractors going forward&lt;/li&gt;
  &lt;li&gt; Incorporating	ITAR, EAR and sanctions compliance into your contingency contracting compliance strategy&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;PLUS! Don't miss our practical, highly specialized post-conference working groups, designed to deliver proven-effective strategies to be implemented immediately in your daily work flow. Learn from working group leaders who bring their on-the-ground experiences to these sessions, and allow for an	intimate	setting	for	all	of	your	specific	and	most	pressing	challenges.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A: &lt;/strong&gt;A Complete Roadmap to Resolving Logistical, Operational and Contract Performance Challenges in Iraq: From Business Registration to Working with Local Authorities and Establishing Satellite Communications&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B:&lt;/strong&gt;  A Deep Dive into Afghanistan Culture, Customs and Contract Dispute	Resolution:	How	to	Work	with	Local	Elders,	and	Address	Unique Transportation, Security and Import Challenges to Ensure Contract Performance&lt;/p&gt;
&lt;p&gt;Due to popular demand, seats are expected to sell out. Register by calling &lt;strong&gt;888.224.2480&lt;/strong&gt;; fax your registration form to &lt;strong&gt;877-927-1563&lt;/strong&gt; or register online at &lt;strong&gt;www.AmericanConference.com/Battlespace.&lt;/strong&gt;&lt;/p&gt;
&lt;br&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/853/contracting-in-iraq--afghanistan/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">ITAR Boot Camp</title>
<link>http://www.americanconference.com/2012/874/itar-boot-camp/</link>
<pubDate>Tue 28 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Diego | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Attend this
Critically-Acclaimed ITAR Boot Camp and Benefit from Practical Discussions and
Unique Industry Benchmarking.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;/b&gt;&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Whether You are
a Large, Mid-Size or Small Company, You Will Gain Best Practices for Managing the
Most Critical ITAR Compliance Risks Impacting Your Business!&lt;/span&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-font-weight:bold&quot; lang=&quot;EN-GB&quot;&gt;U.S.&lt;b&gt;
&lt;/b&gt;officials are stepping up ITAR enforcement&lt;/span&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB;mso-fareast-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt; across the globe,&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;mso-bidi-font-weight:bold&quot;&gt;slapping&lt;/span&gt; &lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;harsh civil penalties&lt;/b&gt; &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;on
companies&lt;/b&gt; and, in some cases, &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;cracking
down on empowered officials and executives for criminal liability&lt;/b&gt;.&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;Large, mid-size &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;and&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt; small companies&lt;/b&gt; that deal with defense articles services or
related &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;technical data&lt;/b&gt; must ensure
that their export practices and &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;global
supply chains&lt;/b&gt; comply with the U.S. &lt;i&gt;International Traffic in Arms
Regulations &lt;/i&gt;(&quot;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;ITAR&lt;/b&gt;&quot;).&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB;mso-fareast-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;

&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;An exporter that does not have a handle on key
requirements can &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;unknowingly violate
strict provisions of the ITAR&lt;/b&gt; - and incorrectly assume that their articles,
technical data or services aren't even subject to the ITAR!&amp;nbsp; &lt;/p&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&lt;/span&gt;&lt;/span&gt;

&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB;mso-fareast-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Back in San Diego by popular demand, &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;American Conference Institute&lt;/b&gt;'s
acclaimed &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;ITAR Boot Camp&lt;/b&gt; is an
in-depth, practical course on the nuts and bolts of ITAR compliance. &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;

&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Senior ITAR
compliance executives and attorneys&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt; will teach you how to overcome your &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;practical, real-life ITAR compliance
challenges&lt;/b&gt;, and update you on the latest&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt; policy&lt;/b&gt;, regulatory and enforcement developments. This course will
allow for ample Q &amp;amp; A, hands-on exercises and case studies, and will
provide you with &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;valuable
speaker-prepared materials that you can reference in your daily work&lt;/b&gt;.&lt;/span&gt;

&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;u&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Critical topics will include:&lt;/span&gt;&lt;/u&gt;

&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;u&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;span style=&quot;text-decoration:none&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;How to comply with new&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;
foreign, dual and third country national, and Form I-129 certification &lt;/b&gt;requirements
within foreign anti-discrimination and privacy law limits

&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-font-weight:
bold&quot; lang=&quot;EN-GB&quot;&gt;&lt;span style=&quot;mso-list:Ignore&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;mso-ansi-language:EN-GB;
mso-fareast-language:EN-GB;mso-bidi-font-weight:bold&quot; lang=&quot;EN-GB&quot;&gt;Identify ITAR-controlled &lt;b&gt;technical
data &lt;/b&gt;and&lt;b&gt; defense services &lt;/b&gt;amid pending&lt;b&gt; regulatory changes&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;

&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;How to satisfy&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt; DDTC and DTSA expectations&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;for
TAAs and MLAs&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;

&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Preparing &lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;DSP-5s, DSP-73s
and DSP-61s&lt;/b&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;, &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;and preventing harsh penalties for misuse of &lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;exemptions&lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot;&gt;

&lt;/p&gt;

&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Building &lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span lang=&quot;EN-GB&quot;&gt;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;an effective ITAR compliance program, &lt;/b&gt;and
refining your policies, manuals and guidelines to meet heightened compliance
risks&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;

&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Minimize &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;global supply chain
risks &lt;/b&gt;through&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt; end-use/end-user&lt;/b&gt;
and &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;third party&lt;/b&gt; screening &lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Investigating suspected or actual ITAR
violations, &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;and how to
draft a &lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;voluntary disclosure &lt;/b&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;

&lt;p class=&quot;MsoNormalCxSpFirst&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:
EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;span style=&quot;mso-bidi-font-family:
AGaramond-Semibold;color:#6E0000&quot;&gt;&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;&lt;span style=&quot;mso-bidi-font-family:AGaramond-Semibold&quot;&gt;PLUS! New
sessions for 2011:&lt;/span&gt;&lt;/b&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal;mso-layout-grid-align:none;text-autospace:none&quot;&gt;

&lt;/p&gt;&lt;ol&gt;&lt;li&gt;&lt;span style=&quot;mso-bidi-font-family:
AGaramond-Semibold;color:#6E0000&quot;&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;Empowered
Official Roundtable Discussion: &lt;/b&gt;How to manage responsibilities, and reduce personal
liability risks for ITAR &lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp;&lt;/span&gt;violations&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&lt;/span&gt;&lt;span style=&quot;&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;b style=&quot;mso-bidi-font-weight:normal&quot;&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;Training &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;mso-bidi-font-family:
&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;your global sales, engineering,
purchasing and other teams to support your ITAR compliance efforts&lt;/span&gt;&lt;span style=&quot;&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;
mso-bidi-font-family:&amp;quot;Times New Roman&amp;quot;;mso-ansi-language:EN-GB&quot; lang=&quot;EN-GB&quot;&gt;&lt;/span&gt;Complying with&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt;&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;ITAR recordkeeping&lt;span style=&quot;mso-spacerun:yes&quot;&gt;&amp;nbsp; &lt;/span&gt;&lt;/b&gt;requirementsSatisfying&lt;b style=&quot;mso-bidi-font-weight:
normal&quot;&gt; re-export and re-transfer&lt;/b&gt; restriction

&lt;br&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p class=&quot;MsoListParagraphCxSpMiddle&quot; style=&quot;margin-bottom:0in;margin-bottom:
.0001pt;mso-add-space:auto;line-height:normal&quot;&gt;

&lt;/p&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/874/itar-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Medical Device Patents</title>
<link>http://www.americanconference.com/2012/705/medical-device-patents/</link>
<pubDate>Tue 28 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Boston | &lt;br&gt;&lt;i&gt;&lt;b&gt;?Finally, a forum dedicated solely to the challenges and opportunities facing medical device patent practitioners in the post-patent reform world...&lt;/b&gt;&lt;/i&gt;&lt;br&gt;A medical device specific intellectual property conference to provide you with practical and tactical strategies for patent filings and challenges, which are more critical than ever in this time of sweeping change.&lt;br&gt;&lt;br&gt;&lt;b&gt;Arm yourself with the tools to file device patents flawlessly and defend patents vigorously.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Amidst pivotal case law changes affecting the patentability of devices and landmark patent reform legislation, it is more crucial than ever for medical device companies to diligently protect intellectual property and maximize device patent life through a cohesive prosecution and litigation strategy. In response to the challenges facing the device industry in this daunting economic climate including the looming medical device tax, ACI's Advanced Summit on Medical Device Patents provides a forum for the key players- preeminent in-house IP counsel, patent prosecutors and litigators, the PTO, and judges - to unite and share their collective knowledge to provide you with the most up to date strategies you can immediately incorporate into your practice. Featuring first-hand insight from the USPTO and retired judges in medical device litigation hotbeds including the Eastern District of Texas, this event is the premiere conference for medical device companies to devise strategies to strengthen patent rights and seize market share.&lt;br&gt;&lt;br&gt;&lt;b&gt;Remain competitive in this constantly burgeoning market and strengthen your device patent portfolio&lt;/b&gt;&lt;br&gt;&lt;br&gt;Learn how to use the major developments in prosecution and litigation from leading members of the patent bar who are setting the standards in the device industry, including representatives from&lt;i&gt; Boston Scientific, C.R. Bard &amp;amp; Medtronic&lt;/i&gt;. Complete your training by attending the pre-conference session designed to prepare both prosecutors and litigators for the entire process of getting a device to the market, The 510(k) Process and Patentability: Reformulating Patent Strategies in Light of Changes in the Regulatory Approval Process.&lt;br&gt;&lt;b&gt;&lt;br&gt;Capitalize on an epic and international opportunity for global growth.&lt;/b&gt;&lt;br&gt;&lt;br&gt;While this is a time of great challenges for device companies, there is also a sky-high potential for growth in both domestic and previously untapped global markets. Indeed, a leading industry report estimated that the device industry was worth more than $300 billion in 2011 with the U.S. representing the largest market with sales in excess of $95 billion. At this conference, expert international and domestic practitioners will arm you with the tools to heighten patent protection in both established and emerging markets.&lt;br&gt;&lt;br&gt;Do not miss your chance to be part of the most in-depth and comprehensive conference analyzing and strategizing techniques to protect your medical device patent portfolio amidst rapidly-evolving industry standards.&lt;br&gt;&lt;br&gt;&amp;nbsp;Register today by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your form to &lt;b&gt;877-927-1563 &lt;/b&gt;or online at &lt;b&gt;&lt;a href=&quot;http://www.AmericanConference.com/devicepatents&quot;&gt;www.AmericanConference.com/devicepatents&lt;/a&gt;&lt;/b&gt;.&lt;br&gt;&lt;br&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/705/medical-device-patents/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Managing Third Party &amp; Counterparty Relationship Risks</title>
<link>http://www.americanconference.com/2012/693/managing-third-party--counterparty-relationship-risks/</link>
<pubDate>Tue 28 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">London | &lt;p style=&quot;text-align: left; &quot;&gt;&lt;/p&gt;&lt;p&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;font-size: 12px; &quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;In an age of increasingly globalised trade, companies are having to outsource more and more of their business operations to maximize productivity, profitability and growth. With this increased reliance on external suppliers and partners comes the increased risk that their acts and omissions will expose your company not only to commercial risks of loss of profit or reputation but compliance risks associated with global sanctions and export control requirements and fraud, bribery and corruption.&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;font-size: 12px; text-align: center; &quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;Managing Third Party and Counterparty Relationship Risks&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;font-size: 12px; &quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;&lt;u&gt;5 Reasons You Can't Afford to Miss C5's comprehensive forum on strategies for managing all third party relationship risks across all sectors:&lt;/u&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;font-size: 12px; &quot;&gt;&lt;/p&gt;&lt;ol&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;Benefit from getting inside guidance from senior in-house counsels from over 20 leading multinational companies:&lt;/b&gt; Exclusively hear the latest insights and experiences from top level in-house compliance experts as they walk you through all possible red flags and compliance risks which can occur from initial third party negotiations and due diligence right through to post-contract termination.&amp;nbsp;&lt;br&gt;&lt;br&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;A true cross-industry networking opportunity:&lt;/b&gt; This industry-led conference brings together representatives from across manufacturing, shipping, pharmaceutical, oil &amp;amp; gas, defence and aerospace, food production, telecommunications and financial services industries to discuss the biggest compliance risk facing their respective sectors today ? third parties. &amp;nbsp;&lt;br&gt;&lt;br&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;Exclusive UK SFO insights regarding the enforcement of anti-corruption and bribery legislation:&lt;/b&gt; &lt;u&gt;&lt;i&gt;Rosemary Donnabella, Head of Policy from the UK Serious Fraud Office&lt;/i&gt;&lt;/u&gt; joins the speaker faculty to discuss the latest investigations, what those companies under scrutiny did to come under the spotlight and what your company can do to avoid the same fate.&amp;nbsp;&lt;br&gt;&lt;br&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;Special Interactive Workshop Sessions:&lt;/b&gt; &amp;nbsp;Post-Conference Interactive Workshops: Thursday 1 March 2012: If your business has operations in Africa, ensure you don't miss C5's tailor-made session on &lt;b&gt;&quot;Tailored Due Diligence Investigations to Address Local Content and Other Specific Risks in Africa&quot;&lt;/b&gt; involving an in-depth introduction to local content requirements across African nations and how your company can overcome the associated risks &amp;nbsp;&lt;b&gt;AND/OR&lt;/b&gt; &amp;nbsp;if you are a member of the highly profitable yet highly risky pharmaceutical industry, make the most of your attendance by gaining essential tools for detecting and preventing industry-specific third party risks by participating in the post-conference workshop entitled &lt;b&gt;&quot;Third Party Compliance Risks in the Heavily Regulated Pharmaceutical and Life Sciences Industry&quot;.&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;Take new tips and strategies back to your colleagues:&lt;/b&gt; Get up-to-the-minute practical advice on best practices to detect and prevent compliance risks when contracting with such third parties as agents, distributors, freight forwarders, suppliers, joint venture partners and many more including how to sustain ongoing monitoring and tools for thoroughly investigating third party activities should suspicions or red flags arise. &amp;nbsp;&lt;/font&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;&lt;/p&gt;&lt;p style=&quot;text-align: left; &quot;&gt;&lt;/p&gt;&lt;p&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;PLUS DON'T MISS -&lt;/b&gt;&amp;nbsp;hear insider tips from senior level executives from leading multinational companies such as:&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Jean-Daniel Lainé, Senior Vice-President, Compliance, &lt;b&gt;Alstom&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Alfred Farha, Compliance Counsel, &lt;b&gt;Associated British Foods plc&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Dominique Lamoureux, Vice President, Ethics and Corporate Responsibility, &lt;b&gt;Thales Group&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Kees van Ophem, General Counsel &amp;amp; VP ? Corporate Management, &lt;b&gt;Leica Microsystems GmbH&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Sujatha Iyer, Third Party Program Director, &lt;b&gt;Tyco International&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Joseph Simon, Senior Legal Counsel, &lt;b&gt;A.P. Moller-Maersk A/S&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Don Hughes, Vice President and General Counsel EMEA, &lt;b&gt;Hitachi Data Systems (UK)&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;Andy McClarron, Director, Ethics &amp;amp; Compliance, &lt;b&gt;BP plc (UK)&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px; &quot;&gt;On 28 ? 29 February 2012 take the opportunity to network with industry peers and colleagues who share your concerns. Reserve your place now.&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p style=&quot;font-size: 12px; &quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;b&gt;3 easy ways to book your place today:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;font-size: 12px; &quot;&gt;&lt;/p&gt;&lt;ol&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;PHONE our registration hotline on +44 (0)20 7878 6888&amp;nbsp;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;EMAIL your details directly to registration@c5-online.com&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;Register &lt;a href=&quot;https://transactions.c5groupinc.com/event_reg.php?conf=2981&amp;amp;site=4&amp;amp;lang=en&amp;amp;gap=5&quot;&gt;&lt;b&gt;ONLINE&lt;/b&gt;&lt;/a&gt;&lt;/font&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;




&lt;/span&gt;&lt;/font&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Legal</category>
<category>Regulatory Compliance and Trade</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/693/managing-third-party--counterparty-relationship-risks/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Construction Litigation</title>
<link>http://www.americanconference.com/2012/703/construction-litigation/</link>
<pubDate>Wed 29 Feb 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Orlando | &lt;p&gt;Led by an unparalleled faculty of in-house counsel, insurance professionals, top litigators and renowned jurists, ACI's premier &lt;strong&gt;CONSTRUCTION LITIGATION &lt;/strong&gt;conference will shape the future of the industry for today's leading professionals.&lt;/p&gt;
&lt;p&gt;The issues facing the construction industry have never been as complex as they are now. The economy has severely hampered new project development and the completion of existing projects, bankruptcies and collapsed companies have become obstacles to getting paid, and parent companies, insurers and sureties are being brought into claims just for their deep pockets. With every dollar essentially being worth more, construction litigation is on the rise. Industry players have never been so reliant on their attorneys to help keep their companies above water. &lt;/p&gt;
&lt;p&gt;With a multitude of various players involved in every project, determining the cause of delays and defects can often seem impossible. Add this to the layers and layers of insurance coverage and the factors involved in litigating and resolving construction cases just become more complex. &lt;/p&gt;
&lt;p&gt;The ability to understand and navigate these various issues are essential elements to handling construction cases. With all of these factors, counsel are fighting an uphill battle from the very start. As such, there has never been a more important time for the industry to convene and trade valuable pointers and insights on the most current strategies and techniques for defending and managing construction litigation.&lt;/p&gt;
&lt;p&gt;In response, American Conference Institute is proud to introduce its premier installment of the essential forum that will shape the future of litigation strategies for attorneys, in-house counsel from companies working as builders, general contractors, owners, subcontractors and design professionals, claims professionals and counsel from insurance companies: &lt;em&gt;National Advanced Conference&lt;/em&gt; on &lt;strong&gt;CONSTRUCTION LITIGATION&lt;/strong&gt;. Renowned judges, leading outside counsel and in-house professionals will provide even the most seasoned professionals with the clarity and certainty needed to remain ahead of the curve on today's key issues needed to vigorously represent your clients. &lt;/p&gt;
&lt;p&gt;This conference offers unique opportunities for law fi rm litigators to learn from some of the best in the industry and for in-house counsel and risk managers to gain expertise in evaluating litigation strategies and bring valuable tactics back to their legal departments. The event will also offer tremendous networking opportunities with senior practitioners in the field.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;</description>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/703/construction-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">IT Management of Export Controls</title>
<link>http://www.americanconference.com/2012/874/it-management-of-export-controls/</link>
<pubDate>Thu 1 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Diego | For the first time on the West Coast, this unique seminar will bring together top IT and trade professionals, who are working at the cutting edge of virtual export compliance. Leading executives will provide you with practical insights on how to protect ITAR and EAR-controlled data, and manage foreign national access on shared networks and collaborative platforms. By attending this event, you will strengthen your understanding of IT environments and associated trade compliance risks, and gain practical tools for building a virtual export compliance program.&amp;nbsp; The event will also be an invaluable forum for networking and benchmarking with key players in the virtual compliance community. &lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<category>Aerospace and Defense</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/874/it-management-of-export-controls/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Legal Marketing Association</title>
<link>http://www.americanconference.com/2012/899/legal-marketing-association/</link>
<pubDate>Wed 14 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Dallas | </description>
<guid isPermaLink="true">http://www.americanconference.com/2012/899/legal-marketing-association/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Food &amp; Beverage Marketing &amp; Advertising</title>
<link>http://www.americanconference.com/2012/889/food--beverage-marketing--advertising/</link>
<pubDate>Mon 19 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | In light of recent regulatory efforts and continuing private litigation, ACI's annual &lt;strong&gt;Food &amp;amp; Beverage Marketing &amp;amp; Advertising Summit&lt;/strong&gt; provides a prime opportunity for marketing and advertising attorneys who practice within the food and beverage industry to gain specific advice on how to structure, implement and maintain regulatory-compliant and litigation-proof marketing and advertising practices.
&lt;p&gt;Active enforcement by the&lt;strong&gt; FTC &lt;/strong&gt;and &lt;strong&gt;FDA&lt;/strong&gt; coupled with looming pendency over the highly-contested &lt;strong&gt;proposals on food marketing&lt;/strong&gt; to children and continuing uncertainty over &lt;strong&gt;front-of-package labeling&lt;/strong&gt; are only a few of the issues currently confronting the food and beverage industry on the marketing and advertising front. In light of these issues, it is crucial that counsel remain up to speed regarding current enforcement trends and industry practices specifically within the food and beverage industry. Take advantage of this opportunity to benchmark and strategize with your peers as you &lt;strong&gt;pose your most pressing questions directly to the government and key industry leaders, including:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;James Kohm, Division of Enforcement, Bureau of Consumer Protection, FTC&lt;/li&gt;
  &lt;li&gt;Richard Cleland, Division of Advertising Practices, Bureau of Consumer Protection, FTC&lt;/li&gt;
  &lt;li&gt;Devin Domond, Division of Advertising Practices, Bureau of Consumer Protection, FTC&lt;/li&gt;
  &lt;li&gt;Phyllis Marcus, Division of Enforcement, Bureau of Consumer Protection, FTC&lt;/li&gt;
  &lt;li&gt;Kathleen Lewis, Division of Enforcement, Office of Compliance, CFSAN, FDA&lt;/li&gt;
  &lt;li&gt;Vincent de Jesus, Office of Nutrition Labeling and Dietary Supplements, CFSAN, FDA&lt;/li&gt;
  &lt;li&gt;Jennifer Seymour, Division of Nutrition, Physical Activity, and Obesity, CDC &lt;/li&gt;
  &lt;li&gt;Elaine D. Kolish, Vice President &amp;amp; Director, CFBAI&lt;/li&gt;
  &lt;li&gt;Wayne Keeley, Vice President &amp;amp; Director, CARU&lt;/li&gt;
  &lt;li&gt;Robert C. Post, Center for Nutrition Policy and Promotion, USDA&lt;/li&gt;
  &lt;li&gt;Genie Barton, VP &amp;amp; Director, Online Behavioral Advertising &amp;amp; Mobile Marketing, BBB&lt;/li&gt;
  &lt;li&gt;Kat Dunnigan, Staff Attorney, NAD&lt;/li&gt;
  &lt;li&gt;Mary Sophos, Executive Vice President for Policy and Strategic Planning, GMA&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;A unique offering among industry events, ACI's Food &amp;amp; Beverage Marketing &amp;amp; Advertising Summit provides an opportunity for attendees to engage in an un-biased and open discussion with peers, specifically within the food and beverage industry, while also interacting directly with key leaders within government agencies who are actively involved with marketing and advertising enforcement. Attendees of this conference will benefit from practical, hands-on, solution-driven discussions that will provide informative guidance on how to implement the most effective and regulatory-compliant marketing and advertising strategies.&lt;/p&gt;
&lt;p&gt;Continue the benchmarking and networking that will be the hallmark of the main conference by attending the Advanced Interactive Working Groups on March 21st:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A     Deep Dive into Food &amp;amp; Beverage Claim Substantiation: How to meet FDA &amp;amp; FTC requirements and ensure sufficient scientific evidence for health, structure/function and nutrient/content claims&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B     Online Behavioral Advertising and COPPA Reform: Learn and benchmark how to structure legally-compliant marketing and advertising efforts when collecting and using data online&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Building on the momentum from last year's highly successful conference, seats at this year's installment are expected to go quickly given the great and continuing interest in this topic. Reserve a space now for a member of your marketing, advertising, regulatory and legal teams by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt;; faxing your registration to &lt;strong&gt;1-877-927-1563&lt;/strong&gt; or registering online at:&lt;strong&gt; www.AmericanConference.com/foodmarketing. &lt;br&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;/p&gt;</description>
<category>Advertising &amp; Marketing</category>
<category>Food and Beverage</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/889/food--beverage-marketing--advertising/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">4th Russia and CIS Summit on Anti-Corruption</title>
<link>http://www.americanconference.com/2012/973/4th-russia-and-cis-summit-on-anti-corruption/</link>
<pubDate>Tue 20 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Moscow | &lt;P align=center&gt;&lt;STRONG&gt;?????????? ?????????????????? ???????????????? ???????? ??????? ?????? ?????? ?????????? ?????????? ? ??????? ???????. ?? ??????? ?? ???? ???????? ? ?????? ???????? ????????? ????????? ????????????? ???????????, ???????????? ?????????????????? ??????????, ???????? ??? ???? ? ????? ????????? ????????, ????????? ? ???????????? ?? ?????????? ????????????????.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;??????????????? ? ????? ????????-????????? &quot;????????? ??? ?????? ? ??? ??????? ?? ?????????????????? ??????????». ??? ????? ????????????? ?????????? ??????????? ??? ??????? ? ???????? ? ????????? ?????????? ?????. ??? ??? ? 4-? ???, ?????? ?????? ? ??? ?? ?????????????, ?????????? ???????????? ?????????? ???????????, ??????????? ??? ??????????? ???????????? ?????????? ? ?????????? ???????, ????????? ? ??????????? ?????????????????? ????????????????, ? ????? ? ?????????? ???? ?????????????? ? ?????????? ????? ?????????-??????.&lt;/P&gt;
&lt;P align=left&gt;?????????? ? ???????? ?????? ??? ? ????????????? ???????????? ?? ??????? ???????? ???????, ? ?? ????? ??? ????? ?????????????? ? ??????????????, ? ????? ????? ????????????????? ????? ?????? ?????????? ????????????? ?????????? ???????? ??????? ??????????????? ??????? ? ?????????? ?????????-????????. ? ?? ?? ?????, ????? ?????????????? ? ????????? ? ?????? ? ??????? ??? ??-???????? ??????????? ??????. ???????? ??????? ?????????? ????????? ???????????? ?????????? ????? 28 ?????????? ????? ????, ? ?????? 2011 ????, ?????????? ?????????? ????????? ????? ?? ????? ?????? ??????? ? 2007 ????. ?????? ???????? ????? ?? ????? ???????????????? ???????? ????? ? ????. ???? ?????????? ? ??????????? ??????? ? ????????? ??? ?????? ???????????? ???????????????? ??? ????????, ??????????????? ??????????? ?????????? ? ?????? ??????. ??? ???????????? ? ?????????????? ??????????? ??????? ?????? ????????????? ?????????????? ? ??????? ????????????? ????? ? ??????????? ????????, ????????? ? ?????????????? ?????????????.&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;??????????? ????????? 2012 ???? ??????????? ??? ??????????? ?????????? ? ??? ???:&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;- ??????? ?????, ?????????, ??????? ?????????? ? ???????????? ?????? ? ??????????? ??????? ?????????&lt;BR&gt;- ??????????? ???????? ?????????-???????? ??????? ??? ????? ????????? ??????????? ??????&lt;BR&gt;- ??????????? ? ?????? ?????????? ???????? ???????? ???????? (???????????? ???? ?? ?????????? ???????? ??? ?? ????? ????????????? ????????? ?? ??????? ??????? ???????)&lt;BR&gt;- ??????? ??????????, ?????????? ????-??????? ???????????? ?????????? ???????????&lt;BR&gt;- ???????? ? ???????????? ?????????? ????? ? ??????????? ? ????????????????? ????????????????? ??? ????-???? ???????&lt;BR&gt;- ???????? ????????? ? «??????? ??????» ????????????? ????????&lt;BR&gt;- ?????????????? ???? ???????????? ???, ??????????? ????????? ????????????? ????-????-?????&lt;BR&gt;- ?????????? ????????????????? ????????????? ? ??????????&lt;BR&gt;&lt;BR&gt;&lt;STRONG&gt;????! ???????? ?????????? ?? ?????? ??? ?? ?????????????? ???????????? ??????? ??? ???????????? ??????????? ? ?????????? ?????????? ?????? ??? ? ????????????? ???????????? ?? ???????, ? ????? ?????????? ?? ?????? ? ????????? ?????????????? ?????????????? ???????????? ????? ??????? ????????? ?????? ?????????????? ? ??????????????.&lt;BR&gt;&lt;BR&gt;? ?????????? ? ???????? ??????????? ?? ?????????? ??????? ? ????? ??????? ???????:&lt;BR&gt;&lt;BR&gt;A.&lt;/STRONG&gt; ?????, ???????????? ? ?????????? ?????? ???? ????????????????? ?????????-????????? ????? ???????????&lt;BR&gt;&lt;STRONG&gt;B.&lt;/STRONG&gt; ????????????? ????????, ???????, ??????????? ? ??????????????: ??????????? ???????????? ??????????? ? ???, ??? ????????? ? ??????????? ? ?????? ? ???&lt;BR&gt;&lt;STRONG&gt;&lt;BR&gt;?????????, ??? ??????????? ????? ?????????? ??????? ?? ??????.&lt;BR&gt;????????????????? ???????, ???????? 1-416-926-8200 ? ???, +44 20 7878 6888 ? ??????, ??? ?????? &lt;/STRONG&gt;&lt;A href=&quot;http://www.americanconferenced.com/anticorruptionRUS&quot;&gt;&lt;STRONG&gt;www.AmericanConference.com/anticorruptionRUS&lt;/STRONG&gt;&lt;/A&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;BR&gt;* ?? ????? ??????????? ????? ???????????? ?????????? ??????? ? ???????? ?? ?????????? ? ? ??????????? ?? ??????? ?????.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;?? ?????????????? ???????????: &lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;?? ???????? ???????????:&lt;BR&gt;????? ?? ?????&lt;BR&gt;???.: 1-212-352-3220 ???. 5480&lt;BR&gt;&lt;A href=&quot;mailto:v.dipalma@americanconference.com&quot;&gt;v.dipalma@americanconference.com&lt;/A&gt; &lt;BR&gt;&lt;BR&gt;?? ???????? ???????? ???????:&lt;BR&gt;????? ??????&lt;BR&gt;???.: 1-212-352-3220 ???. 5242&lt;BR&gt;&lt;A href=&quot;mailto:w.tyler@americanconference.com&quot;&gt;w.tyler@americanconference.com&lt;/A&gt;&lt;BR&gt;&lt;BR&gt;&lt;/STRONG&gt;&lt;STRONG&gt;?? ???????? ?????????? ? ??????????????? ??????????????:&lt;BR&gt;????? ????????&lt;BR&gt;???.:&amp;nbsp;1-212-352-3220 ???. 5488&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/STRONG&gt;&lt;A href=&quot;mailto:m.romanova@americanconference.com&quot;&gt;&lt;STRONG&gt;m.romanova@americanconference.com&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P align=center&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;BR&gt;Anti-corruption enforcement is here to stay and changing the way global entities approach compliance. Are you falling behind? Attend the region's premier anti-corruption compliance conference and stay ahead of the enforcement curve.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Join your peers for what is regarded as &quot;a key event for all multinationals dedicated to anti-corruption compliance in Russia and the CIS&quot; and benefit from unparalleled networking and benchmarking opportunities. Now in its 4th successful year, &lt;STRONG&gt;ACI's Russia and CIS Summit on Anti-Corruption &lt;/STRONG&gt;will once again provide you with advanced and practical insights on the global enforcement landscape, a roadmap to compliance and risk mitigation in Russia and the CIS, and enhanced detection strategies.&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Enforcement of the US Foreign Corrupt Practices Act continues at rapid pace, while on the international stage, the UK Bribery Act and other anti-corruption initiatives including Russia's new foreign bribery legislation, are forcing multinationals to rethink compliance. At the same time, doing business in Russia and the CIS continues to present significant corruption risks. In the 2011 Transparency International Bribe Payer's Index, which ranks the world's 28 largest economies, Russia ranked last. Such rankings remind companies to tread carefully in any investment involving the region. &lt;/P&gt;
&lt;P&gt;This is the only program that addresses your company's local bribery risks and provides practical solutions to your most pressing anti-corruption compliance challenges. &lt;STRONG&gt;The updated 2012 agenda will provide real-world information on:&amp;nbsp; &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;?&amp;nbsp;How to detect bribery schemes, high risk structures, hidden parties and other questionable transactions &lt;BR&gt;?&amp;nbsp;Conducting effective compliance reviews of your third parties and how to obtain conclusive and accurate data to support your compliance initiatives &lt;BR&gt;?&amp;nbsp;What to do if local authorities come knocking ? best practices for preparing and responding to a Russian bribery investigation&lt;BR&gt;?&amp;nbsp;How to assess unique, heightened risk factors of minority joint ventures and implement effective bribery controls &lt;BR&gt;?&amp;nbsp;Reconciling Russian competition law and the US FCPA post-Novo Nordisk &lt;BR&gt;?&amp;nbsp;How company executives are caught in the bribery net and preventing personal liability &lt;BR&gt;?&amp;nbsp;Minimizing whistleblower exposure post-Dodd-Frank &lt;BR&gt;?&amp;nbsp;Navigating the anti-corruption regulatory and enforcement landscape in Kazakhstan &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;PLUS! Get an update on the UK Bribery Act and its enforcement, investigations and enforcement priorities under the US FCPA, and Russia's new anti-corruption legislation. &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Complete your conference experience by attending new &lt;STRONG&gt;Working Groups:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A.&lt;/STRONG&gt;&amp;nbsp;Auditing/Testing Your Anti-Corruption Compliance Program: Probing Weak Spots to Improve Your Company's Compliance &lt;BR&gt;&lt;STRONG&gt;B.&lt;/STRONG&gt;&amp;nbsp;Gift Giving, Travel, Entertainment and Hospitality: A Complete and Practical Guide on What You Can and Can't do in Russia and the CIS &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conference expected to sell out.&lt;/STRONG&gt; Register for this exclusive event today by calling &lt;STRONG&gt;1-416-926-8200&lt;/STRONG&gt; in the US, or &lt;STRONG&gt;+44 20 7878 6888&lt;/STRONG&gt; in Europe; or register online at &lt;BR&gt;&lt;A href=&quot;http://www.americanconference.com/anticorruptionRUS&quot;&gt;&lt;STRONG&gt;www.AmericanConference.com/anticorruptionRUS&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;.&lt;/STRONG&gt;&amp;nbsp; ________________________________________&lt;BR&gt;&lt;BR&gt;In our continuous effort to improve the quality of our programs and offer you more value, we are pleased to provide you with the opportunity to submit suggestions and nominate speakers for next year's program. Please contact &lt;STRONG&gt;Virna Di Palma&lt;/STRONG&gt;, Senior Program Director, at v.dipalma@americanconference.com or at 212-352-3220 ext.5 480. &lt;BR&gt;&lt;BR&gt;If you are interested in learning more about sponsorship for this event, please contact &lt;STRONG&gt;Wendy Tyler&lt;/STRONG&gt;, Group Leader at W.Tyler@AmericanConference.com or at 212-352-3220 ext. 242.&lt;BR&gt;&lt;BR&gt;For more information on media partnerships please contact &lt;STRONG&gt;Virna Di Palma,&lt;/STRONG&gt; Senior Program Director, at v.dipalma@americanconference.com or &lt;STRONG&gt;John Stoops&lt;/STRONG&gt;, Partnership Executive, j.stoops@americanconference.com.&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Russia and CIS</category>
<category>Legal</category>
<category>Regulatory Compliance and Trade</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/973/4th-russia-and-cis-summit-on-anti-corruption/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">FDA Boot Camp</title>
<link>http://www.americanconference.com/2012/879/fda-boot-camp/</link>
<pubDate>Tue 20 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | The approval process?pre-approval concerns?product labeling?clinical trials?adverse events reports?patent concerns?exclusivity. ? all are critical aspects in the commercialization process for drugs, biologics, and devices which are governed by FDA law and regulation. Recent court cases, and high-profile trials concerning FDA-regulated products have made it clear that it is essential for attorneys who do not have regulatory practices ? but who do deal with FDA-regulated products ? to have a familiarity with these concepts. Th e changing business dynamics of the life sciences industry have also made it critical for business executives, policy analysts and securities experts who work in this fi eld to have a clear understanding of the dynamics of the FDA.&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Law-suits ? Business Development and Investment Strategies ? Compliance Protocols ? Policy Matters ? Pricing and Reimbursement Decisions ? Patent and Product Life Cycle Management&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Litigation as well as numerous other legal, business, and policy decisions concerning &lt;/b&gt;&lt;b&gt;FDA-regulated products often hinge on what happened during the pre-approval, approval, or post-approval periods.&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;/div&gt;Many products liability lawyers, patent counsel, business and investment experts, medical and regulatory affairs professionals, and those involved in pricing and reimbursement ? despite their tenure in working with FDA-regulated products ? are not well-versed in the essentials of the approval process and the regulatory hurdles of the post-approval period. Whether you are a products liability or patent litigator, in-house counsel, in-house business development or federal affairs professional, FDA Boot Camp will provide you the insights you need.&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Boost your FDA regulatory IQ Learn about the FDA approval process and the ins and outs of post-approval challenges&lt;br&gt;&lt;br&gt;&lt;/b&gt;&lt;div align=&quot;left&quot;&gt;&lt;b&gt;ACI's FDA Boot Camp&lt;/b&gt; has been designed to give products or patent litigators, as well as patent prosecutors, industry in-house counsel, and life sciences investment and securities experts, a strong working knowledge of core&lt;b&gt; FDA&lt;/b&gt; competencies.&lt;br&gt;&lt;br&gt;A distinguished faculty of top FDA regulatory experts ? a &lt;i&gt;&lt;b&gt;&quot;Who's Who of the FDA Bar&quot;&lt;/b&gt;&lt;/i&gt; ? will share their knowledge and give you critical insights on:&lt;br&gt;&lt;br&gt;? The organization, jurisdiction, functions, and operations of the FDA&lt;br&gt;? The essentials of the approval process for drugs, biologics, and devices, including:&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; - NDAs&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; - OTC Approval&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; - INDs&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; - 510(k) submissions&lt;br&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; - BLAs&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; - PMA process&lt;br&gt;? Clinical trials for drugs and biologics and the clearance process for devices&lt;br&gt;? The classification of devices and the concept of &quot;risk-based&quot; classification&lt;br&gt;? Th e role of the Hatch-Waxman Act in the patenting of drugs and biologics&lt;br&gt;? Labeling in the drug and biologics approval process&lt;br&gt;? cGMPs and other manufacturing concerns relative to products liability&lt;br&gt;? Proactive adverse events monitoring and signal detection&lt;br&gt;? Recalls, product withdrawals, and FDA oversight authority&lt;br&gt;&lt;br&gt;Attend the pre-conference workshop or post-conference master classes to get the background and/or the in-depth information you need to maximize your learning and networking experience at this event!&lt;br&gt;&lt;br&gt;&lt;b&gt;Workshop A: Fundamentals of FDA Regulatory Law&lt;/b&gt; will address topics to set the stage for the main conference by helping you thoroughly comprehend the structure of the FDA and the essentials of the pre-approval, approval, and post-approval process. Get the background you need to fl ow seamlessly into the conversations at FDA Boot Camp.&lt;br&gt;&lt;br&gt;&lt;b&gt;Master Class B: Hatch-Waxman and BPCIA&lt;/b&gt;: Overview of Biosimilars and Life Cycle Planning for Drugs and Biologics will provide an in-depth overview of biosimilars as well as analyses of bioequivalency and exclusivities and their role in patent and product life cycle management.&lt;br&gt;&lt;br&gt;&lt;b&gt;Master Class C: Post-Approval Marketing Guidance and Preemption Protocols&lt;/b&gt; will address issues that arise post-approval, including advertising, promotion, and off -label promotion and enforcement, as well as preemption fundamentals.&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Attend this conference and learn to navigate your way through the regulatory maze that plays such a crucial role to your cases and practice areas. Seats at prior iterations of ACI's FDA Boot Camps old out. Don't delay ? register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563, or registering online at &lt;a href=&quot;www.AmericanConference.com/FDABootCampNYC&quot;&gt;www.AmericanConference.com/FDABootCampNYC&lt;/a&gt;.&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Law Firm Management</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/879/fda-boot-camp/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Fraud and Abuse in the Sale and Marketing of Drugs</title>
<link>http://www.americanconference.com/2012/881/fraud-and-abuse-in-the-sale-and-marketing-of-drugs/</link>
<pubDate>Tue 27 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;div align=&quot;center&quot;&gt;&lt;i&gt;In 2010, more than $3 billion in penalties were paid under the False Claims Act alone.[1]&amp;nbsp; &lt;/i&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Attend the one event that has shaped compliance programs combating fraud and abuse for nearly a decade&lt;br&gt;&lt;/b&gt;&lt;br&gt;&lt;div align=&quot;left&quot;&gt;The numbers are staggering.&amp;nbsp; The threat of individual liability looms ever larger with recent prosecutions making headlines.&amp;nbsp; These and numerous other developments have conspired to create a period of unprecedented turbulence and uncertainty for counsel and executives charged with preventing and defending against accusations of fraud and abuse in pharmaceutical drug sales and marketing.&amp;nbsp; Between ever-larger recoveries made under the False Claims Act, continued prosecution and exclusion of executives through the Park Doctrine, and increasingly contradictory court opinions on off-label drug marketing, it is more important than ever to receive expert guidance to traverse an increasingly vague regulatory landscape.&lt;br&gt;&lt;/div&gt;&lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;div align=&quot;left&quot;&gt;American Conference Institute's&lt;b&gt; 12th National Forum on Fraud and Abuse in Sale and Marketing of Drugs&lt;/b&gt; is the industry-leading conference uniting respected practitioners, top prosecutors, and leading in-house counsel and compliance executives.&amp;nbsp; Featuring in-depth analysis of landmark cases involving individual liability for executives and in-house counsel, detailed discussions of the Foreign Corrupt Practices Act, useful guidance on the new aggregate spend reporting requirements, and analysis of critical federal appellate and Supreme Court opinions, this event will leave you with a specific plan of action for combating fraud allegations and put you in position to help your company or clients thrive.&lt;br&gt;&lt;/div&gt;&lt;b&gt;&lt;br&gt;Take advantage of an unparalleled networking opportunity&lt;br&gt;&lt;br&gt;&lt;/b&gt;&lt;div align=&quot;left&quot;&gt;This conference will give you the chance to interact with government officials and high-level compliance executives from many major pharmaceutical companies.&amp;nbsp; Benefit your business by benchmarking your practices against peers, exchange ideas with other seasoned professionals, and meet expert white collar defense and corporate counsel who have seen it all.&lt;br&gt;&lt;/div&gt;&lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;div align=&quot;left&quot;&gt;Gain detailed guidance from our pre-conference session &lt;b&gt;Defending Against Allegations of Fraud and Abuse under the UK Bribery and Foreign Corrupt Practices Acts.&lt;/b&gt;&amp;nbsp; Keep abreast of complying with onerous new federal reporting requirements in our post-conference session &lt;b&gt;Discussing the Implementation and Consequences of the New Aggregate Spend Physician Payment Sunshine Provision of the PPACA.&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;Take the opportunity to hear from leading experts in the fraud and abuse enforcement, defense, and compliance spaces.&amp;nbsp; Register now to ensure your spot at this crucial industry event.&amp;nbsp; Call &lt;b&gt;1-888-224-280&lt;/b&gt;, fax your registration form to&lt;b&gt; 1-877-927-1563&lt;/b&gt;, or register online at &lt;a href=&quot;http://www.americanconference.com/FADrugs&quot;&gt;www.americanconference.com/FADrugs&lt;/a&gt;.&lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;br&gt;&lt;/div&gt;</description>
<category>Advertising &amp; Marketing</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/881/fraud-and-abuse-in-the-sale-and-marketing-of-drugs/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Nuclear Exports</title>
<link>http://www.americanconference.com/2012/836/nuclear-exports/</link>
<pubDate>Tue 27 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;p&gt;Government regulations surrounding nuclear export controls in the United States and around the globe are complex... and rapidly evolving. Proposed revisions to Part 810 regulations add another layer of complexity to an already confusing regulatory landscape. Companies that want to access lucrative foreign nuclear markets and obtain authorization to export nuclear technology and services must implement a sustainable system of effective compliance controls without unduly hampering legitimate trade.&lt;/p&gt;
&lt;p&gt;The U.S. Departments of Energy, Commerce, State and the Nuclear Regulatory Commission have overlapping authority over the export of nuclear technology and services, and each require sophisticated controls and compliance protocols.&lt;/p&gt;
&lt;p&gt;To capitalize on global business opportunities, exporters of nuclear technology, services and software must be able to properly classify their products in order to obtain the required government licenses or authorizations to export. &lt;/p&gt;
&lt;p&gt;With these issues in mind, American Conference Institute presents its industry-acclaimed &lt;strong&gt;2nd National Advanced Summit on Complying with Nuclear Export Controls&lt;/strong&gt;. This leading industry event will focus on providing compliance officers, general counsel, licensing officers and export controls executives with practical solutions for navigating the unique compliance issues presented to exporters of nuclear technology and services. Industry leading presenters will focus on the most challenging issues, including:&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Dr. Alex R. Burkart&lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
U.S. Department of State&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Richard Goorevich &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
U.S. Department of Energy &lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Jill Shepherd&lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
U.S. Nuclear Regulatory Commission&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Ronald Rolfe&lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
Bureau of Industry and Security&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Bernard Kritzer &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
Bureau of Industry and Security&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Steve Clagett&lt;/strong&gt;&lt;/em&gt;&lt;br&gt; 
Bureau of Industry and Security&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Katie Strangis &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
U.S. Department of Energy&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Changes to Part 810 regulations&lt;/li&gt;
  &lt;li&gt; Getting required end-use and end-user authorizations&lt;/li&gt;
  &lt;li&gt; Classifying nuclear technology and making correct jurisdictional determinations&lt;/li&gt;
  &lt;li&gt; Putting a TCP in place and complying with deemed export and re-export limitations&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt; Don't miss the unique opportunity to hear from government officials from the &lt;strong&gt;DOE, NRC, State and Commerce Departments&lt;/strong&gt;, including:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;PLUS!&lt;/strong&gt; Benefit from exclusive perspectives on India and China landscape and how to set up appropriate compliance controls to sustain nuclear exports to these lucrative international markets. &lt;/p&gt;
&lt;p&gt;Benchmark your compliance program with leading companies in the industry and ask your most pressing questions to senior regulators. This unique conference will fi ll up fast! Reserve your seat today by calling&lt;strong&gt; 888-224-2480&lt;/strong&gt;, by faxing your registration to &lt;strong&gt;877-927-1563&lt;/strong&gt; or by registering online at &lt;strong&gt;www.AmericanConference.com/NuclearExports.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;/p&gt;</description>
<category>Energy &amp; Resources</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Environmental</category>
<category>Aerospace and Defense</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/836/nuclear-exports/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Residential Mortgage Litigation and Regulatory Enforcement</title>
<link>http://www.americanconference.com/2012/861/residential-mortgage-litigation-and-regulatory-enforcement/</link>
<pubDate>Thu 29 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;p&gt;&lt;strong&gt;FEATURING MORE IN-HOUSE COUNSEL,  JUDGES &amp;amp; REGULATORS THAN EVER BEFORE!&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Join top litigators, in-house counsel, key federal and state regulators, and renowed jurists to ensure you are fully prepared to defend against the continuing deluge of residential mortgage claims.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;W&lt;/strong&gt;ith a renewed regulatory focus stemming from the implementation of the CFPB, residential mortgage litigation is more prominent than ever. The authority of the state Attorneys General continues to expand to enforce the new regulations, and it is critical that both in-house and outside counsel remain up-to-date on emerging borrower and investor claims as well as ongoing state and federal investigations. Defending against fair lending claims under TILA and SCRA, mitigating loss in loan servicing and responding to allegations of HAMP and MERS violations, and attacking the latest bankruptcy claims are all key.&lt;/p&gt;
&lt;p&gt;In response, &lt;strong&gt;American Conference Institute&lt;/strong&gt; is pleased to announce its &lt;strong&gt;8th National Forum on Residential Mortgage Litigation &amp;amp; Regulatory Enforcement&lt;/strong&gt;. Our unparalleled faculty of regulatory and enforcement officials, renowned jurists, expert in-house counsel, and leading outside counsel will provide you insights and strategies tailored to defend against new claims and adapt to the evolving regulatory landscape. Topics will include: &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; Adapting	to	evolving	state	and	federal	regulatory	initiatives	in	light	of	new	regulations	under	the	CFPB&lt;/li&gt;
  &lt;li&gt;A	look	at	the	latest	investor	claims	and	regulatory	initiatives	in	capital	markets	litigation&lt;/li&gt;
  &lt;li&gt; Legal	and	compliance	strategies	for	preventing	and	defending	against		TILA	and	SCRA	claims&lt;/li&gt;
  &lt;li&gt; Responding	to	allegations	of	HAMP	and	MERS	violations	and	minimizing	risk	through	proper	procedures	 and loss mitigation strategies&lt;/li&gt;
  &lt;li&gt; Navigating	the	foreclosure	litigation	process	and	foreclosure	mediation	programs,	including	standing	and	compliance	issues,	 proof of MERS assignments, and refuting claims of  loan documentation error&lt;/li&gt;
  &lt;li&gt; Combating	the	use	of	bankruptcy	as	a	borrower	tool&lt;/li&gt;
  &lt;li&gt; Prevailing	against	the	latest	bankruptcy	litigation	claims&lt;/li&gt;
  &lt;li&gt; Managing	and	defending	against	residential	mortgage	class	actions&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Plus, register for the Pre-Conference In-Depth Focus Sessions&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt; |  Residential Mortgage Litigation Focus on the Hotbed of California&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt; |  Defending and Managing Claims/Class Actions in an Unrivaled Litigious Environment&lt;/p&gt;
&lt;p&gt;Register now by calling &lt;strong&gt;888-224-2480&lt;/strong&gt; or faxing your registration form to &lt;strong&gt;877-927-1563&lt;/strong&gt;. You can also register online at &lt;strong&gt;www.AmericanConference.com/ResidentialMortgage&lt;/strong&gt;&lt;/p&gt;
&lt;br&gt;&lt;p&gt;&lt;/p&gt;</description>
<category>Financial Services</category>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/861/residential-mortgage-litigation-and-regulatory-enforcement/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Brain Injury Litigation Summit</title>
<link>http://www.americanconference.com/2012/702/brain-injury-litigation-summit/</link>
<pubDate>Thu 29 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Philadelphia | &lt;p&gt;&lt;b&gt;Be a part of the nation's premier brain injury conference and gain key updates on current and emerging litigation trends and the standard of care while networking with insurance, hospital and hospital professionals&lt;/b&gt;&lt;br&gt;
  &lt;br&gt;
  Jury verdicts for brain injury litigation claims are on the rise and can range in the $10-$16 million. With so much at stake, it is essential for both plaintiff and defense attorneys and in-house insurance and hospital professionals to remain abreast of all that is happening in the brain injury litigation landscape. &lt;br&gt;
  &lt;br&gt;
  Attend &lt;b&gt;ACI's Premier Summit on Brain Injury Litigation&lt;/b&gt; and hear from an unparalleled medical and legal faculty that will provide new tips and strategies for establishing causation/alternative causation theories and developing a solid case from the very beginning stages of litigation. Learn how to craft courtroom strategies for effective jury communication, use cutting edge technology for demonstrative evidence, interview engaging and knowledgeable medical expert witnesses, and assess the monetary value of your case. &lt;br&gt;
  &lt;br&gt;
  Recently, there has been a surge in mild to moderate traumatic brain injury litigation. Because of this shift in focus, it is essential for outside counsel to learn how to detect mild to moderate traumatic brain injury, understand subtle nuances and wade through sophisticated medical terminology. Our panel of leading medical and legal experts will guide you through the complex medical terms associated with mild to moderate traumatic brain injury. No longer is the MRI/CAT scan the only game in town in detecting and imaging a brain injury. Experts in the field will explain the science behind the current and emerging neuroimaging tests to detect mild to moderate TBI that are shaking the industry and creating controversy.&amp;nbsp; Outside counsel will benefit from a thorough review of these neuroimaging tests and determine which are worth spending the cost up front and which are &quot;junk science.&quot;&lt;br&gt;
  &lt;br&gt;
  Furthermore, pre-trial costs can reach in the six figures making it vital for outside counsel to have the necessary tools to assess the monetary value of the case before hand in order to maximize the strength of the case. Telling the jury the extent of the brain injury through use of demonstrative evidence such as 3D animation and brain slicing video has become the norm. This costly method can be effective and useful if the right medical expert witness can testify, deconstruct complex medical terms and engage with the jury. Learn how to wade through the myriad of choices out there in terms of demonstrative evidence and which will add value to your case.&lt;br&gt;
  &lt;br&gt;
  &lt;u&gt;PLUS, add value to your attendance by also registering for the Post-Conference Strategy Sessions on the Intersection of Law &amp;amp; Science: &lt;/u&gt;&lt;br&gt;
  &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Successfully Litigating a Brain Injury Case from Start to Finish&lt;/li&gt;
  &lt;li&gt;Sound Discovery Practices Related to Depositions, Social Media, Expert Witnesses and Lay Witnesses&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;br&gt;
  This event is a premier, must-attend event for outside counsel, medical professionals, and insurance professionals involved with brain injury litigation cases.&amp;nbsp; You will not want to miss this unparalleled opportunity to obtain up-to-the-minute information and critical advice from the nation's leading medical and legal experts. &lt;br&gt;
  &lt;br&gt;
  Register now by calling &lt;b&gt;1-888-224-2480&lt;/b&gt; or by faxing your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;. &lt;br&gt;


  &lt;/p&gt;</description>
<category>Employment &amp; Benefits</category>
<category>Insurance &amp; Reinsurance</category>
<category>Litigation</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/702/brain-injury-litigation-summit/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">ADMIRALTY &amp; MARITIME LITIGATION</title>
<link>http://www.americanconference.com/2012/882/admiralty--maritime-litigation/</link>
<pubDate>Thu 29 Mar 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Houston | &lt;div align=&quot;center&quot;&gt;&lt;i&gt;&lt;b&gt;The nation's premier admiralty &amp;amp; maritime litigation forum devoted entirely to the defense of claims, led by an unparalleled faculty of the most experienced in-house counsel, claims officers, and risk managers, as well as expert outside counsel and renowned federal judges &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;The issues surrounding admiralty and maritime litigation have never been as complex as they are now. In the wake of Deepwater Horizon, all eyes are focused on the potential for litigation arising from environmental accidents, and defense counsel must be prepared to defend against new and emerging theories of liability from the plaintiffs' bar. &lt;b&gt;Moreover, the law governing admiralty and maritime claims continues to evolve&lt;/b&gt;, impacting everything from the type of claims that can be filed to the remedies that are available for a given claim. Add to this the multitude of factors involved in determining the proximate causes of an accident, the complex insurance claims that are often intertwined with admiralty and maritime litigation, and the procedural and jurisdictional intricacies inherent in maritime litigation, and it is clear that &lt;b&gt;defense counsel face an uphill battle&lt;/b&gt;. With all of these factors putting defense counsel behind the 8-ball from the very start, there has never been a more important time in the industry to &lt;i&gt;convene and exchange valuable insights and strategies with colleagues from around the nation. &lt;/i&gt;&lt;br&gt;&lt;br&gt;In response to demand from the market, &lt;b&gt;American Conference Institute&lt;/b&gt; has developed the &lt;b&gt;National Forum on Defending and Managing Admiralty &amp;amp; Maritime Litigation&lt;/b&gt;. Our unparalleled speaker faculty, consisting of senior industry professionals, leading outside defense counsel, and renowned federal judges, will provide even the most seasoned professionals with the clarity and certainty needed to remain ahead of the curve on today's key issues to mounting a rigorous and complete defense.&lt;br&gt;&lt;br&gt;&lt;hr&gt;&lt;span style=&quot;font-weight: bold;&quot;&gt;PLUS, add value to your attendance by also registering for the exclusive&amp;nbsp; pre-conference Maritime Law Boot Camp and post-conference Litigation Master Class:&lt;/span&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;A.&lt;/b&gt; Pre-Conference Maritime Law Boot Camp ? An In-Depth Analysis&amp;nbsp; of the Essentials of Admiralty &amp;amp; Maritime Law for New Practitioners March 28, 2012 ? 2:00 p.m.-5:00 p.m.&lt;br&gt;&lt;br&gt;&lt;b&gt;B.&lt;/b&gt; Post-Conference Master Class ? Litigation of a Maritime Personal Injury Case From Start to Finish: Ensuring Proper Handling of the Case From the Moment the Injury Occurs and Developing an Effective Defense Strategy From Day OneMarch 30, 2012 ? 2:00 p.m.-4:30 p.m.&lt;br&gt;&lt;hr&gt;&lt;br&gt;Register now by calling 1-888-224-2480 or by faxing your registration form to 1-877-927-1563. You can also register online at&amp;nbsp; &lt;a href=&quot;www.AmericanConference.com/Maritime&quot;&gt;www.AmericanConference.com/Maritime&lt;/a&gt;&lt;br&gt;&lt;p&gt;&lt;/p&gt;&lt;br&gt;</description>
<category>Litigation</category>
<category>Transportation</category>
<category>Insurance &amp; Reinsurance</category>
<category>Environmental</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/882/admiralty--maritime-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Emerging Payment Systems</title>
<link>http://www.americanconference.com/2012/896/emerging-payment-systems/</link>
<pubDate>Mon 16 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;b&gt;Are you prepared for the legal, compliance, technical, and business issues arising from new products and technologies? Be a part of the nation's premier forum on emerging payment systems, this time on the west coast! &lt;/b&gt;&lt;br&gt;&lt;br&gt;Mobile payments, virtual and digital currencies, social coupons, mobile wallets...With continuous growth, rapid technological innovations and a flood of new entrants to the market, the payments industry is looking to implement and capitalize on these new payment vehicles. As advancements increase you must be aware of which federal and state regulatory schemes you may be subject to. Questions will arise as to how all of the stakeholders will work together, best practices for managing privacy and data security and how to ensure that your internal processes meet the compliance standards. &lt;br&gt;&lt;br&gt;Building on the incredible success of our east coast event and in response to demand from the market, American Conference Institute has developed the&lt;b&gt; 3rd National Forum on Balancing Innovation with Consumer Protection in Emerging Payment Systems&lt;/b&gt;. This is a unique opportunity for financial product, payments and retail professionals and attorneys to gain a crucial understanding of the mobile and emerging payments landscape and hear insights from industry leaders on how the key new payments fit into the regulatory framework.&amp;nbsp;&amp;nbsp; &lt;br&gt;&lt;u&gt;&lt;br&gt;PLUS, add value to your attendance by also registering for the Pre- and Post-Conference Master Classes:&lt;/u&gt;&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;&lt;b&gt;Pre-Conference Master Class ? Understanding the Technology Underlying Emerging Payment Systems:&amp;nbsp; Practical, Legal, and Regulatory Considerations for Attorneys and Compliance Professionals&lt;/b&gt;&lt;br&gt;April 16: 8:00am-10:00am&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;Post-Conference Master Class ? Credit, Debit, and Prepaid Cards: New Regulations and Reforms and Their Impact on ?Traditional' Payment Methods&lt;/b&gt;&lt;br&gt;April 17: 2:15pm -4:15pm &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;</description>
<category>Financial Services</category>
<category>Telecoms &amp; Technology</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/896/emerging-payment-systems/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">GOVERNMENT CONTRACT COST &amp; PRICING</title>
<link>http://www.americanconference.com/2012/897/government-contract-cost--pricing/</link>
<pubDate>Tue 17 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Arlington | &lt;strong&gt;WHY THIS UNIQUE CONFERENCE HAS BECOME THE PREMIER NETWORKING AND BENCHMARKING COST &amp;amp; PRICING COMPLIANCE EVENT OF THE YEAR. &lt;/strong&gt;
&lt;p&gt;&lt;strong&gt;Time and money are at stake&lt;/strong&gt;. U.S. Government contractors are contending with increased regulatory oversight, rigorous &lt;strong&gt;DCAA audits, subcontracting &lt;/strong&gt;compliance risks, and strict &lt;strong&gt;reporting&lt;/strong&gt; and &lt;strong&gt;disclosure&lt;/strong&gt; requirements.&lt;/p&gt;
&lt;p&gt; Following extensive research with industry stakeholders and outside advisors, &lt;strong&gt;American Conference Institute &lt;/strong&gt;has assembled a &lt;strong&gt;sophisticated program&lt;/strong&gt; and &lt;strong&gt;multi-dimensional speaker faculty&lt;/strong&gt;, who will discuss the most complex, pressing cost or pricing compliance issues affecting your business. &lt;/p&gt;
&lt;p&gt;In addition to &lt;strong&gt;CLE&lt;/strong&gt; and &lt;strong&gt;CPE&lt;/strong&gt;, the 2012 Advanced Forum on Government Contract Cost &amp;amp; Pricing features &lt;strong&gt;a new government, industry and private practice speaker faculty, as well as enhanced networking &lt;/strong&gt;and&lt;strong&gt; Q &amp;amp; A sessions.&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;New 2012 Keynote Speakers:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;em&gt;&lt;strong&gt; Kenneth J. Saccoccia, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
  Assistant Director,&lt;strong&gt; DCAA&lt;/strong&gt; Policy &amp;amp; Plans Directorate &lt;/li&gt;
  &lt;li&gt;&lt;em&gt;&lt;strong&gt; Ronald J. Youngs, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
  Director, Cost and Pricing Center, &lt;strong&gt;DCMA&lt;/strong&gt; &lt;/li&gt;
  &lt;li&gt;&lt;em&gt;&lt;strong&gt; Shay Assad, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
  Director, Defense Pricing, &lt;strong&gt;Defense Procurement and Acquisition Policy&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;&lt;em&gt;&lt;strong&gt; Henry Kleinknecht, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
  Director of Pricing and Logistics Acquisition, &lt;strong&gt;Office of the Inspector General&lt;/strong&gt;, U.S. Department of Defense &lt;/li&gt;
  &lt;li&gt;&lt;em&gt;&lt;strong&gt; Jonathan L. Kang,&lt;/strong&gt;&lt;/em&gt; &lt;br&gt;
  Deputy Assistant General Counsel,&lt;strong&gt; GAO &lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Fully Updated 2012 Industry Speaker Line-Up.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Benchmark&lt;/strong&gt; and &lt;strong&gt;network&lt;/strong&gt; with:   DynCorp, Lockheed Martin, General Dynamics, Textron, Austal USA, United   Launch Alliance, Fluor, Alion Science &amp;amp; Technology, GTSI and   Honeywell.&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt; &lt;strong&gt;Enhanced Focus On Subcontracting Issues&lt;/strong&gt;.&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; Scope of prime and subcontractor data disclosure and reporting obligations &lt;/li&gt;
  &lt;li&gt; Conducting cost or price analyse of subcontractor proposals&lt;/li&gt;
  &lt;li&gt; Resolving disputes over a prime's access to subcontractor books and records&lt;/li&gt;
&lt;/ul&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Practical, Intensive Pre-Conference Working Groups:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; A Deep Dive into the FAR Definitions of &quot;Certified Cost or   Pricing Data&quot; and &quot;Other Than Certified Cost or Pricing Data&quot;: How to   Comply with TINA, Accommodate Data Requests, and Minimize Risk&lt;/li&gt;
  &lt;li&gt; Managing DCAA Access to Records, Employee Interview Requests and Unfavorable Audit Reports &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Seats at this highly anticipated event always fill up&lt;/strong&gt;. Register now by calling &lt;strong&gt;1-888-884-2480&lt;/strong&gt;, by faxing your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;, or by registering online at &lt;strong&gt;www.americanconference.com/costpricing&lt;/strong&gt;&lt;/p&gt;</description>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<category>Ethics Credits</category>
<category>Aerospace and Defense</category>
<category>CPE Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/897/government-contract-cost--pricing/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">China Employment and Labor Management</title>
<link>http://www.americanconference.com/2012/981/china-employment-and-labor-management/</link>
<pubDate>Tue 17 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Shanghai | &lt;br&gt;&lt;b&gt;A&lt;/b&gt;&lt;b&gt; groundbreaking conference uniquely designed for labor/employment&lt;br&gt;executives and attorneys in China. Benefit from unparalleled benchmarking&lt;br&gt;and networking opportunities.&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Learn How to Overcome Complex Compliance Challenges&lt;br&gt;&lt;br&gt;Ensure Your Legal and HR Departments Work Hand-In-Hand to Mitigate Business and Legal Risks&lt;/b&gt;&lt;br&gt;&lt;br&gt;China has been making notable strides to update and improve its employment and labor regulations. Recent developments include a groundbreaking new China labor law, new social security for foreign workers, union initiatives and collective contracts. At the same time, lawsuits filed by employees against multinational companies have been rising.&lt;br&gt;&lt;br&gt;Foreign multinationals operating in China must navigate a fast evolving employment and labor environment. It is crucial to comply with new laws and regulations while putting strategies in place to hire and retain key employees and executives.&lt;br&gt;&lt;br&gt;&lt;b&gt;American Conference Institute&lt;/b&gt; and&lt;b&gt; C5 Group&lt;/b&gt; are delighted to announce &lt;b&gt;The In-House Counsel and HR Executives Advanced Summit on China Employment and Labor Management.&lt;/b&gt; This advanced conference brings together an exceptional faculty of top legal and HR minds, who will provide the most up to date review of complex issues that arise from employment and labor management in China.&lt;br&gt;&lt;br&gt;&lt;b&gt;Program Topics Focus on high-Risk Areas Where Legal and HR Have to Work Together&lt;/b&gt;&lt;br&gt;&lt;br&gt;? Upgrading internal controls and compliance process to comply with new social security for foreign workers&lt;br&gt;? Designing a solid termination policy and records management procedure to mitigate litigation risks&lt;br&gt;? How HR can support compliance team to detect and address employee's corrupt conduct&lt;br&gt;? Preventing IP and trade secret leakage and theft from internal employees&lt;br&gt;? Conducting effective HR due diligence in M&amp;amp;A&lt;br&gt;? And more&lt;br&gt;&lt;br&gt;&lt;b&gt;A Real Benchmarking Platform to Learn About Practical &quot;Getting-it-Done&quot; Solutions from Industry Peers&lt;/b&gt;&lt;br&gt;&lt;br&gt;The discussion will go beyond the law itself, and focus on how multinational companies should respond to the new legal landscape. Employment and labor law tend to have local practices by nature. However, this summit will provide you with solutions from strategic and national-wide perspective. Speakers&amp;nbsp; from various industries will share best practices which have been tested on the ground.&lt;br&gt;&lt;br&gt;&lt;b&gt;Upgrade Your Learning through Exclusive Working Group Sessions&lt;/b&gt;&lt;br&gt;&lt;br&gt;Two exclusive and highly interactive sessions are tailored for attendees who want to be immersed in in-depth discussions and obtain more detailed information. Whether you are new to the field or are a senior executive who needs a comprehensive refresher, these sessions will provide you with practical guidance on complex HR and labor issues.&lt;br&gt;&lt;br&gt;Working Group A:&lt;b&gt; A Complete Guide for Terminating Senior Management and Foreign Expats in China &lt;/b&gt;&lt;br&gt;&lt;br&gt;Benchmarking Session B: &lt;b&gt;Practical Approaches to Union and Collective Contracts&lt;/b&gt;&lt;br&gt;&lt;br&gt;Seats at this unique event are expected to fill out. Do not miss this unique opportunity to benchmark best practices with your peers. Reserve your seat today:&lt;br&gt;&lt;br&gt;(1) Website: www.AmericanConference.com/ChinaEmployment&lt;br&gt;(2) To call + 44 20 7878 6888 in Europe, or +1 416 926 8200 in the USA&lt;br&gt;(3) Email: CustomerService@AmericanConference.com&lt;br&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Employment &amp; Benefits</category>
<category>China &amp; Singapore</category>
<category>Regulatory &amp; Compliance</category>
<category>Regulatory Compliance and Trade</category>
<category>Legal</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/981/china-employment-and-labor-management/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Foreign Corrupt Practices Act</title>
<link>http://www.americanconference.com/2012/860/foreign-corrupt-practices-act/</link>
<pubDate>Tue 17 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;THE PREMIER LEGAL &amp;amp; REGULATORY &lt;br&gt;ANTI-CORRUPTION COMPLIANCE EVENT&lt;/b&gt; &lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Join the conversation. Attend the FCPA conference that shapes&lt;br&gt; the anti-corruption industry. In New York for an encore!&lt;br&gt;&lt;/b&gt;&lt;/div&gt;&lt;br&gt;Reserve your seat today for the most advanced and comprehensive FCPA event on the market. Now in its 27th successful year, ACI's National Conference on the Foreign Corrupt Practices Act will once again provide advanced and practical insights on the latest FCPA cases, global anti-corruption compliance strategies and unparalleled networking opportunities. &lt;br&gt;&lt;br&gt;&lt;b&gt;Updated with new panels and speakers the New York agenda promises to deliver more opportunities for benchmarking and practical learning. &lt;/b&gt;&lt;br&gt;&lt;br&gt;The conference will open with the hallmark &quot;FCPA Year in Review Panel&quot; and breakdown of the latest cases including Lindsey Manufacturing. A Q&amp;amp;A discussion will follow and provide delegates with the unique opportunity to engage in a dialogue with the US DOJ and SEC on FCPA enforcement and compliance.&lt;br&gt;&lt;br&gt;&lt;b&gt;RETHINK FCPA COMPLIANCE &lt;/b&gt;&lt;br&gt;&lt;br&gt;Learn how innovative global organizations have gone beyond the standard FCPA compliance program. Industry leaders will share practical pointers on how they have developed cost-conscious and innovative FCPA compliance strategies. &lt;br&gt;&lt;br&gt;&lt;b&gt;NEW FOR NEW YORK PROGRAM:&lt;/b&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Legislative reform of the Foreign Corrupt Practices Act&lt;/li&gt;&lt;li&gt;FCPA compliance and risk management&amp;nbsp; for private equity firms and hedge funds &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;b&gt;Benefit from advanced discussions on: &lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Detecting bribery schemes, high risk structures, hidden parties and other questionable transactions&lt;/li&gt;&lt;li&gt;Auditing and testing your anti-corruption compliance program&amp;nbsp;&lt;/li&gt;&lt;li&gt;Disclosing post Dodd-Frank: Balancing whistle-blower, defense and corporate governance obligations&amp;nbsp;&lt;/li&gt;&lt;li&gt;Contrasting NPAs, DPAs and plea agreements&lt;/li&gt;&lt;li&gt;How to achieve the right level of control and supervision in joint-venture arrangements&lt;/li&gt;&lt;li&gt;Developing more effective internal controls to support your compliance initiatives&lt;/li&gt;&lt;li&gt;Lessons learned from the Lindsey decision&amp;nbsp;&lt;/li&gt;&lt;li&gt;Designing risk-based third party auditing and monitoring strategies &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;b&gt;Complete your conference experience with these acclaimed interactive Working Groups:&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;A.&lt;/b&gt; The Fundamentals of FCPA Compliance: The Foreign Corrupt Practices Act Demystified &lt;br&gt;&lt;br&gt;&lt;b&gt;B.&lt;/b&gt; Gifts, Entertainment and Hospitality in High Risk Markets: A Practical Guide on What you Can, and Can't Do &lt;br&gt;&lt;br&gt;&lt;b&gt;C.&lt;/b&gt; Sharpening Your Third-Party FCPA Due Diligence Program to Better Target Your Risks &lt;br&gt;&lt;br&gt;&lt;b&gt;D.&lt;/b&gt; FCPA Internal Investigations: A Complete Guide on How to Set up, Manage and Conduct Thorough Internal Investigations into Bribery Allegations &lt;br&gt;&lt;br&gt;Come prepared with your most pressing compliance questions and take advantage of this unique opportunity to join in discussions with industry leaders and senior government officials that shape best practices and the anti-corruption industry. &lt;br&gt;&lt;br&gt;This is the event that corporate counsel, compliance officers, outside counsel and forensic accountants rely on for comprehensive, insightful, and practical guidance on critical FCPA compliance issues. Book your place today. Last event in November 2011 was the largest turnout ever for this conference. Be sure to register early. Call &lt;b&gt;1-888-224-2480&lt;/b&gt;; fax your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;; or register online at &lt;b&gt;&lt;a href=&quot;http://www.americanconference.com/FCPANY&quot;&gt;www.americanconference.com/FCPANY&lt;/a&gt;. &lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/860/foreign-corrupt-practices-act/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Global Encryption Controls</title>
<link>http://www.americanconference.com/2012/883/global-encryption-controls/</link>
<pubDate>Wed 18 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;p&gt;How this conference differs from other events: &lt;strong&gt;American Conference Institute's 3rd Advanced Summit on Global Encryption Controls&lt;/strong&gt; is an industry-led program that will provide an optimal benchmarking opportunity for companies on how to reduce new, complex and emerging compliance risks worldwide. Don't miss this opportunity to obtain critical information that is&lt;em&gt; not available in print or on the web&lt;/em&gt;. Network and learn from export counsel and compliance officers &lt;strong&gt;experienced in navigating foreign encryption control regulations&lt;/strong&gt;, in key jurisdictions, including &lt;strong&gt;China, Asia &lt;/strong&gt;and&lt;strong&gt; Europe.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Countries such as &lt;strong&gt;China, Russia, India, France, Ireland, the UK &lt;/strong&gt;and&lt;strong&gt; Canada&lt;/strong&gt; are all developing comprehensive laws on the import and export of encryption items ? requiring specific licenses or authorizations to import, use and export items with encryption technology. &lt;/p&gt;
&lt;p&gt;The &lt;strong&gt;Wassenaar Arrangement &lt;/strong&gt;and other international agreements such as the&lt;strong&gt; Trans Pacific Partnership&lt;/strong&gt;, are becoming more influential as countries seek to work together on developing a comprehensive set of encryption regulations. &lt;strong&gt;Knowing each country's specific laws is essential for companies that do business on a global scale.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;As the global landscape is changing dramatically each year, export compliance professionals must understand both foreign and U.S. encryption regulations. More and more, companies are using encryption items to protect the integrity of their information. In addition, more employees are traveling internationally, bringing up the challenge of remaining compliant with import laws as they enter each country.&lt;/p&gt;
&lt;p&gt; The need for a comprehensive compliance program that incorporates all regulations and policy developments is necessary to &lt;strong&gt;prevent severe monetary fines, loss of import/export privileges and criminal penalties. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Key topics will include:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;How &lt;strong&gt;international agreements &lt;/strong&gt;affect the import and export of cryptography&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt; Obtaining export permits from the SEMB in China&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;Preventing steep fines for &lt;strong&gt;export violations in&lt;/strong&gt; &lt;strong&gt;Malaysia &lt;/strong&gt;and &lt;strong&gt;Hong Kong&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt; How to handle&lt;strong&gt; technology transfers through cloud computing&lt;/strong&gt; without violating encryption regulations around the globe&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Russia's recent joining of the WTO&lt;/strong&gt;, the U.S.-Russia 2006 Bilateral Agreement and what this means for your export compliance program&lt;/li&gt;
  &lt;li&gt; How to use &lt;strong&gt;Ireland&lt;/strong&gt; and the &lt;strong&gt;Netherlands&lt;/strong&gt; as key software and hardware EU distribution centers&lt;/li&gt;
  &lt;li&gt; &lt;strong&gt;Complying with Israeli encryption registration&lt;/strong&gt; and distribution requirements to prevent strict penalties and license revocation&lt;/li&gt;
  &lt;li&gt; Complying with &lt;strong&gt;Canadian &lt;/strong&gt;and &lt;strong&gt;Mexican&lt;/strong&gt; export controls to prevent business losses and delays  &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Also, benefit from interactive pre-summit working groups:&lt;br&gt;
&lt;strong&gt;April 17, 2012&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Group A: &lt;/strong&gt;&lt;/em&gt;When and How to Obtain an ERN, Apply License Exception ENC, and Self-Classify: A Practical Guide to What Every Export Controls Professional Needs to Know&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;Group B: &lt;/strong&gt;&lt;/em&gt;Employee Travel with Encryption Controlled-Items: Preventing Unauthorized Access and Setting up Internal Compliance Procedures for International Travel&lt;/p&gt;
&lt;p&gt;Reserve your seat early by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt;, faxing your registration to &lt;strong&gt;1-877-927-1563&lt;/strong&gt; or registering online at: &lt;strong&gt;www.americanconference.com/encryption&lt;/strong&gt;&lt;/p&gt;


</description>
<category>International Trade</category>
<category>Intellectual Property</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<category>Aerospace and Defense</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/883/global-encryption-controls/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Reducing Legal Risks in the Sales and Marketing of Medical Devices</title>
<link>http://www.americanconference.com/2012/886/reducing-legal-risks-in-the-sales-and-marketing-of-medical-devices/</link>
<pubDate>Mon 23 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;p&gt;In a new era of heightened scrutiny, there is &lt;strong&gt;one place&lt;/strong&gt; where you can learn how to &lt;strong&gt;reduce the risk&lt;/strong&gt; of massive fi nes, litigation costs, misconduct charges, guilty pleas, negative publicity and more -&lt;strong&gt; ACI's 12th National Summit on Reducing Legal Risks in the Sales and Marketing of Medical Devices&lt;/strong&gt;. This annual conference will enable you to reshape your compliance programs to refl ect recent legislation and changes in enforcement priorities and to develop corporate policies that protect against future fraud claims.&lt;/p&gt;
&lt;p&gt; Never before have device companies been so pressured by issues arising simultaneously on the state, national and international levels. At this uniquely trying time, day-to-day activities can become the focus of inquiries by members of Congress, investigations by federal and/or state prosecutors, and whistleblower claims.  Additionally, see how other device manufacturers are responding to Sunshine Act requirements as you benchmark against your peers from:&lt;strong&gt; Baxter International, CareFusion, Covidien, Cyberonics, Inc., Fresenius Medical Care, Hollister Incorporated, Medline Industries, Medtronic, Roche Diagnostics Corporation, Smith &amp;amp; Nephew, University of Chicago Medical Center, Wright Medical, and Zimmer Holdings. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;u&gt;The Government Has You Under a Microscope ? Learn The Enforcement Priorities for 2012&lt;/u&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Prosecutors are using all the tools at their disposal to ensure that fraud and abuse by device manufacturers is kept at bay, including increased fi nes, prosecution of individuals and recalls?. By attending this conference, you will have an unparalleled opportunity to hear directly from government representatives regarding what activities are currently triggering enforcement. Gain insights from: federal and state enforcers:  &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; &lt;em&gt;&lt;strong&gt;J. Gilmore Childers, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
    First Assistant U.S. Attorney, &lt;br&gt;
    New Jersey District&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;&lt;strong&gt;Gejaa Gobena,&lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
    Trial Attorney, Fraud Section, Criminal Division, &lt;br&gt;
    U.S. Department of Justice&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;&lt;strong&gt;Keith V. Morgan, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
    Assistant U.S. Attorney, Deputy Chief, Civil Division, &lt;br&gt;
    District of Columbia District&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;&lt;strong&gt;Stephanie Morse, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
    Assistant Attorney General, Complex Civil Enforcement Bureau, &lt;br&gt;
    State of Florida Office of the Attorney General &lt;/li&gt;
  &lt;li&gt; &lt;em&gt;&lt;strong&gt;Tracy L. Price, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
    Assistant Director, &lt;br&gt;
    FCPA Unit, Division of Enforcement, U.S. Securities &amp;amp; Exchange Commission&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;&lt;strong&gt;Jeremy Sternberg, &lt;/strong&gt;&lt;/em&gt;&lt;br&gt;
    Deputy Chief, Health Care Fraud Unit, &lt;br&gt;
    U.S. Attorney's Office, District of Massachusetts. &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;As Device Operations Become More Global, So Do the Global Compliance RisksIt is not uncommon for multinational device manufacturers to be put on notice that they are being investigated for payments made to foreign physicians and health offi cials in various countries. With FCPA enforcement heating up, and the UK Bribery Actbeginning to take shape, it is critical for you to learn how to build a global compliance program to withstand the scrutiny of multiple countries. Expert speakers from the &lt;strong&gt;SEC, Bausch &amp;amp; Lomb, Biomet and Becton Dickinson&lt;/strong&gt; will share tips for installing adequate internal controls to oversee foreign  subsidiaries.  &lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Post-Conference Workshops Complete Your Training&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Complement your conference experience and gain hands-on and in-depth guidance on training and contracting. The Interactive Working Group: Executing a Comprehensive Training and Monitoring System to Minimize the Risks of Sending Your Sales Team Into the Field will enable you to see what training techniques your competitors are utilizing and how to most effectively ensure your team is engaging in compliant practices. The Master Class on Drafting an Effective and Compliant Contract Between Device Manufactures and Hospitals will give attendees a better understanding of the requirements for the hospital-manufacturer contract, and highlight what areas are subject to increasing government review. &lt;/p&gt;
&lt;p&gt;Register today by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt;, faxing 1-&lt;strong&gt;877-927-1563&lt;/strong&gt;, or visiting ACI online at &lt;strong&gt;www.americanconference.com/MedicalDevices. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Advertising &amp; Marketing</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/886/reducing-legal-risks-in-the-sales-and-marketing-of-medical-devices/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Paragraph IV Disputes</title>
<link>http://www.americanconference.com/2012/870/paragraph-iv-disputes/</link>
<pubDate>Tue 24 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York City | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Over 80% of drug manufacturers are unprepared to meet the legal challenges of more than $60 billion in pharmaceutical patent losses.&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt; Is your company one of them?&lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Avoid being caught off guard by attending the only event dedicated to providing brand name and generic legal professionals like you  with the tools needed to master the strategies, standards and tactics of Paragraph IV litigation.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Brand name and generic pharmaceutical companies are beginning to feel the initial impact of the patent cliff: the pecuniary perils of patent loss and the economic consequences associated with the decline of Hatch-Waxman market exclusivity. As a result, the industry has entered an era of &quot;extreme&quot; Paragraph IV litigation where the monetary ante has never been higher.&lt;/p&gt;
&lt;p&gt;To help you respond to the challenges of this new era, &lt;strong&gt;ACI's 6th Annual Paragraph IV Disputes&lt;/strong&gt; conference will guarantee your access to the leading legal minds in this area.  A &lt;strong&gt;&quot;who's who&quot; of Hatch-Waxman litigators ? for both brand names and generics&lt;/strong&gt; ? will help you conquer the patent crisis of 2012 by addressing such industry shaping topics as:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; The	impact	of	the	AIA	on	Hatch	?Waxman	litigation&lt;/li&gt;
  &lt;li&gt; Carve-outs,	use	codes	and	labeling&lt;/li&gt;
  &lt;li&gt; Claim	construction&lt;/li&gt;
  &lt;li&gt; Prior	art	obviousness	and	obvious-type	double	patenting&lt;/li&gt;
  &lt;li&gt;Inducement	of	infringement	and	divided	infringement&lt;/li&gt;
  &lt;li&gt; Inequitable	conduct&lt;/li&gt;
  &lt;li&gt; Damages&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Hear also from &lt;strong&gt;renowned federal jurists&lt;/strong&gt; and a &lt;strong&gt;key official&lt;/strong&gt; from the &lt;strong&gt;Federal Trade Commission&lt;/strong&gt;. Learn firsthand how the bench analyzes the theories of your case and what the FTC deems as &quot;fair and foul&quot; in the settlement of pharmaceutical patent disputes.&lt;/p&gt;
&lt;p&gt;Complete your professional training by attending one or more of these &lt;strong&gt;customized Working Groups, Workshops and Master Classes:&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt; &lt;strong&gt;Hatch-Waxman and BPCIA 101 ? A Primer on IP Basics and Regulatory Fundamentals &lt;/strong&gt;which will provide the patent and regulatory backdrop for the more in-depth Hatch-Waxman litigation controversies discussed in the main conference; &lt;/p&gt;
&lt;p&gt; &lt;strong&gt;A Working Group Session on Assessing The Impact of New PTO Procedures Under the AIA on Paragraph IV Litigation&lt;/strong&gt; which will address how new pre- and post issuance procedures may alter certain components of Paragraph IV litigation and parallel proceedings between the Federal Courts and PTO; and&lt;/p&gt;
&lt;p&gt; &lt;strong&gt;The Master Class on Settling Paragraph IV Disputes: Drafting and Negotiating Strategies for Brand-Names and Generics&lt;/strong&gt; which will give practical and hands-on  strategies for drafting and negotiating settlement agreements that will pass muster  with the FTC.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;In this costly and ruthless endgame, not a moment can be lost&lt;/strong&gt;. Register now by calling&lt;strong&gt; 1-888-224-2480,&lt;/strong&gt; faxing your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt; or logging on to &lt;strong&gt;www.AmericanConference.com/PIVDisputesNYC&lt;/strong&gt;&lt;/p&gt;


&lt;p&gt;&lt;br&gt;&lt;/p&gt;</description>
<category>Litigation</category>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Hatch-Waxman</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/870/paragraph-iv-disputes/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">OFAC Enforcement and Compliance</title>
<link>http://www.americanconference.com/2012/700/ofac-enforcement-and-compliance/</link>
<pubDate>Wed 25 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;p&gt;&lt;strong&gt;VIGOROUS GLOBAL ENFORCEMENT. STAGGERING PENALTIES. NEW AND EVOLVING SANCTIONS RESTRICTIONS. LEARN HOW TO MINIMIZE THE MOST CRITICAL GLOBAL SANCTIONS COMPLIANCE RISKS BEFORE IT'S TOO LATE. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Now in its fifth successful year, American Conference Institute's
  Advanced Forum on OFAC Compliance and Enforcement is widely
  regarded as the premier benchmarking and networking event for
  sanctions professionals. This advanced, flagship conference focuses
  on the most complex, hot button issues that impact global financial,
  insurance and export transactions.&lt;/p&gt;
&lt;p&gt;Big ticket settlements, including JPMorgan, Flowserve, Credit Suisse,
  Lloyds and Barclays Bank demonstrate the potentially heavy price tag
  associated with U.S. sanctions violations, as well as the U.S. government's
  resolve to aggressively prosecute OFAC violations. Such enforcement
  activity will undoubtedly continue and underscores the importance of
  strengthening internal risk-based sanctions compliance programs.  &lt;/p&gt;
&lt;p&gt;Amid evolving sanctions against Iran, Syria and other regimes, and
  strict EU sanctions, U.S. and foreign entities with global operations
  face unprecedented enforcement risks.&lt;/p&gt;
&lt;p&gt;  The highly sophisticated 2012 agenda is&lt;u&gt; fully updated&lt;/u&gt;, featuring a
  new &lt;u&gt;expert speaker line-up&lt;/u&gt; of senior government officials, industry 
 professionals and private practice experts.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;  New 2012 OFAC and HM Treasury (UK) Keynote Addresses:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; &lt;em&gt;Adam J. Szubin&lt;/em&gt;, Director, OFAC&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Mikael Down&lt;/em&gt;, Deputy Director, Sanctions and Illicit Finance
    Team, HM Treasury (London)&lt;br&gt;
  &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;First-Hand Insights and Q &amp;amp; A with Senior OFAC Officials:&lt;/strong&gt;&lt;br&gt;
 &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; &lt;em&gt;Jonathan Thomas&lt;/em&gt;, Chief, Regulated Industries Oversight   &amp;amp; Evaluation&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Alexandre Manfull&lt;/em&gt;, Chief, Blocked Assets Administration
  and Analysis&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Lorraine B. Lawlor&lt;/em&gt;, Chief of Compliance Outreach&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Michael Geffroy&lt;/em&gt;, Assistant Director for Enforcement&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Dennis Wood&lt;/em&gt;, Assistant Director, Sanctions Compliance  &amp;amp; Evaluation&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;Andrea Gacki&lt;/em&gt;, Assistant Director for Licensing    &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Hear from the State Department on CISADA and Other Policy Updates:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; &lt;em&gt;Linda Specht&lt;/em&gt;, Director, Office of Terrorism Finance and
    Economic Sanctions Policy, U.S. Department of State&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;New 2012 Speakers from DOJ, Federal Reserve Bank of New
    York, OCC and The New York County District Attorney's Office:&lt;/strong&gt;&lt;br&gt;
  &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt; &lt;em&gt;Sean O'Malley&lt;/em&gt;, Vice President and Deputy Chief Investigator
  for Enforcement, Federal Reserve Bank of New York&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;Steven W. Pelak&lt;/em&gt;, National Export Coordinator, U.S.
    Department of Justice&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Adam Kaufmann&lt;/em&gt;, Executive Assistant District Attorney, Chief
    of the Investigation Division, The New York County District
    Attorney's Office&lt;/li&gt;
  &lt;li&gt;&lt;em&gt; Indira Crum&lt;/em&gt;, BSA/AML Compliance Specialist, Office of the
    Comptroller of the Currency&lt;/li&gt;
  &lt;li&gt; &lt;em&gt;Beverly Jules&lt;/em&gt;, Supervising Examiner, Federal Reserve Bank
    of New York&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    Based on the past success of this event, seats are expected to
  sell out. Register now by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt;; faxing your
  registration form to&lt;strong&gt; 1-877-927-1563&lt;/strong&gt;; or registering &lt;a onclick=&quot;newWindow('https://transactions.c5groupinc.com/event_reg.php?conf=3033&amp;amp;site=1&amp;amp;lang=en&amp;amp;gap=3','reg_now','600','720',''); pageTracker._link(this.href); return false;&quot; href=&quot;javascript:void(null);&quot;&gt; online &lt;/a&gt;&lt;/p&gt;

</description>
<category>Financial Services</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/700/ofac-enforcement-and-compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">3rd Annual Chemical Products Liability and Environmental Litigation</title>
<link>http://www.americanconference.com/2012/885/3rd-annual-chemical-products-liability-and-environmental-litigation/</link>
<pubDate>Wed 25 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;p&gt;&lt;strong&gt;Get ahead of crisis situations and protect the company before disaster strikes. Arm yourself with effective strategies and critical information to master strategic communications and crisis management.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Take advantage of the unparalleled opportunities now available to learn lessons from the beginning stages of Gulf Oil Spill litigation and the Supreme Court's holding on the AEP climate change case. The past year's events have made it clear that it is imperative to have plans in place to manage catastrophic events.&lt;/p&gt;
&lt;p&gt; ACI has responded to the needs of the industry by creating the Chemical Products Liability and Environmental Litigation conference, now in its third year. This essential litigation forum is designed to educate practitioners?both in-house and outside counsel?on the leading trends in chemical products liability and environmental litigation.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;There is no other conference available that not only addresses pressing changes in the industry that impact litigation, but also provides practical information to bolster your practice, the cutting-edge information about emerging areas of concern, and an opportunity to hear insights from esteemed jurists from throughout the country. &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Join experts from &lt;strong&gt;AkzoNobel, Chevron, Chevron Phillips Chemical Co., Dow AgroSciences, Dow Chemical, Georgia Gulf Corp., Occidental Chemical Corp., PPG Industries Praxair, Shell Oil, Sunoco&lt;/strong&gt;, &lt;em&gt;and many more&lt;/em&gt;, as they discuss the hottest topics in chemical products liability and environmental litigation, including:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Preparing for the future of climate change litigation post-&lt;em&gt;Connecticut v. AEP&lt;/em&gt;&lt;/li&gt;
  &lt;li&gt; Learning from the Deepwater Horizon to mitigate risk and damages in litigation over catastrophic events&lt;/li&gt;
  &lt;li&gt; Protecting the company by mastering strategic communications and crisis management&lt;/li&gt;
  &lt;li&gt; Learning from Louisiana legacy oilfield contamination cases to mitigate long-term risk in fracking operations&lt;/li&gt;
  &lt;li&gt; Bolstering defense strategy by defeating arguments of exposure and causal nexus to injury&lt;/li&gt;
  &lt;li&gt; Optimizing settlement strategies using the &lt;em&gt;Dukes&lt;/em&gt; decision to your advantage&lt;/li&gt;
  &lt;li&gt; Maintaining ethical standards when settling multiparty cases&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Plus, benefit from the opportunity to hear from 6 state and federal court judges as they discuss important elements of litigation, including Daubert motions and discovery challenges.  Ensure you are prepared to tackle emerging litigation trends and challenges at this unique and important event.  Last year, this event almost sold out; ensure that you can attend this event by reserving your space now. &lt;/p&gt;
&lt;p&gt;Register by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt;, online at &lt;strong&gt;www.AmericanConference.com/ChemProducts &lt;/strong&gt;or faxing your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</description>
<category>Energy &amp; Resources</category>
<category>Litigation</category>
<category>Regulatory &amp; Compliance</category>
<category>Environmental</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/885/3rd-annual-chemical-products-liability-and-environmental-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Fire and Casualty Claims and Litigation</title>
<link>http://www.americanconference.com/2012/727/fire-and-casualty-claims-and-litigation/</link>
<pubDate>Thu 26 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;p&gt;&lt;strong&gt;ACI's Fire &amp;amp; Casualty Claims and Litigation conference is an unparalleled opportunity to get up to speed on changes and updates in NFPA 921, evidentiary standards, and science &lt;em&gt;while networking with scores of in house counsel, claims managers and risk adjusters.&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Latest version of NFPA 921's negative corpus rule?.changes, updates and amendments to NFPA 921?.fraud and arson?..selection and credentialing of cause and origin experts?..exclusionary causes?.costly preliminary investigations?.electrical damages? fire loss?product defect?..construction defect?.&lt;strong&gt;the list goes on and on.&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;Recent developments to the NFPA standards and regulations have changed the fi re &amp;amp; casualty claims and litigation landscape. Now more than ever, attorneys need to be up to date with changes and amendments to NFPA 921. &lt;strong&gt;ACI's lauded Fire &amp;amp; Casualty Claims and Litigation Conference&lt;/strong&gt;, through its leading panel of origin and cause experts, will keep you apprised of the nuances and complexities of NFPA standards and regulations and answer the key questions of how will the negative corpus rule preclude a cause and origin investigation based on elimination and what credentials must cause and origin experts have in order to successful defend against a &lt;em&gt;Daubert&lt;/em&gt; challenge.&lt;/p&gt;
&lt;p&gt;To complicate matters further, often the first responders to a scene will fail to properly preserve evidence resulting in evidence spoliation. This conference will help you identify the unique issues as they relate to a fire scene (including how to identify a red herring when a critical piece of evidence is removed), establish a valid defense of lack of notice as a subrogation defendant, and draft a motion to exclude evidence and request instructions when exclusions are denied.&lt;/p&gt;
&lt;p&gt;This is the premier Fire &amp;amp; Casualty summit that will shape the future of the industry's claims and litigation strategies for leading litigators and in house professionals.  This event is a  must-attend event for cause and origin experts, insurance professionals and outside counsel involved with fire &amp;amp; casualty claims &amp;amp; litigation cases. You will not want to miss this unparalleled opportunity to obtain up-to-the-minute information and critical advice from the nation's leading scientific and legal experts. &lt;/p&gt;
&lt;p&gt;Register now by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt; or by faxing your registration form to &lt;strong&gt;1-877-927-1563&lt;/strong&gt;. You can also register online at &lt;/p&gt;
&lt;p&gt;PLUS, add value to your attendance by also registering for the Pre-Conference Primer and Post-Conference Master Class:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A Pre-Conference Fire &amp;amp; Casualty Law Boot Camp ? An In-Depth Analysis of the Essentials for New Practitioners &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B Formulating a Discovery/E-Discovery and Document Retention Plan to Defend and Manage Fire &amp;amp; Casualty Claims&lt;/strong&gt;&lt;/p&gt;

</description>
<category>Manufacturing &amp; Industrial</category>
<category>Environmental</category>
<category>Litigation</category>
<category>Insurance &amp; Reinsurance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/727/fire-and-casualty-claims-and-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Reinsurance Disputes in Litigation &amp; Arbitration</title>
<link>http://www.americanconference.com/2012/726/reinsurance-disputes-in-litigation--arbitration/</link>
<pubDate>Mon 30 Apr 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;p&gt;&lt;strong&gt;There has never been a disputes-based reinsurance conference with a faculty as renowned as this one, including leading in-house professionals, federal and state regulators and distinguished jurists. By attending, you'll not only get up to speed on the new claims, targets and hot spots, but the networking will be unparalleled!&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;With the growing contentiousness of reinsurance disputes and the constantly increasing time, expense and uncertainty of arbitration proceedings, it is critical that insurers, reinsurers and the outside counsel who represent them are able to devise and pursue effective strategies for success in disputes. Dodd-Frank, recent NAIC revisions and new priorities and trends in state regulation are already having a huge effect on the reinsurance industry, and with continuing fallout from catastrophic events, asbestos and other long tail claims it is important for companies and their counsel to get ahead of these potential disputes while ensuring the best strategies to resolve them in arbitration. &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;ACI's Advanced Forum on Reinsurance Disputes in Arbitration and Litigation&lt;/strong&gt; is designed to offer cedents, reinsurers, brokers, attorneys and other reinsurance professionals valuable insight into the dispute and arbitration process. Our faculty  of regulatory and enforcement officials, renowned jurists, experienced arbitrators and leading outside counsel will provide insights and strategies for managing disputes and winning arbitration awards. Hear directly from insurance commissioners on NAIC action and the latest trends in state enforcement, as well as from leaders in the reinsurance industry, including in-house counsel from: &lt;strong&gt;Willis Re, SCOR, Aon Benfield, Chartis, Aspen U.S. Holding, The Hartford, RGA Reinsurance Group, Partner Re, Allstate,  Liberty Mutual Group, Trans Re and RiverStone-US.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Topics will include: &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;An	in-house	think	tank	with	insight	from	major	corporations	on	the	latest	risks,	claims and trends and how outside counsel can adapt as a result &lt;/li&gt;
  &lt;li&gt; A	panel	of	5	state	insurance	commissioners	moderated	by	the	Chief	State	Liaison at the NAIC, with a discussion of recent NAIC action and revisions, new priorities and emerging trends in state regulation, and the impact of it all for reinsurance litigators and arbitrators&lt;/li&gt;
  &lt;li&gt; View	from	the	Bench	led	by	Federal	Magistrate	judges	who	will	provide	their	expert views on overturning arbitration decisions, umpire and arbitrator disqualification, loss allocation and consolidation, and agreements to maintain confidentiality &lt;/li&gt;
  &lt;li&gt; A	panel	of	experienced	arbitrators	will	show	you	how	to	resolve	the	thorniest	issues of discovery, claim consolidation and acting outside the scope of  the contract &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Plus, complete your conference experience with two in-depth focus sessions:&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A&lt;/strong&gt;- Reinsurance Case Law Update: Recent Notable Decisions and Their Impact  on Reinsurance Disputes&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;B&lt;/strong&gt; - On the Horizon: Longstanding and Emerging Reinsurance Disputes  Regarding WTC, Asbestos, Mortgage Backed Securities, Hydro-Fracking  and Natural Disaster Claims &lt;/p&gt;
&lt;p&gt;Register now by calling &lt;strong&gt;888-224-2480&lt;/strong&gt; or faxing your registration form to &lt;strong&gt;877-927-1563&lt;/strong&gt;. You can also register online at &lt;strong&gt;www.AmericanConference.com/Reinsurance&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;bold&quot;&gt;&lt;/span&gt;&lt;/p&gt;</description>
<category>Insurance &amp; Reinsurance</category>
<category>Litigation</category>
<category>Ethics Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/726/reinsurance-disputes-in-litigation--arbitration/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Rx Drug Pricing Boot Camp - West Coast Edition</title>
<link>http://www.americanconference.com/2012/713/rx-drug-pricing-boot-camp---west-coast-edition/</link>
<pubDate>Wed 2 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;p&gt;&lt;strong&gt;Master calculations and grasp complexities 
  inherent to government payor programs&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The ninth iteration of &lt;strong&gt;ACI's National Rx Drug Pricing Boot Camp&lt;/strong&gt; promises to
  supply crucial information on effective and efficient management of government
  pricing programs to drug manufacturers, PBMs, plans, and pharmacies. Marrying a
  primer on the basics of pricing for government payor programs and a comprehensive,
  in-depth, training program, this conference ensures that pricing groups and other
  related departments are well-versed in critical concepts and methodologies. Further,
  you will be apprised of trends, best practices, and imminent changes in government
  payor programs and pricing areas. This course will enhance your understanding
  of complicated pricing calculations and will bring you up to speed on the latest in
  government pharmaceutical pricing.&lt;/p&gt;
&lt;p&gt;  &lt;strong&gt;Gain best practices to comply with new regulations&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;  At press time, CMS has yet to issue its new regulations governing the calculation AMP. 
  It is anticipated that at the time of this event the CMS rule will be finalized and the
  industry will be facing the challenge of complying with and responding to these new
  rules. This conference will bring you up-to-the-minute information on recently enacted
  rules, regulations, and CMS guidance, detailing how your company can incorporate
  changes resulting from the implementation of health care reform into your pricing
  and compliance practices. Our faculty of pricing experts will help maximize your
  company's participation in government payor programs by eliminating the confusion
and uncertainty created by health care reform.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt; Network with and learn from your fellow pricing and reimbursement professionals&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt; In addition to intensive training in core pricing concepts, the &lt;strong&gt;9th National Rx Drug
  Pricing Boot Camp&lt;/strong&gt; is also an excellent forum for drug pricing professionals to
  network with their peers. This event typically has about 80% of its attendees come
  from drug manufacturers, PBMs, plans and pharmacies, making it an excellent place
  to hear experts from other companies on how they overcome pricing challenges.  &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Maximize the value of attendance with pre- and post-conference workshops
  featuring background information and in-depth analysis of pricing issues&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;  The Pre-Conference Workshop A: &lt;strong&gt;Government Payor Pricing 101: Primer for
    Professionals New to Pharmaceutical Pricing &lt;/strong&gt;has been designed specifically
    for those attendees who need a basic introduction to the complex subject
    of government drug pricing. This workshop will set the stage for the main
    conference and help attendees fl ow seamlessly into the conversations over the
  following days.&lt;/li&gt;
  &lt;li&gt; The Post-Conference Workshop B: &lt;strong&gt;The Master Class on Federal Government
    Contracts and Pricing: FSS, VA, DoD, and More&lt;/strong&gt; will build on the pricing
    fundamentals covered during the main conference and delve into the core
    pricing competencies for the &quot;Big Four&quot; government agencies.  &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Past iterations of the Boot Camp sold out; register now to ensure your place at this
    unique and important event. Call &lt;strong&gt;1-888-224-2480&lt;/strong&gt;, fax your registration form to
  &lt;strong&gt;1-877-927-1563&lt;/strong&gt;, or &lt;a onclick=&quot;newWindow('https://transactions.c5groupinc.com/event_reg.php?conf=3053&amp;amp;site=1&amp;amp;lang=en&amp;amp;gap=3','reg_now','600','720',''); pageTracker._link(this.href); return false;&quot; href=&quot;javascript:void(null);&quot;&gt; online&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/713/rx-drug-pricing-boot-camp---west-coast-edition/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">FCPA and Anti-Corruption for the Life Sciences Industry</title>
<link>http://www.americanconference.com/2012/709/fcpa-and-anti-corruption-for-the-life-sciences-industry/</link>
<pubDate>Tue 8 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;o:OfficeDocumentSettings&gt;
  &lt;o:AllowPNG/&gt;
 &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; Name=&quot;Plain Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;&quot;Johnson &amp;amp; Johnson will pay a $21.4 million penalty to resolve criminal FCPA charges with the DOJ?&quot;&lt;br&gt;&lt;br&gt;&quot;Johnson &amp;amp; Johnson in $77 Million Global Settlement,&quot; The FCPA Blog, April 2011&lt;br&gt;&lt;br&gt;&quot;Pfizer will pay more than $60 million to settle alleged violations of the U.S. Foreign Corrupt Practices Act?Spurred by the investigations, companies throughout the industry are developing multimillion-dollar compliance programs?with these settlements &lt;i&gt;the government has created incentives for companies to come forward, not only to cooperate in investigations but also to&lt;/i&gt;&lt;u&gt; inform on competitors.&lt;/u&gt;&quot;&lt;br&gt;&lt;br&gt;&quot;Pfizer Settlement Offers Window Into Pharmaceutical Industry Probe,&quot; November 2011, Wall Street Journal&lt;br&gt;&lt;br&gt;&lt;b&gt;The life sciences &quot;industry sweep&quot; is in full swing. Recent high-profile settlements by two large, multi-national pharmaceutical manufacturers for violations of the FCPA make one fact clear ? this is only the beginning?&lt;/b&gt;&lt;br&gt;&lt;br&gt;Structured specifically to provide a forum for addressing continuing and emerging areas of focus for FCPA enforcement by the U.S. DOJ and SEC, &lt;b&gt;ACI's&lt;/b&gt; &lt;i&gt;National Conference&lt;/i&gt; &lt;i&gt;on &lt;/i&gt;&lt;b&gt;FCPA &amp;amp; Anti-Corruption for the Life Sciences Industry&lt;/b&gt; is the annual must-attend event for legal and investigative counsel, global compliance officers, and FCPA attorneys, &lt;i&gt;specifically within the life sciences industry&lt;/i&gt;. Don't miss out on this opportunity to learn what steps you should be taking now to take now to proactively protect your company before, during and after the Government comes knocking.&lt;br&gt;&lt;br&gt;&lt;b&gt;How is your company poised to respond when the time comes to negotiate a settlement with the Government? Are you sure who retains oversight over foreign HCPs, consultants and doctors? What proactive steps are being taken now to minimize the blow from an FCPA settlement?&lt;/b&gt;&lt;br&gt;&lt;br&gt;Don't miss this opportunity to &lt;u&gt;meet the prosecutors&lt;/u&gt; and&lt;u&gt; strategize with top FCPA counsel&lt;/u&gt; as you are provided with proactive strategies for fortifying your compliance program in the following key areas:&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Screening and monitoring foreign third parties, HCPs, doctors and consultants&lt;/li&gt;&lt;li&gt;Compliance protocols and internal controls for global life science operations&lt;/li&gt;&lt;li&gt;Travel, gifts, entertainment and hospitality&lt;/li&gt;&lt;li&gt;Clinical research, physician sponsorships, grants and advisory boards&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;&lt;b&gt;Ensure your team is equipped with the tools it needs to withstand an FCPA investigation in this era of heightened enforcement. Learn what to do now to minimize your company's FCPA exposure tomorrow.&lt;/b&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Ethics Credits</category>
<category>CPE Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/709/fcpa-and-anti-corruption-for-the-life-sciences-industry/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Big Four</title>
<link>http://www.americanconference.com/2012/706/big-four/</link>
<pubDate>Tue 15 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;br&gt;At this annual conference, pricing experts will lay out the fundamentals of &quot;Big Four&quot; pricing and pharmacy benefits programs in a logical, easy-to-understand format and will provide intensive training in the essential pricing concepts and methodologies related to &lt;b&gt;VA, DoD, PHS&lt;/b&gt;, and Coast Guard programs.&lt;br&gt;&lt;br&gt;The U.S. government spends billions of dollars per year on the purchase of drugs making it one of the largest purchasers of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company's total revenue, and a company cannot remain competitive in today's market without selling to the government. As pharmaceutical manufacturers' revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.&lt;br&gt;&lt;br&gt;While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of &quot;Big Four&quot; pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the &quot;Big Four's&quot; numerous rules and regulations, companies must also evaluate how their &quot;Big Four&quot; prices affect their overall pricing. &lt;br&gt;&lt;br&gt;Designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies, ACI has assembled a faculty of the &lt;b&gt;government authorities&lt;/b&gt; on &quot;Big Four&quot; pricing and pharmacy benefits programs along with &lt;b&gt;expert pricing practitioners&lt;/b&gt;. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the &quot;Big Four&quot; agencies.&lt;br&gt;&lt;br&gt;As our delegates would agree, you cannot afford to miss this event.&amp;nbsp; &lt;br&gt;&lt;b&gt;&lt;i&gt;&lt;br&gt;&quot;The ?Big Four' conference provided me with a great source of concepts and examples to follow and understand. I believe the boot camp is a fabulous tool for people who are new to government contracting and pricing.&quot;&lt;/i&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;Towanda Little, Associate Manager of Government Pricing, Eisai Inc, Prior Delegate&lt;br&gt;For those attendees seeking a primer on &quot;Big Four&quot; pricing, the pre-conference workshop, &quot;Big Four Pricing 101,&quot; is a great opportunity to learn the fundamentals of federal pricing and will prepare you for the more advanced discussions that will take place during the main conference. The post-conference workshop, &quot;Advanced Training in DoD and TRICARE Contracting, Formulary, and Operational Issues,&quot; will provide the information and strategies you need to make interactions with the DoD and TMA more efficient and less burdensome.&lt;br&gt;&lt;br&gt;&lt;b&gt;Register now by calling 888-224-2480, faxing your registration form to 877-927-1563 or registering online at &lt;a href=&quot;http://www.americanconference.com/bigfourpharma&quot;&gt;www.americanconference.com/bigfourpharma&lt;/a&gt;&amp;nbsp; &lt;br&gt;&lt;/b&gt;&lt;br&gt;Full conference details are on the way shortly.&amp;nbsp; If you are interested in speaking at this event, contact Leigh Leventhal at l.leventhal@americanconference.com.&amp;nbsp; For information on sponsoring or exhibiting at this event, contact Wendy Tyler at w.tyler@americanconference.com.&lt;b&gt;&lt;/b&gt;&lt;br&gt;</description>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/706/big-four/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Managed Care Litigation</title>
<link>http://www.americanconference.com/2012/714/managed-care-litigation/</link>
<pubDate>Tue 22 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Philadelphia | In 2011, more than 100 leaders in the Managed Care field converged in Philadelphia for American Conference Institute's inaugural managed care litigation program. In 2012, Managed Care Organizations (MCOs) continue to represent &quot;deep pockets&quot; for potential plaintiffs and classes. The pursuit and defense of these suits requires meticulous planning, and often involve high costs. &lt;b&gt;ACI &lt;/b&gt;is pleased to present its 2nd Advanced Forum on &lt;b&gt;Managed Care Disputes and Litigation&lt;/b&gt;, taking place &lt;b&gt;May 21 ? 23, 2012&lt;/b&gt; in Philadelphia, and featuring trial attorneys and in-house counsel who have been active in some of the year's biggest cases. No other forum provides the opportunity to share defense strategies and tactics to enhance your litigation toolkit.&lt;br&gt;&lt;br&gt;While the dust has begun to settle on the industry-changing Ingenix suits, MCOs are still struggling to fight off rampant litigation centered on: antitrust violations, ERISA, medical loss ratios, class actions, False Claims Act violations, and Medicare Advantage. Litigation in the managed care space has become increasingly complex. As a result, it is now imperative for you to have in-depth discussions with your industry peers. With the government taking a most scrupulous eye towards the MCOs, it is important to hear where enforcement priorities are headed. This forum will provide the opportunity to hear from the &lt;b&gt;U.S. Department of Justice as well as the U.S. Attorney's Office&lt;/b&gt;.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;As Litigation Costs Skyrocket, Learn How Arbitration Can Reduce These Costs&lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;br&gt;Every MCO contract contains an arbitration provision, though it is a little used method for resolving disputes. The American Arbitration Association recently enacted new healthcare payor provider rules for resolving payor provider disputes. With these new provisions, arbitration will be an excellent way for you to mitigate the costs of litigation, while fostering a positive relationship with the provider. Hear directly from the AAA, and the other speakers who are actively engaged in alternative dispute resolution.&lt;br&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;Managed Care Contracting 101 Helps Shore Up on the Basics&lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;br&gt;In order to successfully defend a managed care suit, you must understand its foundation, the managed care contract. By attending our Managed Care Contracting 101 workshop, you will identify key contract provisions that may raise red flags during litigation. Failure to have a clear understanding of these documents can lead to costly litigation and long-term financial problems. Contracting experts will delve deeper into the fundamentals.&lt;br&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;Defense Counsel Working Group Provides Opportunity for Frank Discussion&lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;br&gt;In the small managed care world, it may feel like you are the only one facing a particular legal challenge or litigation nightmare. Rest assured, others have been in your shoes and can offer methodologies for defending a specific type of suit. This Defense Counsel Working Group will provide you the chance to have really open and robust conversations with your fellow defense counsel. Gain a better understanding of how other MCOs are battling challenges brought about by Health Care Reform, medical loss ratios, and over eager plaintiffs.&lt;br&gt;&lt;br&gt;Register today to ensure you place in the conversation. The event sold out in 2011, and the same is expected in 2012. Call &lt;b&gt;1-888-224-2480&lt;/b&gt;, fax your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;, or register online at &lt;b&gt;&lt;a href=&quot;http://www.americanconference.com/managedcare&quot;&gt;www.americanconference.com/managedcare&lt;/a&gt;.&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/714/managed-care-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">DAS CONGRESS</title>
<link>http://www.americanconference.com/2012/710/das-congress/</link>
<pubDate>Tue 22 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Las Vegas | ACI's DAS Summit, now in its 5th iteration, will explore the business and technical challenges surrounding DAS, and highlights the value proposition of DAS through a number of end-user deployment case studies.</description>
<category>Telecoms &amp; Technology</category>
<category>Regulatory &amp; Compliance</category>
<category>Aerospace and Defense</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/710/das-congress/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">IT Management of Export Controls</title>
<link>http://www.americanconference.com/2012/707/it-management-of-export-controls/</link>
<pubDate>Tue 22 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;P align=center&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;
&lt;P style=&quot;TEXT-ALIGN: center&quot; align=left&gt;&lt;STRONG&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 11pt&quot;&gt;Pre-Conference Seminar&lt;BR&gt;May 22, 2012 &lt;BR&gt;&lt;/SPAN&gt;&lt;/STRONG&gt;&lt;STRONG&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 11pt&quot;&gt;IT Management of Export Controls&lt;/SPAN&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 12pt 0in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Back by popular demand&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;, this unique one-day seminar will provide &lt;B&gt;your IT and compliance teams &lt;/B&gt;with &lt;B&gt;best practices&lt;/B&gt; for maximizing IT expertise and resources, as well as automated licensing, screening and recordkeeping solutions to strengthen your company's export compliance program. Amid heightened U.S. export agency requirements for IT controls, &lt;B&gt;leading IT executives&lt;/B&gt; will provide you with first-hand practical insights on how to enhance the protection of ITAR and EAR-controlled data, and control the IT access of foreign national employees and third parties in Web 2.0. &lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 12pt 0in&quot; class=MsoNormal&gt;You will also take away invaluable guidance on how your export compliance and IT departments can work together to implement a successful, cost-effective compliance strategy, including how to properly vet and select IT vendors and automated solutions. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 12pt 0in&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Topics will include:&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo1; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Maximizing &lt;B&gt;Coordination between Export Compliance and IT Departments&lt;/B&gt; to Support Global Export Compliance: Standardizing Your Approach to Technology Controls and Data Collection &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l3 level1 lfo2; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Automating Your Export Operations&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;: Measuring the Capabilities of Vendor Solutions to Address Critical Export Compliance Risks &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo3; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Implementing &lt;B&gt;Laptop, Server and Email Controls&lt;/B&gt; to Protect Export-Controlled Data: Overcoming Challenges related to &lt;B&gt;Employee Travel&lt;/B&gt; and Data Storage &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo4; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Limiting Virtual Access of Foreign National Employees and Third Parties &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;in Web 2.0: Using Shared Networks and Collaborative Platforms to Reduce Security Risks &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l7 level1 lfo5; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Rolling Out an Integrated Approach to IT Compliance: Overcoming &lt;B&gt;Network and Application Challenges to Successful Program Management&lt;/B&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l6 level1 lfo6; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Electronic &lt;B&gt;Recordkeeping&lt;/B&gt;: Logging, Maintaining and Retrieving Technical Data Export Records &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l4 level1 lfo7; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Outsourcing Helpdesk, Third Level Support, R &amp;amp; D and Software Development&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;: Managing Unique, Heightened Risks of Unauthorized Technology Transfers &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo8; tab-stops: list .5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Leveraging the &lt;B&gt;Forensic Capabilities of Your IT Systems&lt;/B&gt; for Effective Internal Audits and Investigations&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;DIV align=center&gt;
&lt;TABLE style=&quot;BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-COLLAPSE: collapse; BACKGROUND: #eaf1dd; BORDER-TOP: medium none; BORDER-RIGHT: medium none; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext&quot; class=MsoNormalTable border=1 cellSpacing=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR style=&quot;mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes&quot;&gt;
&lt;TD style=&quot;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0in; mso-border-alt: solid windowtext .5pt&quot; vAlign=top width=638&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;PLUS: &lt;SPAN style=&quot;COLOR: black&quot;&gt;ACI's highly anticipated &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;A href=&quot;http://www.americanconference.com/exportcontrols&quot;&gt;&lt;FONT color=#0000ff&gt;15&lt;SUP&gt;th&lt;/SUP&gt; National Forum on Global Export Controls Compliance&lt;/FONT&gt;&lt;/A&gt; &lt;/B&gt;is scheduled for May 23-24. Leading experts in export compliance, senior U.S. and foreign government officials, and legal trade professionals will help you to strengthen your global export compliance practices to withstand the changing, complex U.S. and international landscape. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/DIV&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Early bird pricing is now available. Based on the past success of this event, &lt;B&gt;seats are expected to sell out quickly&lt;/B&gt;. Register now by calling &lt;B&gt;1-888-224-2480 &lt;/B&gt;or online.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;I&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;For questions regarding the program and speaking opportunities&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;, please contact Adam Denenberg at &lt;A href=&quot;mailto:A.Denenberg@AmericanConference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;A.Denenberg@AmericanConference.com&lt;/SPAN&gt;&lt;/A&gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA&quot;&gt;&lt;BR&gt;&lt;I&gt;For sponsorship opportunities&lt;/I&gt;, please contact Wendy Tyler at &lt;A href=&quot;mailto:w.tyler@americanconference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;w.tyler@americanconference.com&lt;/SPAN&gt;&lt;/A&gt;.&lt;BR&gt;&lt;BR&gt;&lt;I&gt;For association and media partnerships&lt;/I&gt;, please contact John Stoops at &lt;A href=&quot;mailto:J.Stoops@americanconference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;J.Stoops@americanconference.com&lt;/SPAN&gt;&lt;/A&gt;.&lt;BR&gt;&lt;/SPAN&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/707/it-management-of-export-controls/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Biosimilars</title>
<link>http://www.americanconference.com/2012/715/biosimilars/</link>
<pubDate>Tue 22 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif][if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif][if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;}
&lt;/style&gt;
&lt;![endif]--&gt;

&lt;p class=&quot;MsoNormal&quot; align=&quot;center&quot;&gt;&lt;b&gt;Breaking news:&amp;nbsp; FDA releases draft guidance on biosimilars.&amp;nbsp;
For the full report from the FDA &lt;a href=&quot;http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm291232.htm&quot;&gt;Click Here&lt;/a&gt;&lt;/b&gt;&lt;br&gt;&lt;/p&gt;&lt;hr&gt;&lt;p&gt;&lt;/p&gt;

&lt;br&gt;Attend the one event where the industry leaders driving the business of biosimilars unite to set the standards which will shape an evolving legal and regulatory landscape&lt;br&gt;&lt;br&gt;&lt;b&gt;Hear what our prior delegates have to say about this event:&lt;/b&gt;&lt;br&gt;&lt;br&gt;&quot;One of the best CLEs I've been to in 10 years&quot; &lt;br&gt;&lt;i&gt;&lt;b&gt;Maryann Wiskerchen, Counsel, Eli Lilly &amp;amp; Co. (prior delegate)&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;br&gt;&quot;Excellent program ? informative and thought-provoking.&quot;&lt;br&gt;&lt;i&gt;&lt;b&gt;Mark Bowditch, Patent Attorney, Sandoz Inc.&lt;br&gt;&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&quot;I thought all the speakers did an excellent job in terms of content and delivery.&quot;&amp;nbsp; &lt;i&gt;&lt;b&gt;Gregory York, Associate, Pearne &amp;amp; Gordon LLP&lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;br&gt;At ACI's third annual Biosimilars conference, the key figures who are shaping the evolving biosimilar landscape--- leading policy makers, in-house representatives from branded and generic biotechnology and pharmaceutical companies, and top-tier litigators and patent prosecutors--- will convene to formulate solutions to the challenging questions left standing in the wake of the historic BPCIA legislation:&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Complying with the yet to be released FDA standards on the abbreviated biosimilars pathway requirements&lt;/li&gt;&lt;li&gt;Meeting the heightened standard of interchangeability and proving or disproving similarity &lt;/li&gt;&lt;li&gt;Delineating the scope of the exclusivity provision and analyzing the potential impact of the statutory 12-year period on research, innovation and consumer access to drugs &lt;/li&gt;&lt;li&gt;Analyzing the complex patent resolution mechanisms outlined in the statute and proactively preparing for the intricate exchange process &lt;/li&gt;&lt;li&gt;Ascertaining the volume and level of safety data that will be required to prove patient safety and efficacy to facilitate approval&amp;nbsp; &lt;/li&gt;&lt;li&gt;Determining the financial viability of biosimilars and exploring alternative pathways to approval including biobetters &lt;/li&gt;&lt;/ul&gt;&lt;b&gt;&lt;br&gt;The major players are preparing for the inevitable--- the litigation and the attacks on biosimilar IP that are sure to come&lt;/b&gt;&lt;br&gt;&lt;br&gt;With an estimated $100 billion in potential biologics sales at stake annually and a wave of patent expirations starting in 2014, there will be a hard-fought battle to protect and increase market share.&amp;nbsp; Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway.&amp;nbsp; Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.&amp;nbsp; &lt;br&gt;&lt;br&gt;Full conference details are on the way shortly.&amp;nbsp; If you are interested in speaking at this event, contact Nicole Cutrufello at n.cutrufello@americanconference.com.&amp;nbsp; For information on sponsoring or exhibiting at this event, contact Esther Fleischhacker at e.fleischhacker@americanconference.com.&lt;br&gt;&lt;br&gt;Based on past success, spaces will fill up quickly. Register now by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;877-927-1563&lt;/b&gt; or registering online at &lt;a href=&quot;http://www.americanconference.com/biosimilars&quot;&gt;www.americanconference.com/biosimilars&lt;/a&gt;. &lt;b&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Intellectual Property</category>
<category>Pharmaceuticals/Biotech/Life Sciences</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/715/biosimilars/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Global Export Controls Compliance</title>
<link>http://www.americanconference.com/2012/707/global-export-controls-compliance/</link>
<pubDate>Wed 23 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt&quot;&gt;&lt;?xml:namespace prefix = o ns = &quot;urn:schemas-microsoft-com:office:office&quot; /&gt;&lt;o:p&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt&quot;&gt;&lt;SPAN style=&quot;COLOR: black&quot;&gt; 
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;2011 was a banner year for U.S. export controls ? The Obama administration sought to streamline and reform the entire U.S. export control system, issued a new &quot;Consolidated Screening List&quot;, BIS amended their licensing requirements on encryption controls, a new STA license exception was created, and the ITAR dual and third- country nationals rules were updated. In addition, navigating through the maelstrom of proposed rules, most notably the consolidation of the USML and CCL, is proving a daunting task for trade compliance professionals around the world.&lt;BR&gt;&lt;BR&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0in 0in 10pt&quot; class=MsoNormal align=center&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;ACI's Flagship Export Controls Forum will help you to Strengthen Your Global Export Compliance Practices to Withstand the Changing, Complex U.S. and International Landscape&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;As U.S. and foreign export enforcement agencies continue to increase their coordination, export compliance becomes a necessity for facilitating the growth and continuance of your export business, preventing massive monetary penalties against your company, and avoiding potential criminal prosecution of empowered officials and executives. At American Conference Institute's acclaimed &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;15&lt;SUP&gt;th&lt;/SUP&gt; National Forum on Global Export Controls Compliance&lt;/B&gt;, you will learn from and meet the who's who of leading experts in export compliance, senior U.S. and foreign government officials, and legal trade professionals. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;The updated 2012 agenda includes: &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;How &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;Commerce Munitions List and policy changes&lt;/B&gt; are affecting internal compliance, export licensing and business opportunities&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Responding to the uptick in civil, administrative and criminal &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;enforcement&lt;/B&gt; by BIS, DDTC and OFAC against both companies and individuals&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;CHINA&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;: Managing U.S. and Chinese export compliance challenges arising from supplier relationships&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;UAE, Singapore and Hong Kong&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;: Preventing trans-shipments and diversion risks amid new, emerging risk factors&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;ITAR Brokering&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;: DDTC insights on proposed new rules and their compliance expectations going forward&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Iran Sanctions&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;: Minimizing compliance, enforcement and reputational risks in the face of expanding U.S. and E.U. restrictions&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-INDENT: -0.25in; MARGIN: 0in 0in 10pt 0.5in&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: Symbol; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol&quot;&gt;·&lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: Symbol&quot;&gt; &lt;/SPAN&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Mitigating exposure through accurate and complete &lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;voluntary disclosures&lt;/B&gt; and a positive Government reaction on your voluntary disclosures&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Exclusive Post Forum Interactive Working Groups May 25, 2012:&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;A: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;CLASSIFYING DUAL-USE ITEMS: A Comprehensive How-To Guide on Classification Post-New Commerce Munitions List and USML-CCL Migration&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 12pt&quot; class=MsoNormal&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;B: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;GLOBAL COMPLIANCE PROGRAM BENCHMARKING: Best Practices and Lessons Learned&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;TABLE style=&quot;BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-COLLAPSE: collapse; BACKGROUND: #eaf1dd; BORDER-TOP: medium none; BORDER-RIGHT: medium none; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-background-themecolor: accent3; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext&quot; class=MsoNormalTable border=1 cellSpacing=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR style=&quot;mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes&quot;&gt;
&lt;TD style=&quot;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0in; mso-border-alt: solid windowtext .5pt&quot; vAlign=top width=638&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;PLUS: &lt;SPAN style=&quot;COLOR: black&quot;&gt;ACI's highly anticipated &lt;A href=&quot;http://www.americanconference.com/exportIT&quot;&gt;&lt;B style=&quot;mso-bidi-font-weight: normal&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;4&lt;SUP&gt;th&lt;/SUP&gt; Industry Seminar on IT Management&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt; &lt;B&gt;of Export Controls&lt;/B&gt;&lt;/SPAN&gt;&lt;/A&gt; is scheduled for May 22&lt;SUP&gt;nd&lt;/SUP&gt;. Leading IT and automation executives will provide you with practical insights on how to enhance the protection of ITAR and EAR-controlled data on laptops, servers and email, and use shared networks and collaborative platforms to reduce access security risks.&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&amp;nbsp;&lt;BR&gt;&lt;/P&gt;
&lt;P style=&quot;LINE-HEIGHT: normal; MARGIN: 0in 0in 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;Early bird pricing is now available. Based on the past success of this event, &lt;B&gt;seats are expected to sell out quickly&lt;/B&gt;. Register now by calling &lt;B&gt;1-888-224-2480 &lt;/B&gt;or &lt;A href=&quot;https://transactions.c5groupinc.com/event_reg.php?conf=3109&amp;amp;site=2&amp;amp;lang=en&amp;amp;gap=4&quot;&gt;online&lt;/A&gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style=&quot;COLOR: black; FONT-SIZE: 10pt&quot;&gt;&lt;o:p&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;I&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;For questions regarding the program and speaking opportunities&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style=&quot;LINE-HEIGHT: 115%; FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'&quot;&gt;, please contact Adam Denenberg at &lt;A href=&quot;mailto:A.Denenberg@AmericanConference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;A.Denenberg@AmericanConference.com&lt;/SPAN&gt;&lt;/A&gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 0pt&quot; class=MsoNormal&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;BR&gt;&lt;I&gt;For sponsorship opportunities&lt;/I&gt;, please contact Wendy Tyler at &lt;A href=&quot;mailto:w.tyler@americanconference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;w.tyler@americanconference.com&lt;/SPAN&gt;&lt;/A&gt;.&lt;BR&gt;&lt;BR&gt;&lt;I&gt;For association and media partnerships&lt;/I&gt;, please contact John Stoops at &lt;A href=&quot;mailto:J.Stoops@americanconference.com&quot;&gt;&lt;SPAN style=&quot;COLOR: blue&quot;&gt;J.Stoops@americanconference.com&lt;/SPAN&gt;&lt;/A&gt;.&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;
&lt;P style=&quot;MARGIN: 0in 0in 10pt&quot; class=MsoNormal&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Times New Roman','serif'&quot;&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;&lt;SPAN style=&quot;COLOR: black&quot;&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;BR&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/707/global-export-controls-compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Brazil Summit on Customs &amp; Import Compliance</title>
<link>http://www.americanconference.com/2012/979/brazil-summit-on-customs--import-compliance/</link>
<pubDate>Wed 30 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">São Paulo | Following the tremendous success of its flagship trade compliance conferences in the United States, Europe and Asia, &lt;b&gt;American Conference Institute&lt;/b&gt; is pleased to introduce its inaugural &lt;b&gt;Advanced Brazil Summit on Customs Compliance and Enforcement&lt;/b&gt;, a groundbreaking international conference addressing the complex customs compliance challenges in Brazil. This unique and insightful conference is designed to provide trade compliance executives in Brazil, and senior global customs compliance professionals with regional oversight responsibilities, with advanced import compliance and duty saving strategies. &lt;br&gt;&lt;br&gt;Under the Rousseff administration the Brazilian government has issued several new customs and tax regulations and quadrupled the number of investigators in the Ministry of Development, Industry and Foreign Trade in an effort to gain greater quality control on imported goods and boost domestic manufacturing. Increased country of origin investigations, facilitated by a new regulation for the gray channel, and an uptick in anti-dumping cases, are evidence of the Brazilian government's resolve to enforce new measures. &lt;br&gt;&lt;br&gt;Benefit from the practical perspective of customs and trade executives from a wide range of industries including automotive, consumer products, life sciences, textile, agriculture, food, chemical and information technology, and get an update on the customs regulatory and enforcement landscape in Brazil from senior consultants and lawyers. Topics will include:&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Building a customs compliance team locally and implementing a robust import compliance program for your Brazilian operations&lt;/li&gt;&lt;li&gt;Preparing for an uptick in customs audits and investigations ? how to best work with Customs and other government agencies that regulate imports&amp;nbsp;&lt;/li&gt;&lt;li&gt;RADAR and Siscomex ? process for registering and how to satisfy requirements&lt;/li&gt;&lt;li&gt;Status update on customs modernization in Brazil&lt;/li&gt;&lt;li&gt;Minimizing indirect taxes applicable to imports&lt;/li&gt;&lt;li&gt;How to maximize duty savings of Brazil's Free Trade Agreements&amp;nbsp;&lt;/li&gt;&lt;li&gt;The view from global customs HQ ? Assessing Brazil customs risks and expectations for trade compliance&lt;/li&gt;&lt;li&gt;Leveraging special import regimes ? Drawback, Bonded Warehouse, RECOF, and Blue Line&lt;/li&gt;&lt;li&gt;Defending your transaction value and responding to customs valuation challenges&lt;/li&gt;&lt;li&gt;Obtaining an import license for refurbished and used equipment ? when and how to secure permits&lt;/li&gt;&lt;li&gt;Tariff classification in Brazil ? how not to classify imported articles&lt;/li&gt;&lt;li&gt;Modalities of importation in Brazil&lt;/li&gt;&lt;li&gt;How to prepare for an uptick in anti-dumping investigations and enforcement &lt;br&gt;&lt;/li&gt;&lt;li&gt;Selecting and auditing&amp;nbsp; customs brokers&amp;nbsp; &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;Seats at this premier trade compliance conference are expected to sell out fast. Register early to reserve your place and&lt;u&gt; take advantage of the early bird rate&lt;/u&gt;. To register, please call &lt;b&gt;1-888-224-2480&lt;/b&gt;; fax your registration form to &lt;b&gt;1-877-927-1563&lt;/b&gt;; or register online at &lt;a href=&quot;http://www.americanconference.com/Brazilcustoms&quot;&gt;www.americanconference.com/Brazilcustoms&lt;/a&gt;.&amp;nbsp; &lt;br&gt;&lt;br&gt;The brochure is currently in development. For information regarding the agenda and speaking opportunities, contact Virna Di Palma, Senior Program Director,International Trade, at &lt;a href=&quot;v.dipalma@americanconference.com&quot;&gt;v.dipalma@americanconference.com&lt;/a&gt;. For sponsorship opportunities, contact Wendy Tyler at &lt;a href=&quot;w.tyler@americanconference.com&quot;&gt;w.tyler@americanconference.com&lt;/a&gt;. For media and association partnerships, contact John Stoops at&lt;a href=&quot;j.stoops@americanconference.com&quot;&gt; j.stoops@americanconference.com&lt;/a&gt;.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/979/brazil-summit-on-customs--import-compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">LPL/Legal Malpractice Claims &amp; Litigation</title>
<link>http://www.americanconference.com/2012/732/lpl/legal-malpractice-claims--litigation/</link>
<pubDate>Thu 31 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;b&gt;Join an unparalleded faculty of leading insurance professionals, counsel specializing in LPL, law firm risk managers and renowned jurists to ensure that you are fully protected against emerging risks and prepared to defend against the latest legal malpractice claims.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Continuing fallout from the implosion of the real estate market, the wave of bankruptcies and Ponzi schemes and the broader state of the economy has led to increasing lawsuits against attorneys by frustrated clients. Additionally, the use of electronic communication, cloud computing and social media brings new retention, network security and privacy risks. &lt;b&gt;Attorneys and law fi rms must stay ahead of the curve to avoid unnecessary exposure to risk and successfully defend against the newest deluge of legal malpractice claims.&lt;/b&gt;&lt;br&gt;&lt;br&gt;ACI's &lt;b&gt;Advanced Forum on LPL/Legal Malpractice Claims and Litigation&lt;/b&gt; is designed to offer insurers, brokers, attorneys and other risk management professionals valuable insight into how to prevent, manage and defend against the most current legal malpractice claims. Get the inside scoop from judges on the latest malpractice claims brought against attorneys as well as from leaders in the insurance industry, including in-house professionals from: &lt;b&gt;CNA Insurance, Swiss Re America Holding Corp., Willis Group, ECC Insurance Brokers, OneBeacon Professional Insurance, Marsh USA, Endurance Service Ltd., Ahern Insurance, Aspen Specialty Insurance Co., Allied World National Assurance Co. and many more.&lt;br&gt;&lt;br&gt;&lt;u&gt;By attending the conference, you will:&lt;/u&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Gain valuable strategies from major corporations as they provide insight into the changing relationship between companies and their outside counsel&lt;/li&gt;&lt;li&gt;Hear directly from 7 federal and state judges, and get their views on the most common legal malpractice claims they are seeing and how to improve your litigation strategy&lt;/li&gt;&lt;li&gt;Ensure protection against emerging areas of risk and understand the latest trends in claims, coverage and underwriting from a panel of expert insurance professionals&lt;/li&gt;&lt;/ul&gt;&lt;b&gt;&lt;u&gt;Plus, maximize your attendance by also registering for the pre/post-conference in depth focus sessions&lt;/u&gt;&lt;br&gt;&lt;br&gt;A. Defeating the Unknown Factor: A Hands-On Examination of the Specifi c Risks and Claims for 2012, What They Mean for the LPL/Legal Malpractice Practice and Their Impact on the Litigation Landscape&lt;br&gt;&lt;br&gt;B. A Practical Due Diligence Checklist on Preventing the Most&lt;br&gt;Common Attorney Errors in Civil Litigation&lt;/b&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Litigation</category>
<category>Law Firm Management</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/732/lpl/legal-malpractice-claims--litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Wage &amp; Hour Claims and Class Actions</title>
<link>http://www.americanconference.com/2012/862/wage--hour-claims-and-class-actions/</link>
<pubDate>Thu 31 May 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York City | &lt;p&gt;The wage and hour landscape has been significantly altered in the wake of Wal-Mart v. Dukes and AT&amp;amp;T Mobility v. Concepcion. Come join your colleagues and clients at the nation's premier wage and hour defense forum and hone the skills and strategies &lt;em&gt;needed to keep pace with this rapidly changing area of law, defend against new and innovative claims, and prepare for emerging regulations and evolving enforcement priorities.&lt;/em&gt; &lt;/p&gt;
&lt;p&gt;  &lt;strong&gt;American Conference Institute's 15th National Forum on Wage &amp;amp; Hour Claims and Class Actions &lt;/strong&gt;will provide you with an unparalleled opportunity &lt;br&gt;
  to convene with expert in-house counsel from &lt;em&gt;Microsoft, Bank of America, IBM, Dow Jones &amp;amp; Co., The Hartford, Allstate Insurance, DIRECTV, Viacom,&lt;br&gt;
  24 Hour Fitness, Cisco Systems, Kaplan, Gannett Co., Medtronic, Darden Restaurants, Ryder System, Marsh &amp;amp; McLennan, Tyco, Ally Financial, Family Dollar Stores, Canam Steel, NextEra Energy, Caterpillar, Solae, PSEG, Covidien, and Reed Elsevier&lt;/em&gt;, as well as leading private practice attorneys and renowned federal and state judges, in order to obtain expert advice, insider strategies, and comprehensive updates on:&lt;br&gt;
  &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Assessing the impact of Wal-Mart v. Dukes on FLSA collective actions, Rule 23 class actions, and hybrid cases&lt;/li&gt;
  &lt;li&gt; How AT&amp;amp;T Mobility v. Concepcion and its progeny are being applied 
    in the wage and hour context&lt;/li&gt;
  &lt;li&gt; Using settlement and mediation to resolve claims and avoid costly litigation&lt;/li&gt;
  &lt;li&gt; Overcoming the complexities of managing and defending against multidistrict litigation&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;PLUS, add value to your attendance by also registering for the exclusive 
  pre-conference Wage and Hour Law Boot Camp and post-conference 
  Master Class on social media and employment law:&lt;br&gt;
&lt;/p&gt;
&lt;table width=&quot;500&quot; border=&quot;0&quot;&gt;
  &lt;tbody&gt;&lt;tr&gt;
    &lt;td width=&quot;19&quot;&gt;A.&lt;/td&gt;
    &lt;td width=&quot;471&quot;&gt;Pre-Conference Boot Camp ? An In-Depth Analysis of the Essentials of Wage and Hour Law for New Practitioners &lt;br&gt;
May 30, 2012 ? 2:00 p.m.-5:00 p.m.&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;B. &lt;/td&gt;
    &lt;td&gt;Post-Conference Master Class ? Social Media and Employment Law: &lt;br&gt;
Best Practices for Establishing a Social Media Employee Policy and Minimizing Your Exposure to Employment Litigation Arising From 
  the Use of Social Media &lt;br&gt;
June 1, 2012 ? 2:30 p.m.-5:00 p.m.&lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;&lt;/table&gt;
&lt;p&gt;&lt;br&gt;
  Register now by calling &lt;strong&gt;1-888-224-2480&lt;/strong&gt; or by faxing your registration 
  form to &lt;strong&gt;1-877-927-1563. &lt;/strong&gt;&lt;br&gt;
You can also register &lt;a onclick=&quot;newWindow('https://transactions.c5groupinc.com/event_reg.php?conf=3120&amp;amp;site=1&amp;amp;lang=en&amp;amp;gap=3','reg_now','600','720',''); pageTracker._link(this.href); return false;&quot; href=&quot;javascript:void(null);&quot;&gt; online&lt;/a&gt; .&lt;/p&gt;


</description>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/862/wage--hour-claims-and-class-actions/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">The 2012 NBPCA Annual Congress</title>
<link>http://www.americanconference.com/2012/898/the-2012-nbpca-annual-congress/</link>
<pubDate>Sun 3 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">201 Waterfront Street, National Harbor | This is inaugural event has been developed by the industry, for the industry. [Tags: NBPCA, Prepaid Event, GiftCard Industry]</description>
<category>Advertising &amp; Marketing</category>
<category>Financial Services</category>
<category>Regulatory &amp; Compliance</category>
<category>Financial Services</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/898/the-2012-nbpca-annual-congress/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">5th China Summit on Anti-Corruption</title>
<link>http://www.americanconference.com/2012/982/5th-china-summit-on-anti-corruption/</link>
<pubDate>Tue 5 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Shanghai | &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;5th&lt;/strong&gt;&lt;strong&gt; China Summit on Anti-Corruption&amp;nbsp; &lt;/strong&gt;&lt;br&gt;
    &lt;strong&gt;???????????&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Shanghai, China&lt;/strong&gt;&lt;br&gt;
    &lt;strong&gt;June 5 &amp;amp; 6, 2012&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Over the last four  years, there is a reason why ACI's  summit was successful year after year.&amp;nbsp; Co-chaired  by Stephen Maloy, General Counsel, Asia Pacific from General Electric and  Gangliang Qiao, General Counsel for North East Asia from Siemens, 2011 China  Anti-Corruption summit had the pleasure of welcoming corporate ethics and  compliance executives, attorneys and government officials dedicated to  anti-corruption issues in China. &lt;/p&gt;
&lt;p&gt;We are now  thrilled to announce 5th China Summit on Anti-Corruption with a pre-brochure  rate for our past attendees to book the seats now.&lt;/p&gt;
&lt;p&gt;We are currently  developing programs for 2012. In our continuous efforts to improve the quality  of our programs and offer the attendees more value, we are delighted to receive  your topic suggestions and speaker nominations for next year. Please contact  Nan Shen, China/Asia Project Executive, at &lt;a href=&quot;mailto:n.shen@americanconference.com&quot;&gt;n.shen@americanconference.com&lt;/a&gt; or &lt;strong&gt;212-352-3220 ext 5239.&lt;/strong&gt;&lt;br&gt;
    &lt;br&gt;
  If you are interested in learning more about sponsorship for this event, please  contact Wendy Tyler, Group Leader at &lt;a href=&quot;mailto:W.Tyler@AmericanConference.com&quot;&gt;W.Tyler@AmericanConference.com&lt;/a&gt; &amp;nbsp;or at 212-&lt;strong&gt;352-3220 ext. 5242.&lt;/strong&gt;&lt;br&gt;
  &lt;br&gt;
For more information on media partnerships please contact John Stoops,  Partnership Executive, &lt;a href=&quot;mailto:j.stoops@americanconference.com&quot;&gt;j.stoops@americanconference.com&lt;/a&gt;. &lt;/p&gt;

</description>
<category>Anti-Corruption / FCPA</category>
<category>Regulatory &amp; Compliance</category>
<category>Regulatory Compliance and Trade</category>
<category>Ethics Credits</category>
<category>China &amp; Singapore</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/982/5th-china-summit-on-anti-corruption/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Cloud Computing</title>
<link>http://www.americanconference.com/2012/731/cloud-computing/</link>
<pubDate>Wed 6 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">San Francisco | &lt;P&gt;With significant advantages over the long-standing model of running all software applications within a traditional corporate data center, cloud computing has become a persuasive alternative to the traditional IT model.&amp;nbsp;&amp;nbsp; Realizing the value of economies of scale and the maintenance efficiencies of service as a software, many companies have already, or would like to, take advantage of the benefits the cloud has to offer.&amp;nbsp; However, certain parts of the cloud don't always have a silver lining.&amp;nbsp; Companies are quickly learning that the move to the cloud comes with inherent risks, including data privacy and security concerns, jurisdictional restrictions on the location of stored data, and server uptime and reliability issues, just to name a few.&amp;nbsp; In addition, the high profile data breach cases that have&amp;nbsp; littered recent news headlines, and the swift and harsh reactions by the DOJ, FTC and state Attorneys General's offices, have added cause for concern.&amp;nbsp; With all of these potential areas of trouble, companies have dialed back their efforts to move to the cloud in order to asses the business risks and costs against the benefits?and they are still looking for answers.&lt;BR&gt;&lt;BR&gt;In response, ACI is proud to bring you our &lt;STRONG&gt;2nd Legal Forum on Negotiating Effective Contracts and Resolving Disputes Related to Cloud Computing.&amp;nbsp; &lt;/STRONG&gt;With an eye towards structuring agreements, this valuable seminar will show you how to balance the business benefits of the cloud model with the legal risks that are inherent in this non-traditional IT service model.&amp;nbsp; Led by in-house counsel on both the buyer and vendor side of the cloud, the front-line private practitioners that are guiding corporations through the structuring of these contracts (and resulting litigation), and the federal and state regulators at the front line of data privacy enforcement actions, this conference will help make you aware of the issues your company should consider before you go to the table.&amp;nbsp; Key topics covered will include:&lt;BR&gt;&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; A deep dive into the inherent differences in cloud contract models&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Balancing the business benefits against legal risks and costs&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Data privacy and security issues in the cloud from the regulators' point of view&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Incorporating the latest security controls into your cloud contract&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; The licensing of public data aggregation tools and how companies are structuring business-to-business exchanges of information&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Addressing uptime, reliability, and business continuity in your contract&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Data manipulation, litigation holds and e-discovery in the cloud&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Vetting subcontractors and third-party data storage vendors&lt;BR&gt;·&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Incorporating foreign data laws and U.S. export regulations into your data controls&lt;BR&gt;&lt;BR&gt;Take advantages of the opportunity to share best practices and gain insights from your peers and colleagues. Companies on the leading edge of today's most innovative cloud deals and regulators at the front line of developing legislation and the lawyers helping to guide the industry through it all will lead ACI's innovative forum.&lt;BR&gt;&lt;BR&gt;Register by calling &lt;STRONG&gt;888-224-2480&lt;/STRONG&gt;; faxing your registration to &lt;STRONG&gt;877-927-1563&lt;/STRONG&gt;; or register online at &lt;U&gt;&lt;FONT color=#0000ff&gt;&lt;A href=&quot;http://www.americanconference.com/CloudComputing&quot;&gt;&lt;STRONG&gt;www.americanconference.com/CloudComputing&lt;/STRONG&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/U&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;</description>
<category>Telecoms &amp; Technology</category>
<category>International Trade</category>
<category>Insurance &amp; Reinsurance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/731/cloud-computing/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Anti-Corruption Compliance in Emerging Markets</title>
<link>http://www.americanconference.com/2012/724/anti-corruption-compliance-in-emerging-markets/</link>
<pubDate>Mon 11 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | &lt;b&gt;Attend the only forum that goes beyond the FCPA and provides country-by-country anti-corruption compliance strategies to help you stay ahead of the global enforcement curve.&lt;/b&gt;&lt;br&gt;&lt;br&gt;BRIC-based entities are increasingly the target of FCPA enforcement actions and investigations, and at the same time, facing prosecutions by local authorities. More and more frequently emerging market governments have been initiating their own investigations against companies who have settled cases with U.S. regulators. This trend, coupled with increased cross-border cooperation and the growing relevance of foreign anti-bribery laws, is changing the global anti-corruption enforcement landscape and forcing companies to adopt a more local approach to compliance. &lt;br&gt;&lt;br&gt;That's why you can't afford to miss ACI's &lt;b&gt;3rd Global Forum on Anti-Corruption Compliance in Emerging Markets&lt;/b&gt;. The 2012 program will once again feature an international line-up of speakers who will provide country-specific anti-corruption compliance guidance you can't get anywhere else. Go beyond the FCPA and walk away with firsthand insights into how to address BRIC and other emerging market risks when you attend this unique forum.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;Brazil&lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Screen, select and monitor joint venture partners and what to do if you suspect corruption&lt;/li&gt;&lt;li&gt;Limit your exposure to bribery risks in the public bidding process and comply with strict government contract laws&lt;/li&gt;&lt;/ul&gt;&lt;b&gt;&lt;u&gt;Russia &lt;/u&gt;&lt;/b&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Respond to a Russian bribery investigation&lt;/li&gt;&lt;li&gt;Detect bribery schemes, high risk structures, hidden parties and other questionable transactions &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;u&gt;&lt;b&gt;India &lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Adapt training to local culture and high risk areas, and effectively promote corporate ethics to employees and third parties&lt;/li&gt;&lt;li&gt;Detect bribery in real estate transactions&lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;u&gt;&lt;b&gt;China &lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;China's new anti-corruption law and how the Chinese government is acting to enforce it&lt;/li&gt;&lt;li&gt;Investigating possible violations in China &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;Join us next year in Washington, DC (venue TBD), June 19-20, 2012 for the &lt;b&gt;only conference of its kind&lt;/b&gt; designed to provide you with a country-by-country approach to anti-corruption compliance. &lt;br&gt;________________________________________&lt;br&gt;The conference program is currently under development. Please check back soon for the program agenda and faculty list or contact &lt;b&gt;Virna Di Palma&lt;/b&gt;, Senior Program Director, at &lt;a href=&quot;v.dipalma@americanconference.com&quot;&gt;v.dipalma@americanconference.com&lt;/a&gt; or at &lt;b&gt;212-352-3220&lt;/b&gt; &lt;b&gt;ext. 5480&lt;/b&gt;.&lt;br&gt;&amp;nbsp; &lt;br&gt;If you are interested in learning more about sponsorship for this event, please contact &lt;b&gt;Wendy Tyler&lt;/b&gt;, Group Leader at&lt;a href=&quot;W.Tyler@AmericanConference.com&quot;&gt; W.Tyler@AmericanConference.com&lt;/a&gt; or at &lt;b&gt;212-352-3220 ext. 5242&lt;/b&gt;.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/724/anti-corruption-compliance-in-emerging-markets/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Emerging Europe Deal Forum</title>
<link>http://www.americanconference.com/2012/675/emerging-europe-deal-forum/</link>
<pubDate>Tue 12 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Vienna | By demonstrating strong resilience to the market volatility, private equity in CEE is rapidly becoming an asset class of choice for many forward thinking investors. Strategies are back and exits becoming easier. With several prominent deals announced in 2012 is expected to be the busiest year in the last three years.&lt;br&gt;&lt;br&gt;However, with many restrictions on the lending side and much tightened regulation, both LPs and GPs are in need of careful guidance like never before: How much room should be made for this asset class in your investment portfolio? What returns does it promise? What are the risks? What should be your firms' key points of differentiation within an increasingly competitive universe of the CEE private equity? How to locate strategic or financial partners and convert proposals into real deals? &lt;br&gt;&lt;br&gt;If you, like many of your colleagues, are facing the challenges of ensuring that you have the most effective and well-defined investment strategy in this maturing market while boosting your deal origination opportunity ? then you should register for C5's new &lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;EMERGING EUROPE DEAL FORUM &lt;/b&gt;&lt;br&gt;Your expert guidance on best investment and fundraising strategies in downturn&lt;br&gt;12? 13 June 2012 | Vienna &lt;br&gt;&lt;/div&gt;&lt;br&gt;Build on success of C5's CEE Private Equity Forum we strive to create a perfect networking platform and secure the participation of most influential GPs, LPs, lenders and industry partners to get to the root of the issues affecting your deal making and fundraising opportunities and strategies. &lt;br&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;5 main reasons to attend or send your team to this event:&lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Locate new investors and financial sponsors.&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Benchmark your strategies against those of the high performers' to develop value-creating, carefully targeted investment plans.&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Avoid costly pitfalls and minimize legal costs by learning from the experiences and &quot;war stories&quot; of the region's leading dealmakers.&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Obtain &quot;need-to-know&quot; tips on sensitive issues, helping you to devise the most effective transactional strategies and partnership agreements.&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Learn how to make your fund terms more &quot;LP-friendly&quot;, helping you to succeed in an extremely challenging fundraising market.&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;</description>
<category>Financial Services</category>
<category>Private Equity and M&amp;A</category>
<category>Russia and CIS</category>
<category>Financial Services</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/675/emerging-europe-deal-forum/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Shutdowns Superconference - Houston</title>
<link>http://www.americanconference.com/2012/903/shutdowns-superconference---houston/</link>
<pubDate>Tue 12 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Houston | &lt;style type=&quot;text/css&quot;&gt;
&lt;!--
.style1 {
	font-size: 16px;
	font-weight: bold;
}
--&gt;
&lt;/style&gt;
For 10 years, the &lt;em&gt;Shutdowns  Superconference&lt;/em&gt; has delivered the critical information you need for project  success from first-class companies.&amp;nbsp; Our  previous speakers and delegates come from companies including: &amp;nbsp;&lt;strong&gt;Suncor,  Syncrude, Dow, ConocoPhillips, Spectra, Agrium, Cameco, Nova, Husky, Imperial  Oil, CNRL, Cenovus, Talisman, Atco Power, OPG, TransAlta, Sherritt  International, Nexen, Lanxess, Irving Oil, Shell, BP&lt;/strong&gt;, ?.and many more!
&lt;p&gt;Now in &lt;strong&gt;Houston&lt;/strong&gt;,  the &lt;strong&gt;Shutdowns Superconference &lt;/strong&gt;taking  place &lt;strong&gt;May 8 &amp;amp; 9, 2012,&lt;/strong&gt; will provide  the latest shutdown techniques from top operators and solution experts. Covering  the full life cycle of a turnaround this event will cover important topics  including: &lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;End-to-end  shutdown planning from initial start up to closing&lt;/li&gt;
  &lt;li&gt;Executing  your shutdown with successful contractor partnering &lt;/li&gt;
  &lt;li&gt;Maximizing  productivity and minimizing operational risk&lt;/li&gt;
  &lt;li&gt;Ensuring  safety is a key priority and improving safety performance during a turnaround&lt;/li&gt;
  &lt;li&gt;Successfully  managing scope creep and planning for emerging work&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Plus you'll get: &lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Practical  solution to your biggest turnaround challenges with information you won't get  anywhere else&lt;/li&gt;
  &lt;li&gt;Case  studies from end-user companies and leading contractors&amp;nbsp; &lt;/li&gt;
  &lt;li&gt;Networking  breaks that will allow you to build professional relationships and generate new  business opportunities &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;If you're involved in oil and gas, chemicals, petrochemicals,  or other continuous process industries, this is one event you can't afford to  miss. &amp;nbsp;Stay on top of your game and get  the essential tools you need to strengthen your shutdown projects.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Register  now and reserve your seat by calling toll-free 1-877-927-7936 or register &lt;a onclick=&quot;newWindow('https://transactions.c5groupinc.com/event_reg.php?conf=3072&amp;amp;site=1&amp;amp;lang=en&amp;amp;gap=3','reg_now','600','720',''); pageTracker._link(this.href); return false;&quot; href=&quot;javascript:void(null);&quot;&gt; online &lt;/a&gt;.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;/shutdownshou/sponsors&quot; class=&quot;style1&quot;&gt;Interested  in Sponsorship and Exhibition Opportunities?&lt;/a&gt;&lt;br&gt;
Contact Dan Gellman at &lt;strong&gt;1-877-927-0718 Ext. 7389&lt;/strong&gt; or email &lt;strong&gt;&lt;a href=&quot;mailto:d.gellman@canadianinstitute.com&quot;&gt;d.gellman@canadianinstitute.com&lt;/a&gt;.&lt;/strong&gt;&lt;/p&gt;
&lt;p class=&quot;style1&quot;&gt;Rave  reviews for the Calgary Shutdowns Superconference?&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&quot;Great speakers, great  knowledge, excellent networking&quot; &lt;/strong&gt;&lt;br&gt;
  Derek Herbert, Capital Power  Corp, 2010 Shutdowns Superconference&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&quot;Really enjoyed the vast  experience and educated speakers that were present&quot;&lt;/strong&gt;&lt;br&gt;
  Cheryl Gwynn, Cenovus, 2010  Shutdowns Superconference&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&quot;Good topics which deal with  turnaround management &amp;amp; issues..all topics were relevant and dealt with a  broad spectrum of turnaround issues&quot;&lt;/strong&gt;&lt;br&gt;
  Ed Driesen, Nova Chemicals,  2010 Shutdowns Superconference&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&quot;I liked networking with  vendors and presentations dealing with specific shutdowns issues&quot;&lt;/strong&gt;&lt;br&gt;
  Darcie Erickson, Imperial  Oil, 2010 Shutdowns Superconference&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&quot;Sessions were very  informative..to see &amp;amp; hear actual shutdown wins and losses, what worked and  what did not&quot;&lt;/strong&gt;&lt;br&gt;
  Roxanne Gabert, Sherritt  International, 2010 Shutdowns Superconference&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;style1&quot;&gt;Mark  Your Calendar for Other Upcoming Shutdown Events...&lt;/span&gt;&lt;br&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;strong&gt;&lt;a href=&quot;http://www.shutdownsfortmcmurray.com/&quot;&gt;Shutdowns Fort McMurray&lt;/a&gt;&lt;/strong&gt;&lt;br&gt;&lt;p&gt;
    &lt;strong&gt;February  28-29, 2012 ? Fort McMurray, Alberta, Canada &lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;For the first time in Fort McMurray, the  1st Annual Shutdowns Fort McMurray conference will provide the latest shutdown  techniques from the top operators and solution experts.&amp;nbsp; This new event has been specifically tailored  to operators in the oilsands and will focus on overcoming the turnaround  challenges in the upgrading, mining and SAGD plants in Fort McMurray and the  surrounding region. &lt;strong&gt;&lt;a href=&quot;http://www.shutdownsfortmcmurray.com/&quot;&gt;Learn more.&lt;/a&gt; &lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;


</description>
<category>Energy &amp; Resources</category>
<category>Transportation / Manufacturing &amp; Industrial / Logistics</category>
<category>Energy &amp; Resources</category>
<category>Manufacturing &amp; Industrial</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/903/shutdowns-superconference---houston/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">NPE Litigation</title>
<link>http://www.americanconference.com/2012/729/npe-litigation/</link>
<pubDate>Tue 12 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;div align=&quot;center&quot;&gt;&lt;b&gt;A multi-billion dollar industry has emerged based on litigating intellectual property rights for financial gain. &lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;Known by many names within the industry - non-practicing entity (NPE), patent assertion entity (PAE) and most infamously as &quot;patent trolls&quot; - NPEs over the past few years have single-handedly spawned a sub-specialty of patent litigation that companies across industries have become all too familiar with. Often using the threat of litigation as a tool for engaging large corporate defendants into pricey license negotiations, it is estimated that the average patent suit involving NPEs results in &lt;span style=&quot;font-weight: bold; text-decoration: underline;&quot;&gt;$122 million in lost wealth&lt;/span&gt; for the defendant,&amp;nbsp; not to mention the millions of dollars often spent in litigation costs, lost work hours and time-consuming negotiations.&lt;br&gt;&lt;br&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Offered as a one-day event to minimize time spent out of the office&lt;/span&gt; and in contrast to more general IP litigation events, American Conference Institute's &lt;span style=&quot;font-weight: bold;&quot;&gt;NPE Litigation&lt;/span&gt; conference provides an opportunity for attendees to network with colleagues while engaging in an open discussion with peers who are also being confronted with the same issues. &lt;br&gt;&lt;br&gt;Gain and discuss best practices for successfully defending against this new breed of patent infringement claims and walk away with practical tips and proven strategies for ensuring your client achieves success in its next action involving an NPE. &lt;br&gt;&lt;br&gt;Although we are still in the process of developing the program agenda for this event, ACI is pleased to accept your topic and panel suggestions as well as speaker nominations. Please contact Sunsieray McCall, Industry Manager, at s.mccall@americanconference.com with any content related suggestions or for speaking opportunities.&lt;br&gt;&lt;br&gt;Please continue to check this website for conference announcements, speaker additions and the release of the agenda. Reserve your space now by calling &lt;span style=&quot;font-weight: bold;&quot;&gt;888-224-2480&lt;/span&gt;; faxing your registration form to &lt;span style=&quot;font-weight: bold;&quot;&gt;877-926-1563&lt;/span&gt;; or register online.&lt;br&gt;&lt;br&gt;I look forward to seeing you in June in New York!&lt;br&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;Sunsieray McCall, JD&lt;br&gt;Industry Manager&lt;br&gt;American Conference Institute&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:WordDocument&gt;
  &lt;w:View&gt;Normal&lt;/w:View&gt;
  &lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
  &lt;w:TrackMoves/&gt;
  &lt;w:TrackFormatting/&gt;
  &lt;w:PunctuationKerning/&gt;
  &lt;w:ValidateAgainstSchemas/&gt;
  &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
  &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
  &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
  &lt;w:DoNotPromoteQF/&gt;
  &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
  &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
  &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
  &lt;w:Compatibility&gt;
   &lt;w:BreakWrappedTables/&gt;
   &lt;w:SnapToGridInCell/&gt;
   &lt;w:WrapTextWithPunct/&gt;
   &lt;w:UseAsianBreakRules/&gt;
   &lt;w:DontGrowAutofit/&gt;
   &lt;w:SplitPgBreakAndParaMark/&gt;
   &lt;w:EnableOpenTypeKerning/&gt;
   &lt;w:DontFlipMirrorIndents/&gt;
   &lt;w:OverrideTableStyleHps/&gt;
  &lt;/w:Compatibility&gt;
  &lt;m:mathPr&gt;
   &lt;m:mathFont m:val=&quot;Cambria Math&quot;/&gt;
   &lt;m:brkBin m:val=&quot;before&quot;/&gt;
   &lt;m:brkBinSub m:val=&quot;&amp;#45;-&quot;/&gt;
   &lt;m:smallFrac m:val=&quot;off&quot;/&gt;
   &lt;m:dispDef/&gt;
   &lt;m:lMargin m:val=&quot;0&quot;/&gt;
   &lt;m:rMargin m:val=&quot;0&quot;/&gt;
   &lt;m:defJc m:val=&quot;centerGroup&quot;/&gt;
   &lt;m:wrapIndent m:val=&quot;1440&quot;/&gt;
   &lt;m:intLim m:val=&quot;subSup&quot;/&gt;
   &lt;m:naryLim m:val=&quot;undOvr&quot;/&gt;
  &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif][if gte mso 9]&gt;&lt;xml&gt;
 &lt;w:LatentStyles DefLockedState=&quot;false&quot; DefUnhideWhenUsed=&quot;true&quot;
  DefSemiHidden=&quot;true&quot; DefQFormat=&quot;false&quot; DefPriority=&quot;99&quot;
  LatentStyleCount=&quot;267&quot;&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;0&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Normal&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;heading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;9&quot; QFormat=&quot;true&quot; Name=&quot;heading 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 7&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 8&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; Name=&quot;toc 9&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;35&quot; QFormat=&quot;true&quot; Name=&quot;caption&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;10&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; Name=&quot;Default Paragraph Font&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;11&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtitle&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;22&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Strong&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;20&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;59&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Table Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Placeholder Text&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;1&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;No Spacing&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; UnhideWhenUsed=&quot;false&quot; Name=&quot;Revision&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;34&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;List Paragraph&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;29&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;30&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Quote&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 1&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 2&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 3&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 4&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 5&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;60&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;61&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;62&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Light Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;63&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;64&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Shading 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;65&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;66&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium List 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;67&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 1 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;68&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 2 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;69&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Medium Grid 3 Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;70&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Dark List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;71&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Shading Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;72&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful List Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;73&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; Name=&quot;Colorful Grid Accent 6&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;19&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;21&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Emphasis&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;31&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Subtle Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;32&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Intense Reference&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;33&quot; SemiHidden=&quot;false&quot;
   UnhideWhenUsed=&quot;false&quot; QFormat=&quot;true&quot; Name=&quot;Book Title&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;37&quot; Name=&quot;Bibliography&quot;/&gt;
  &lt;w:LsdException Locked=&quot;false&quot; Priority=&quot;39&quot; QFormat=&quot;true&quot; Name=&quot;TOC Heading&quot;/&gt;
 &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif][if gte mso 10]&gt;
&lt;style&gt;
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:&quot;Table Normal&quot;;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:&quot;&quot;;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	text-align:center;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;
	mso-bidi-font-family:&quot;Times New Roman&quot;;
	mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;

&lt;p class=&quot;MsoFootnoteText&quot; style=&quot;text-align:left&quot; align=&quot;left&quot;&gt;&lt;span class=&quot;MsoFootnoteReference&quot;&gt;&lt;span style=&quot;mso-special-character:footnote&quot;&gt;&lt;span class=&quot;MsoFootnoteReference&quot;&gt;&lt;span style=&quot;font-size:10.0pt;line-height:115%;
font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;mso-fareast-font-family:Calibri;
mso-fareast-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA&quot;&gt;[1]&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
RPX Corporation Homepage Company Overview&lt;br&gt;[1] &quot;Patent Trolls Cost Inventors Half a Trillion Dollars,&quot; CNNMoneyTech, September 21, 2011&lt;br&gt;&lt;/p&gt;

&lt;span class=&quot;MsoFootnoteReference&quot;&gt;&lt;span style=&quot;font-size:12.0pt;mso-bidi-font-size:
11.0pt;line-height:115%;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;mso-fareast-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA&quot;&gt;&lt;span style=&quot;mso-special-character:footnote&quot;&gt;&lt;span class=&quot;MsoFootnoteReference&quot;&gt;&lt;span style=&quot;font-size:12.0pt;mso-bidi-font-size:
11.0pt;line-height:115%;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;mso-fareast-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</description>
<category>Intellectual Property</category>
<category>Litigation</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/729/npe-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">High Tech Patent Litigation</title>
<link>http://www.americanconference.com/2012/730/high-tech-patent-litigation/</link>
<pubDate>Wed 13 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;b&gt;Recent headlines tell the story:&lt;br&gt;&lt;br&gt;&quot;Apple's Bid for Preliminary Injunction Against Samsung Denied&quot;&lt;br&gt;&lt;i&gt;The Recorder, December 2011&lt;/i&gt;&lt;br&gt;&lt;br&gt;&quot;Verizon Must Pay $11 Million Per Month in Sunset Royalties&quot;&lt;br&gt;&lt;i&gt;Law.com, December 2011&lt;/i&gt;&lt;br&gt;&lt;br&gt;&quot;Google, Oracle Battle Over Damages&quot;&lt;br&gt;&lt;i&gt;The American Lawyer, December 2011&lt;/i&gt;&lt;br&gt;&lt;br&gt;&quot;AT&amp;amp;T to Pay $215 Million to Settle?&quot;&lt;br&gt;&lt;i&gt;The Recorder, January 2012&lt;br&gt;&lt;br&gt;&lt;/i&gt;&lt;/b&gt;&lt;hr&gt;&lt;br&gt;In a sector where the law often struggles to keep up with the science, in recent years it seems the poles have reversed. Waging war against each other in jurisdictions across the country, 2011 was witness to some of the most high profile, high stakes patent litigation the high technology industry has seen in recent years. Engulfing computer hardware, software, consumer electronics and telecommunications manufacturers in courts from coast to coast, it seems the &quot;smartphone wars&quot; of 2011 were only the tip of the iceberg with no sight of a decrease in litigation in sight. Grounded in allegations involving IP that goes to the core of the operating systems that makes today's high tech products tick, those want to walk away the victor in the high tech patent litigation wars of today must come to the table armed with your best theories of liability in order to achieve success.&lt;br&gt;&lt;br&gt;&lt;i&gt;Is your litigation arsenal full of strategies that will guarantee your client's success in this new era of high stakes patent litigation? Has your litigation team updated its litigation tactics to keep pace with the fast-moving technological advancements in today's products?&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;div align=&quot;center&quot;&gt;&lt;b&gt;Ensure Your IP Litigation Team is Prepared for What May Lie Ahead&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;Learn how &lt;u&gt;one day out of the offic&lt;/u&gt;e could save your client millions in&lt;b&gt; litigation costs, license fees or costly damages&lt;/b&gt;. Join your colleagues at this exclusive industry event as they share and discuss winning strategies for ensuring that the next time your client is engaged in a patent infringement suit, it is armed with the best strategies for protecting its most valuable product ? &lt;u&gt;&lt;b&gt;the patents at stake in the case&lt;/b&gt;&lt;/u&gt;.&lt;br&gt;&lt;br&gt;Seats at this event are expected to go quickly given the great interest in this topic. Reserve a space now for a member of your IP and litigation departments by calling &lt;b&gt;1-888-224-2480&lt;/b&gt;; faxing your registration to &lt;b&gt;1-877-927-1563&lt;/b&gt; or registering online.&lt;br&gt;&lt;br&gt;Although we are still in the process of developing the program agenda for this event, ACI is pleased to accept your topic and panel suggestions as well as speaker nominations. Please contact Sunsieray McCall, Industry Manager, at &lt;a href=&quot;s.mccall@americanconference.com&quot;&gt;s.mccall@americanconference.com&lt;/a&gt; with any content related suggestions or for speaking opportunities.&lt;br&gt;&lt;br&gt;Please continue to check this website for conference announcements, speaker additions and the release of the agenda. Reserve your space now by calling &lt;b&gt;888-224-2480&lt;/b&gt;; faxing your registration form to &lt;b&gt;877-926-1563&lt;/b&gt;; or register online.&lt;br&gt;&lt;br&gt;I look forward to seeing you in June in New York!&lt;br&gt;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;b&gt;Sunsieray McCall, JD&lt;br&gt;Industry Manager&lt;br&gt;American Conference Institute&lt;/b&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Litigation</category>
<category>Intellectual Property</category>
<category>Telecoms &amp; Technology</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/730/high-tech-patent-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Import Compliance and Enforcement</title>
<link>http://www.americanconference.com/2012/728/import-compliance-and-enforcement/</link>
<pubDate>Wed 20 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Washington | Each year, import compliance professionals, international trade attorneys and senior government officials attend &lt;b&gt;American Conference Institute's Advanced Forum on Import Compliance and Enforcement&lt;/b&gt; for the most up-to-date and comprehensive information on enforcement initiatives, evolving customs requirements, supply chain security and increasing standards for internal controls. &lt;br&gt;&lt;br&gt;Now in its 7th successful year, this highly anticipated event will provide you with practical insights on the latest customs and import compliance developments. Amid increased CBP scrutiny and rigorous audits, this program will allow you to &lt;b&gt;benchmark your import compliance practices against leading companies, and ask your questions directly to senior government officials.&lt;/b&gt;&lt;br&gt;&lt;br&gt;Attend this unique industry event and gain specific insights into how to tackle your most complex customs compliance challenges. &lt;b&gt;The 2012 program will be fully updated, and will include a new speaker line-up and session topics.&lt;br&gt;&lt;/b&gt;&lt;br&gt;&lt;u&gt;&lt;b&gt;New sessions will include: &lt;/b&gt;&lt;/u&gt;&lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Hear from CBP on &lt;b&gt;Single Window Developments&lt;/b&gt;:&amp;nbsp; Status of mutual recognition between C-TPAT and AEO, and the potential for reduced inspections&lt;/li&gt;&lt;li&gt;&lt;b&gt;Vetting and managing brokers, suppliers and other third parties&lt;/b&gt;:&amp;nbsp; How to validate third&amp;nbsp; party data, detect warning signs and work together to maintain global compliance&lt;/li&gt;&lt;li&gt;Resolving complex &lt;b&gt;valuation &lt;/b&gt;and &lt;b&gt;transfer pricing issues amid varying IRS and CBP positions&lt;/b&gt;: Post-Importation price adjustments, related party transactions and other hot issues&lt;/li&gt;&lt;li&gt;The &lt;b&gt;largest penalties of the year&lt;/b&gt; and lessons learned&lt;/li&gt;&lt;li&gt;The rise in &lt;b&gt;IPR Enforcement&lt;/b&gt;: Reducing &lt;b&gt;counterfeiting &lt;/b&gt;risks, importing trademark protected and &lt;b&gt;grey market &lt;/b&gt;goods, and what triggers detention and seizures&lt;/li&gt;&lt;li&gt;&lt;b&gt;CBP Audit Plans and Priorities&lt;/b&gt;: How CBP is selecting and notifying importers- and what to expect going forward&lt;/li&gt;&lt;li&gt;The latest on CBP's &lt;b&gt;Centers of Excellence&lt;/b&gt; and&lt;b&gt; Simplified Entry System&lt;/b&gt;&lt;/li&gt;&lt;li&gt;Determining when and how to join the &lt;b&gt;ISA program&lt;/b&gt;: Satisfying strict CBP standards for internal controls&lt;/li&gt;&lt;li&gt;&lt;b&gt;Prior Disclosures&lt;/b&gt;: Maximizing payment reductions with &lt;b&gt;offsetting&lt;/b&gt;, securing senior management buy-in and limiting exposure&lt;/li&gt;&lt;li&gt;Managing the nationwide Impact of &lt;b&gt;The California Transparency in Supply Chains Act&lt;/b&gt;&lt;/li&gt;&lt;li&gt;Passing Rigorous &lt;b&gt;FTA Audits&lt;/b&gt;: The most costly&lt;b&gt; origin determination&lt;/b&gt; and other compliance missteps that can trigger a failing grade&lt;/li&gt;&lt;li&gt;Importing &lt;b&gt;FDA-Regulated Goods&lt;/b&gt;:&amp;nbsp; Satisfying new safety requirements and agency compliance expectations&lt;/li&gt;&lt;li&gt;The transition to &lt;b&gt;ACE &lt;/b&gt;and what it means for importers: How CBP is rolling out new functionalities and managing the process&lt;/li&gt;&lt;li&gt;Applying massive &lt;b&gt;HTS classification changes&lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;What to do if your goods are detained or seized at the border&lt;/b&gt;: Working with CBP to obtain the release of your merchandise &lt;br&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>International Trade</category>
<category>Regulatory &amp; Compliance</category>
<category>Ethics Credits</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/728/import-compliance-and-enforcement/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Litigating &amp; Resolving Advertising Disputes</title>
<link>http://www.americanconference.com/2012/718/litigating--resolving-advertising-disputes/</link>
<pubDate>Thu 21 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">New York | &lt;P&gt;&lt;STRONG&gt;LEARN THE MOST EFFECTIVE STRATEGIES FOR DEFENDING YOUR CLAIMS AND CHALLENGING MISLEADING STATEMENTS BY COMPETITORS&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;As companies respond to economic pressures by being more aggressive with their advertising, it has become vital for their counsel to be prepared for battle. We are now in a new, more litigious environment, as evidenced by the number of cases being brought before the National Advertising Division (NAD), in the federal courts under the Lanham Act, and by the stepped-up regulatory scrutiny at the FTC. In response, industry counsel must be prepared both to bring, and to defend against, complaints and legal actions relating to the making of false or misleading advertising claims. It is necessary to become equipped to expertly weigh the different available options and forums when a dispute arises, and be prepared to develop an effective strategy for protecting a client's brand and high-stakes marketing campaigns.&lt;/P&gt;
&lt;P&gt;Counsel for brand companies must now focus on revising internal practices to &lt;STRONG&gt;meet the new standards&lt;/STRONG&gt; that have been set by regulators, and be prepared to both &lt;STRONG&gt;bring and defend challenges&lt;/STRONG&gt; to competitive claims. &lt;STRONG&gt;American Conference Institute&lt;/STRONG&gt; has specifically designed its &lt;STRONG&gt;3rd Annual Litigating and Resolving Advertising Disputes &lt;/STRONG&gt;conference to be an intensive and comprehensive guide for staying one step ahead of the latest legal exposures and risks, as well as providing effective tactics for success in the different forums where advertising claims are examined and resolved. In the current more litigious environment, it is vital to be prepared to advocate your case before the National Advertising Division (NAD), in the federal courts under the Lanham Act, and to respond effectively to regulatory scrutiny by the FTC. &lt;/P&gt;
&lt;P&gt;In addition, &lt;STRONG&gt;leading jurists&lt;/STRONG&gt; will give you a rare insider look at the evidence and arguments that can turn cases one way or the other in Federal Lanham Act proceeding. Special attention will be paid to how the courts view regulatory activities including FTC actions and NAD determinations.&lt;/P&gt;
&lt;P&gt;Full conference details are on the way shortly.&amp;nbsp; If you are interested in speaking at this event, contact Stacey Evans at &lt;A href=&quot;mailto:s.evans@americanconference.com&quot;&gt;s.evans@americanconference.com&lt;/A&gt;.&amp;nbsp; For information on sponsoring or exhibiting at this event, contact Brianne Dillon at &lt;A href=&quot;mailto:b.dillon@americanconference.com&quot;&gt;b.dillon@americanconference.com&lt;/A&gt;.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;This industry-leading event will provide you with the strategies, tactics, and insights that are critical to protecting your client's brand. Don't delay ? register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563, or registering &lt;A onclick=&quot;newWindow('https://transactions.c5groupinc.com/event_reg.php?conf=3056&amp;amp;site=2&amp;amp;lang=en&amp;amp;gap=2','reg_now','600','720',''); pageTracker._link(this.href); return false;&quot; href=&quot;javascript:void(null);&quot;&gt;online &lt;/A&gt;&lt;/P&gt;</description>
<category>Advertising &amp; Marketing</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/718/litigating--resolving-advertising-disputes/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Food Safety Regulatory Compliance</title>
<link>http://www.americanconference.com/2012/717/food-safety-regulatory-compliance/</link>
<pubDate>Tue 26 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | By the date of this conference the &lt;strong&gt;Food Safety Modernization Act &lt;/strong&gt;will   have been in effect for almost 1½ years. To date, the FDA has already   been very proactive in releasing guidance and implementing regulations   under several sections of the Act addressing &lt;strong&gt;new dietary ingredients&lt;/strong&gt; for the dietary supplement industry, &lt;strong&gt;administrative detention of food, food imports &lt;/strong&gt;and &lt;strong&gt;facility registration &lt;/strong&gt;suspension, with more action mandated by way of implementation over the coming months. &lt;br&gt;
&lt;br&gt;
Attendees of &lt;strong&gt;ACI&lt;/strong&gt;'s 3rd Advanced Summit on &lt;strong&gt;Food Safety Regulatory Compliance &lt;/strong&gt;will be   provided with an in-depth overview and examination of actions taken by   each of FDA's six FSMA &quot;implementation teams,&quot; as well as   with insights and practical advice from &lt;strong&gt;in-house counsel, food safety executives and expert regulatory attorneys&lt;/strong&gt; on how proposed and implemented changes under the FSMA will impact your company's day-to-day operations as well as your &lt;strong&gt;food safety, regulatory&lt;/strong&gt; and &lt;strong&gt;compliance programs.&lt;br&gt;
&lt;/strong&gt;&lt;br&gt;
With so many changes afoot, now is the time for&lt;strong&gt; food manufacturers, retailers, distributors, suppliers, servers &lt;/strong&gt;and &lt;strong&gt;restaurants&lt;/strong&gt; to benchmark with colleagues regarding how industry food safety and   compliance policies can and should be updated in order to remain   compliant with the law.&lt;br&gt;
&lt;br&gt;
Also, gain updates on how to confront the   &quot;evergreen&quot; food safety, compliance and regulatory challenges faced by   food manufacturers, as the following topics are addressed:&lt;br&gt;
&lt;br&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Recall execution&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Inspections, both foreign and domestic&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Food tracking and tracing&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Distribution and supply chain liability&lt;/strong&gt;&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;How to respond to government inquiries&lt;/strong&gt;&lt;br&gt;
  &lt;/li&gt;
&lt;/ul&gt;
&lt;br&gt;
Although we are still in the process of developing this year's agenda in response to updates to the law under the&lt;strong&gt; Food Safety Modernization Act&lt;/strong&gt;,   in our continuous effort to improve the quality of our programs and   offer you the best value, ACI is pleased to accept your topic and panel   suggestions as well as speaker nominations for the 2012 program. Please   contact Sunsieray McCall, Industry Manager, Food, Beverage and Consumer   Products at &lt;a href=&quot;s.mccall@americanconference.com&quot;&gt;s.mccall@americanconference.com&lt;/a&gt; with any content related suggestions or for speaking opportunities.&lt;br&gt;
&lt;br&gt;
For more information on sponsorship opportunities, please contact Brianne Dillon, Business Development Executive at &lt;a href=&quot;b.dillon@americanconference.com&quot;&gt;b.dillon@americanconference.com&lt;/a&gt;.&lt;br&gt;
&lt;br&gt;
For   more information on media and association partnerships please contact   Sunsieray McCall, Industry Manager, Food, Beverage and Consumer Products   at &lt;a href=&quot;s.mccall@americanconference.com&quot;&gt;s.mccall@americanconference.com&lt;/a&gt; or John Stoops, Partnership Executive at &lt;a href=&quot;j.stoops@americanconferemce.com&quot;&gt;j.stoops@americanconferemce.com&lt;/a&gt;
&lt;br&gt;
Please   continue to check this website for conference announcements, speaker   additions and the release of the agenda. Reserve your space now by   calling &lt;strong&gt;888-224-2480&lt;/strong&gt;; faxing your registration form to &lt;strong&gt;877-926-1563&lt;/strong&gt;; or you can register online.&lt;br&gt;
&lt;br&gt;
</description>
<category>Regulatory &amp; Compliance</category>
<category>Healthcare</category>
<category>Environmental</category>
<category>Food and Beverage</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/717/food-safety-regulatory-compliance/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Russian Ports</title>
<link>http://www.americanconference.com/2012/626/russian-ports/</link>
<pubDate>Tue 26 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Saint Petersburg | &lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;????????????? ? ????????????? ????????????? ???????? ? ?????????? ?????? ? ??? ????????&amp;nbsp; ? ???????????? ???? ???????? ?? ???????? ? ?????????????? ????????????????? ?????????? ???????? ?????????. ?? ?????? ????????? ??, ??????????? ??????? ?????? ?????? ? 2016 ???? ???????? ?? 46% ?? ????????? ? 2010?. ? ????????? 770 ???. ?. ??????, ???????? ????????? ?????????, ?????????? ??????????? ??????? ?????? ?? ? 2016?. ???????? ???? 15% ???????. ? ????? ? ????, ????? ???????????? ? ??????????? ????? ????? ?????? ????????????????? ???????? ???? ????????????? ?????????????? ?????? ? ?????????? ?????????? ??????????? ???????-????????????? ?????????. &lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;br&gt;&lt;i style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;«..?? 2015?. ? ???????? ??????? ?????? ?????? ????? ????????????? 430 ???? ???., ?? ??????? 300 ???? ???. ???????? ???????????? ????????», ????? ???????, ???????, ???????????? ?????????? ??????&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;? ???????????? ??????????? ???? ??????? ??????? ???????? ??????????? ?????????, ?? ????? ?? ?????????? ???????????? ?????????????? ????? ? ?????? ?????????????? ????? ????? ???????? ?????????? ?????? ????? ?????? ?????????? ?&amp;nbsp; ?????????????? ????? ??????? ????????.&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;br&gt;&lt;b style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;5-?? ????????????? ????? &quot;????? ?????? ? ???&quot;&lt;/b&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt; ??????? ?????????????? ?????????????, ???????? ??????????, ??????????? ? ???????????? ????????, ??????????????? ? ?????????????????, ????????????? ? ?????????? ?????????? ? ??????????? ? ????? ?????????? ??????????? ????? ? ???????, ??????? ????? ????????:&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;ul style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;&lt;li&gt;??? ???????????? ?&amp;nbsp; ???????? ????? ??????? ????????, ??????? ??????????? ?? ????&lt;/li&gt;&lt;li&gt;??? ?????????? ??????????? ???????? ?????? ? ??????????? ??????????&lt;/li&gt;&lt;li&gt;??? ???????? ????????????? ????????????? ????????? ????????&amp;nbsp; ??????: ???????? ?????????????? ? ????????? ????????????? ???&lt;/li&gt;&lt;li&gt;????? ??????????? ???????? ? ????????? ????? ?????? ?? ???????? &lt;/li&gt;&lt;li&gt;??? ???????????? ??????????? ?????????????? ?????????????? ??????????????? ??????? ? ?????????? ??? &lt;/li&gt;&lt;/ul&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;????????? ?????? ????????? ? ??????????. ???? ?? ??????? ??????? ??????? ? ?????? ??????, ?????? ?????????? ?? ??????????????? ?????????:&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;br&gt;&lt;u style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;?? ???????? ???????????:&lt;/u&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;?????? ?????????&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;???.: +44 (0)20 7878 6878&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;a href=&quot;a.kud@c5-online.com&quot; style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;a.kud@c5-online.com&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;u style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;?? ???????? ?????????? ? ??????????????? ??????????????:&lt;/u&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;????? ??????????&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;???.: +44 (0) 20 7878 6917&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;a href=&quot;o.ponomareva@c5-online.com&quot; style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;o.ponomareva@c5-online.com&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;u style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;?? ???????? ???????? ???????:&lt;/u&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;?????? ????????&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;???.: +44 (0) 20 7878 6941&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;a href=&quot;S.Kostenko@c5-online.com&quot; style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;S.Kostenko@c5-online.com&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;?? ???? ??????? ? ???? ? ?????-?????????? ? ????!&lt;/span&gt;&lt;/font&gt;&lt;br&gt;&lt;br&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;The liberalization of international trade regulation and the accession of Russia into the WTO are designed to increase cargo turnover of Russian ports and significantly influence development of the entire port industry.&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;According to the Ministry of Transport, cargo turnover in Russian seaports is expected to grow by 46% by 2016 compared to 2010 and will total &amp;nbsp;770 million tons. &amp;nbsp;However, according to estimations, the capacity of Russian seaports by 2016 will amount to only 15% of the total reserve. &amp;nbsp;As a result, market participants face the problem of balancing the development of the entire logistics infrastructure in order to increase the turnover capacity of the transport sector.&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;text-align: right;&quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;i&gt;&quot;RUB 430 bn. will be invested in the development of the port industry by 2015, RUB 300 bn. of which will come from non-budgetary funds&quot; , Igor Levitin, Minister, Ministry of Transport of Russia&lt;/i&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Growth of world trade is almost inevitable in the long term, but is Russia's transport infrastructure ready for a new economic boom? &amp;nbsp;The Russian ports industry is facing the challenge of preparing for post-crisis growth in trade volumes but preparation should be taking place now.&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;C5's 5th International Forum &lt;b&gt;&quot;Russian Ports&quot;&lt;/b&gt; will bring together senior Government officials, port operators, stevedoring and container companies, cargo owners and cargo consignors, as well as global and Russian investors and financiers, to discuss the critical concerns facing the sector, including:&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;How to prepare for future growth in trade where goods are transported by sea&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;How to ensure the integrated development of ports infrastructure with the surrounding areas&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;How to increase the efficiency of the land use in the ports industry: creation of industrial and free economic zones&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;How to ensure effective communication of information between state bodies and international trade companies&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;/span&gt;&lt;/font&gt;</description>
<category>Transportation</category>
<category>Russia and CIS</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/626/russian-ports/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Anti-Corruption London</title>
<link>http://www.americanconference.com/2012/683/anti-corruption-london/</link>
<pubDate>Tue 26 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">London | &lt;div style=&quot;text-align: center;&quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Upgrading your Compliance Programme, Detection Strategies and Internal Controls in the New Era of Heightened Enforcement&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;text-align: center;&quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Fully Updated Agenda&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Every June, chief compliance officers, general counsel, forensic accountants from global companies and their advisors attend C5's Forum on Anti-Corruption in London.&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Reserve your seat today for what is regarded as THE must-attend event in Europe that shapes the anti-corruption community.&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;br&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Key topics include:&lt;/span&gt;&lt;div&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Minimising risks when interacting with government officials ? Case studies in real-world problems and practiced solutions&lt;/span&gt;&lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Being prepared for potential private rights of actions arising from corruption-related misconduct&lt;/span&gt;&lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Avoiding debarment for potential violations of the FCPA and UKBA&lt;/span&gt;&lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Leveraging internal controls to detect corrupt payments and track sensitive expenses&lt;/span&gt;&lt;br&gt;&lt;br&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Latest developments in the implementation and enforcement of the UK Bribery Act: A year in review, including the potential use of Deferred Prosecution Agreements (DPAs) with the introduction of the UK Bribery Act&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;text-align: center;&quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Your First Chance to Hear from the New Director of the&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;text-align: center;&quot;&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;b&gt;Serious Fraud Office, David Green&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;&lt;br&gt;&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;font face=&quot;tahoma, arial, helvetica, sans-serif&quot;&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Speakers already confirmed include:&lt;/span&gt;&lt;/font&gt;&lt;/div&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;Fabio De Pasquale, Public Prosecutor, Court of Justice of Milano&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Jean-Bernard Schmid, State Prosecutor, Republic and Canton of Geneva&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Jose Villodre Lopez, Judge ? Chief Magistrate, The Court of First Instance, Barcelona&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Knut Mager, Head Group Legal Country Organisations, Novartis International AG&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;John Freeman, Vice President &amp;amp; General Counsel, Technip USA, Inc.&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Edwardo Lazzarini, EMEA Compliance Officer, Biomet&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Nicola Bonucci, Director Legal Department, OECD&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Pascale Dubois, Sanctions Evaluation and Suspension Officer, The World Bank&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px; font-family: tahoma, arial, helvetica, sans-serif; &quot;&gt;Hassan Hassan, Associate General Counsel, Mars Corporation UAE&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div&gt;&lt;span style=&quot;font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;________________________________________&lt;/span&gt;&lt;/div&gt;
&lt;p style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;In our continuous effort to improve the quality of our programmes and offer you more value, we are pleased to provide you with the opportunity to submit suggestions and nominate speakers for this year's programme. Please contact Yvette Lingom, Division manager ? legal, at &lt;a href=&quot;mailto:y.lingom@c5-online.com&quot;&gt;y.lingom@c5-online.com&lt;/a&gt; or at 020 7878 6923. &lt;/p&gt;
&lt;p style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;If you are interested in learning more about sponsorship for this event, please contact Jo Menzer, Business Development manager at &lt;a href=&quot;j.menzer@c5-online.com&quot;&gt;j.menzer@c5-online.com&lt;/a&gt; or at 020 7878 6978.&lt;/p&gt;
&lt;p style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;For more information on media partnerships please contact Olga Ponomareva, Marketing Manager at &lt;a href=&quot;mailto:o.ponomareva@c5-online.com&quot;&gt;o.ponomareva@c5-online.com&lt;/a&gt; at 020 7878 6917. &lt;/p&gt;
&lt;p style=&quot;color: rgb(0, 0, 0); font-family: tahoma, arial, helvetica, sans-serif; font-size: 12px; &quot;&gt;&lt;br&gt;&lt;/p&gt;</description>
<category>Anti-Corruption / FCPA</category>
<category>Regulatory &amp; Compliance</category>
<category>Legal</category>
<category>Regulatory Compliance and Trade</category>
<category>Anti-Corruption &amp; Fraud</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/683/anti-corruption-london/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Automotive Product Liability Litigation</title>
<link>http://www.americanconference.com/2012/712/automotive-product-liability-litigation/</link>
<pubDate>Tue 26 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Chicago | &lt;div align=&quot;center&quot;&gt;&lt;strong&gt;&lt;/strong&gt;&lt;i&gt;Drawn from the best that the bar, the bench, and the industry have to offer.&lt;/i&gt;&lt;br&gt;&lt;b&gt;A new paradigm in automotive products liability has emerged.&lt;/b&gt;&lt;br&gt;&lt;b&gt;Be a part of the one event that will prepare the industry for this metamorphosis. &lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;p align=&quot;left&quot;&gt;&lt;i&gt;Supreme Court's newest decisions on preemption and personal jurisdiction?.seat belt restraints?.side curtain air bags?.tire claims?.unintended acceleration?..electronic reporting system?.legislation addressing distraction issues...Daubert challenges?class action claims?.&lt;/i&gt;&lt;b&gt;The list goes on and on.&lt;/b&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;Corporate attorneys and outside counsel for auto manufacturers and component part suppliers must find ways to reduce the cost of litigation while simultaneously dealing with the challenges of product recalls, class action claims, the increased cost in litigation product liability cases, and the rise in social media postings.&lt;/p&gt;&lt;div align=&quot;left&quot;&gt;In response, American Conference Institute is proud to introduce its 5th installment of the &lt;i&gt;essential defense summit that shapes the future of products liability strategies for leading litigators and in-house counsel in the automotive industry&lt;/i&gt;: &lt;b&gt;Defending and Managing AUTOMOTIVE PRODUCT LIABILITY LITGATION&lt;/b&gt;. Through a faculty of distinguished in-house counsel from &lt;b&gt;Isuzu, Kia, U-Haul, Toyota, Bridgestone, TK Holdings (Takata), Nissan, Bombardier, Hyundai, Chrysler, Delphi Automotive&lt;/b&gt; and many others, leading outside defense counsel, as well renowned federal and state jurists, this conference will provide even the most seasoned automotive lawyers with clarity and certainty with respect &lt;b&gt;to today's key issues crucial to mounting a rigorous and complete defense&lt;/b&gt;. &lt;br&gt;&lt;/div&gt;&lt;p align=&quot;center&quot;&gt;&lt;i&gt;&lt;b&gt;&lt;br&gt;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;p align=&quot;center&quot;&gt;&lt;i&gt;&lt;b&gt;BE A PART OF THIS ESSENTIAL DEFENSE SUMMIT THAT SHAPES THE FUTURE OF PRODUCTS LIABILITY STRATEGIES IN THE YEAR AHEAD FOR LEADING LITIGATORS AND IN-HOUSE COUNSEL &lt;br&gt;IN THE AUTOMOTIVE INDUSTRY&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;p align=&quot;center&quot;&gt;&lt;br&gt;&lt;/p&gt;&lt;div align=&quot;left&quot;&gt;&lt;b&gt;PLUS, BE SURE TO REGISTER FOR THE PRE-CONFERENCE MASTER CLASS ON JUNE 25 and 26&lt;/b&gt;:&lt;br&gt;&lt;br&gt;A.&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;&amp;nbsp;Going on the Attack When Defending Against Class Actions in the Automotive Context, June 25, 3:00 ? 6:00 pm&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;p align=&quot;center&quot;&gt;B.&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;b&gt;In-House Perspectives on Selection and Evaluation of Outside Counsel: June 26, 7:30 ? 9:30 am&lt;br&gt;&lt;/b&gt;&lt;/p&gt;&lt;p align=&quot;center&quot;&gt;&lt;br&gt;&lt;/p&gt;&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;Register before February 29 to lock in the way in advance $1895 rate&lt;/strong&gt;. &lt;/p&gt;&lt;p align=&quot;center&quot;&gt;Register now by calling &lt;b&gt;888-224-2480&lt;/b&gt;, faxing your registration form to &lt;b&gt;877-927-1563&lt;/b&gt; or registering online at &lt;a href=&quot;http://www.AmericanConference.com/Automotive&quot;&gt;www.AmericanConference.com/Automotive&lt;br&gt;&lt;br&gt;&lt;/a&gt;&lt;/p&gt;


</description>
<category>Ethics Credits</category>
<category>Transportation</category>
<category>Litigation</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/712/automotive-product-liability-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Aviation Litigation</title>
<link>http://www.americanconference.com/2012/711/aviation-litigation/</link>
<pubDate>Tue 26 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Boston | The aviation industry is at a crossroads, facing unique challenges including large scale products liability claims arising from malfunctions and crashes in and out of the United States, increasing tarmac delay and TSA security check claims alleging violations of passenger rights and privacy, and the potential for criminal liability arising out of airline operations and non-compliance.&amp;nbsp; These challenges, coupled with the FAA and NTSB cracking down on connecting carrier liability and other safety matters and a creative and motivated plaintiffs' bar make it critical that &lt;i&gt;outside counsel remain prepared to deal with constantly evolving regulations, case law and new theories of liability and ensure the best defense strategies in order to succeed pre-trial and at trial.&lt;/i&gt;&amp;nbsp; &lt;br&gt;&lt;br&gt;&lt;b&gt;Now in its fourth year,&lt;/b&gt; ACI's conference on Defending and Managing AVIATION LITIGATION is designed to offer even the most seasoned aviation attorneys valuable insights on solving these challenges and provide unparalleled networking opportunities with the likes of: &lt;i&gt;&lt;b&gt;Jet Blue Airways, Bell Helicopter Textron, XL Insurance Company, British Airways, Trans States Holding, United Air Lines, Allianz Global Corporate &amp;amp; Specialty, United States Aviation Underwriters, Garmin International, Air Canada, Honeywell Aerospace, Airbus, Dassault Falcon Jet ?and many others.&amp;nbsp; &lt;/b&gt;&lt;/i&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;This is the only event in the industry that brings together federal judges, regulatory and enforcement officials, leading outside litigators and key in-house counsel and claims officers.&lt;/b&gt; By attending you will: &lt;br&gt;&lt;br&gt;&lt;ul&gt;&lt;li&gt;Gain valuable business development strategies from&lt;b&gt; dozens of&amp;nbsp; in-house counsel and claims officers&lt;/b&gt; who will provide insight into case evaluation, managing the costs of litigation and working with outside counsel&lt;/li&gt;&lt;li&gt;Improve your litigation strategy by &lt;b&gt;hearing directly from 6 federal judges&lt;/b&gt; on how they interpret evidence and arguments specifically in the aviation context &lt;/li&gt;&lt;li&gt;Get the latest updates on aviation investigation and enforcement trends from &lt;b&gt;NTSB and FAA&lt;/b&gt; officials &lt;/li&gt;&lt;li&gt;Understand &lt;b&gt;the plaintiffs' perspective&lt;/b&gt; regarding which claims are most attractive, emerging theories of liability and a plaintiff's approach to managing aviation claims &lt;/li&gt;&lt;/ul&gt;&lt;div align=&quot;center&quot;&gt;&lt;hr&gt;&lt;b&gt;Plus, complete your 2-day experience by also signing up for the Pre and Post-Conference Master Classes:&lt;/b&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;b&gt;A- Business Development Master Class: &lt;/b&gt;In-House Perspectives on Selection and Evaluation of Outside Counsel&lt;br&gt;&lt;br&gt;&lt;b&gt;B-&amp;nbsp; Working Within the Triangle:&lt;/b&gt; Expert Strategies on How Defense Counsel, Insurers and Companies Can Work Together to Successfully Resolve Claims and Litigation&lt;br&gt;&lt;br&gt;Register now by calling &lt;span style=&quot;font-weight: bold;&quot;&gt;888-224-2480&lt;/span&gt; or faxing your registration form to &lt;span style=&quot;font-weight: bold;&quot;&gt;877-927-1563.&lt;/span&gt;&amp;nbsp; You can also register online at &lt;a href=&quot;www.AmericanConference.com/Aviation&quot;&gt;www.AmericanConference.com/Aviation&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;</description>
<category>Transportation</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/711/aviation-litigation/</guid>
</item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text">Obstetric Malpractice</title>
<link>http://www.americanconference.com/2012/721/obstetric-malpractice/</link>
<pubDate>Wed 27 Jun 2012</pubDate><author>American Conference Institute</author>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html">Philadelphia | &lt;p align=&quot;center&quot;&gt;&lt;a name=&quot;_GoBack&quot;&gt;&lt;strong&gt;American  Conference Institute's 11th Annual Advanced Forum on Preventing, Managing and  Defending Against Claims of&lt;/strong&gt;&lt;/a&gt;&lt;br&gt;
    &lt;strong&gt;Obstetric Malpractice&lt;/strong&gt;&lt;br&gt;
  June 27-28, 2012&lt;br&gt;
  Philadelphia,  PA&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&quot;Wonderful program ? really explains the medicine,  which lawyers &lt;u&gt;need&lt;/u&gt;!&quot; ? Jacqueline Stein, NYC Health &amp;amp; Hospitals&lt;br&gt;
  &quot;A great balance of Medicine and the Law&quot; ? David R.  Lucchese, Galloway, Lucchese, Everson &amp;amp; Picchi, P.C.&lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;The nation's premier  obstetric malpractice conference returns for its 11th year to keep  you abreast of evolving standards of care, emerging theories of liability, and  new defense strategies. Research is underway to formulate the agenda for this&lt;strong&gt; &lt;/strong&gt;the program that brings together an unparalleled faculty of medical and  claims professionals, as well as leading plaintiffs' and defense attorneys, to  provide you with the most up-to-date information on complex medical issues and  help you avoid potential liability. &lt;strong&gt;&lt;/strong&gt;&lt;br&gt;
    &lt;strong&gt;&lt;br&gt;
&lt;/strong&gt;&lt;strong&gt;Register before February 29 to lock in the way in advance $1895 rate&lt;/strong&gt;. &lt;/p&gt;
&lt;p align=&quot;center&quot;&gt;&lt;br&gt;
    &lt;strong&gt;888-224-2480, &lt;/strong&gt;faxing your  registration form to &lt;strong&gt;877-927-1563 &lt;/strong&gt;or registering at &lt;a href=&quot;http://www.AmericanConference.com/ObMal&quot;&gt;www.AmericanConference.com/ObMal&lt;/a&gt;&lt;u&gt; &lt;/u&gt;&lt;/p&gt;

</description>
<category>Litigation</category>
<category>Healthcare</category>
<guid isPermaLink="true">http://www.americanconference.com/2012/721/obstetric-malpractice/</guid>
</item>


</channel>

</rss>
